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Summary 
In the field of bio-organic research, steroids have been one of the most 
attractive areas for exploration due to the biological activities associated with such 
molecules. Organic chemists have reported a number of modifications in natural 
steroids resulting in the promotion or loss of their biological activities. This still 
continues to be a fascinating field worldwide. Previous work fi-om our laboratories 
described the preparation and study of a number of unknown steroidal derivatives in 
the cholestane series. These included azasteroids, oxasteroids, pyrazoles, pyrans etc. 
In continuation of the above work an attempt has been made to prepare new 
compounds with probable biological properties. In some cases, abnormal products 
have been obtained and this has offered scope for some mechanistic and 
stereochemical studies also. The resuhs are summarized as below. 
Chapter-3 
Thermally Induced One Step Synthesis Of Intermolecular 
Azacyclic Steroidal Derivatives: 
Azacyclic subunit has proved to be useful reactive intermediate in many 
organic synthetic strategies directed towards the synthesis of important natural 
products. Bicyclic and tricyclic derivatives have also been used as synthetic tool in 
organic chemistry especially in cycloaddition reaction. 
Initially the double Mannich reaction of ketone with methylamine was 
reported by Scheiber and Hemes in their synthesis of diamine which poses chiral 
architecture similar to sparteine which is a naturally occurring alkaloid extracted fi-om 
plants such as Scotch Broom. 
The simplicity of this strategy has obvious advantages for accessing unusual 
methyl amine, and in the past few decades, a great deal of effort has been devoted 
towards developing asymmetric variants of the double Mannich reaction. 
Although some double Mannich reactions have been reported in recent years. 
The reports on the first asymmetric intermolecular as well as intramolecular reactions 
having external chiral induction have therefore attracted considerable interest. 
The formation of carbon-carbon muhiple bonds rank among the most efficient 
methods for the new carbon-carbon bonds. We moved on to examine more useful 
electrophile trapping reactions that would allow the creation of new carbon-carbon 
(0 
Summary 
and carbon heteroatom bonds which are moderately more successful. We have 
synthesized azacyclic 47, 49, 51 and 53 of cholest-5-en-3-one and cholest-5-en-7-one 
and its analogue the mimic's of sparteine sufficiently. There have been no reports in 
the literature on the preparation of such azacyclic derivatives of cholesterol. Here we 
report the synthesis of some steroidal compounds with azacyclic moiety namely [2,4-
c.dJ-A'-methylpiperidinocholest-S-en-S-one 47, [6,8-c,d]-A'-methylpiperidinocholest-
4-ene-7-one 49, [6,8-c,d]-A'-methylpiperidino-3^-chlorocholest-4-ene-7-one 51 and 
[6,8-c,d]-A^-methylpiperidino-3>5-acetoxycholest-4-ene-7-one 53 from easily 
accessible steroidal ketones 46, 48, 50 and 52. 
In this part we have described the preparation of azacyclic cholesterol 
derivatives using the troublesome double Mannich reaction. Moreover we have been 
able to ache the first intermolecular synthesis of cholesterol derivatives. 
46 
(CH20)n. 
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(ii) 
Summary 
CIjaptet-3S3 
Synthesis and Characterization of Steroidal Derivatives having 
Thiazolidinone Rings: 
For a long time imines have been used successfully in the synthesis of 
nitrogen containing heterocycles. As part of ongoing project aimed at the synthesis of 
bioactive 4-thiazoIidinone, we employed the SchifF bases 93, 98, 103, and 108 
towards their synthesis. Furthermore, most of the 4-thiazolidinones and their 
benzylidene derivatives display a large variety of activities such as antibiotic, diuretic, 
organoleptic, tuberculostatic and antiparasitical. 
HC=N-CH2CH2-N ''kyO 
6 93 N-CH2CH2--N=CH-/~~^ R 
98 H 
103 CI 
108 OAc 
The pharmacological properties of 4-thiazolidinones encouraged our interest 
in synthesizing several new compounds featuring various heterocyclic rings, attached 
to 4-thiazolidinone moieties. As a part of our aim to search for biologically active 
heterocycles containing sulfur and nitrogen, we have undertaken the synthesis of 
some steroidal 1,3,4-thiazolidinones, eg. cholest-5-en-(J/?)-^/ro-3,3"-aminoethyl-
r,3',4'-thiazolidinone 92, cholest-5-en-(3i?>J5p/ro-3,3'-[2"-(2'"-phenyl-r",3'",4"'-
thiazolidinon-3"'-yl)ethyl]-l',3',4'-thiazolidinone 94, 5a-cholestan-(6i?)-5p/>o-6,3'-
aminoethyl-1 ',3',4'-thiazolidinone 97, 5a-cholestan-(6i?)-^/ro-6,3'-[2"-(2"'-phenyl-
1 "',3'",4"'-thiazolidinon-3"'-yl)]ethyI-1•,3',4'-thiazolidinone 99, 3^-chloro-5a-cholestan-
(6R)-spJro-6,y-ammoethy\-1 •,3',4'-thiazolidinone 102, 3y?-chloro-5a-cholestan-(67?)-
J5p;>o-6,3'-[2"-(2--phenyl-r",3-,4"'.thiazolidinon-3"'-yl)]ethyl-r,3',4"-thiazolidinone 
104, 3y?-acetoxy-5a-cholestan-(6/?)-5/7;ro-6,3'-aminoethyl-r,3',4'-thiazolidinone 107, 
3^-acetoxy-5a-cholestan-(67?)-5p;>o-6,3'-[2"-(2"'-phenyl-l'",3'",4"'-thiazolidinon-3'"-
yl)]ethyl-l',3',4'-thia2olidinonel09. 
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C{iapter-M3 
Synthesis and Characterization of New Steroidal Pyrazole and 
1,3,4-Oxadiazole Derivatives: 
The growing need for the compound libraries especially for biological 
evaluation, there is an increasing demand for clean and efficient synthesis of organic 
molecules. Recently, synthesis of steroidal pyrazoles and oxadiazoles have attracted 
the attention of organic chemists because they display remarkable and unusual 
physiological activity and material interest. Pyrazoles have been found in diverse 
application in pharmaceutical and agrochemical industries. The fusion of pyrazole 
ring to steroidal nucleus can act as potential drugs. The unusual anabolic activity 
observed in humans attached vital significance with such compounds in steroids. 
In addition, 1,3,4-oxadiazole constitute an important family of heterocyclic 
compounds. Since many of them display a remarkable biological activity, and are 
often used in drug discovery as potential agonists for cortical muscarinic, 
benzodiazepine histamine H3 receptors, antirhinoviral, growth hormone 
secretagogues. 
Thus, inspired by these results obtained by earlier workers, we have made an 
attempt to synthesize steroidal pyrazoles and oxadiazoles from steroidal hydrazide 
belonging to cholestane series. Here, we have synthesized 3yff-[(3'-methyl-5'-oxa-2'-
pyra2olin-l'-yl)carbonylmethoxy]cholest-5-ene 111, from cholest-5-en-3y8-0-acetyl 
hydrazide 110 using methyl acetoacetate. The treatment of compound 110 with 
benzoic acid or 4-chloro benzoic acid in presence of phosphorous oxychloride affords 
3y9-[5'-phenyl-l*,3',4'-oxadiazol-2'-yl]methoxycholest-5-ene 112 and 3/?-[5'-(4"-
chlorophenyl)-r,3',4'-oxadiazol-2'-yl]methoxycholest-5-ene 113. During the reaction, 
the acid was first converted to acid chloride, which subsequently reacted with 
compound 110 to give the corresponding acyl hydrazinocarbonyl compound, which 
underwent cyclodehydration to yield final products 112, 113. The compounds 3^-[5'-
(4"-ethylphenyl)-l',3',4'-oxadiazole-2'-yl)methoxycholest-5-ene 114 and 3yff-[5'-
phenyl-r,3',4'-oxadiazole-2'-yl]methoxycholest-5-ene 112 are synthesized via 
cyclodehydration of diacylhydrazine. The cyclodehydration reaction condition was 
promoted by heat and anhydrous reagent POCI3. The compound 110 was obtained 
from easily assessable ethyl-5-cholesten-3^-0-acetate 109 which was obtained by 
(v) 
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treating cholest-5-en-3^-ol (cholesterol) 108 with ethyl chloroacetate. The structures 
of new compounds were established on the basis of analytical and spectral studies. 
108 
o 
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Chapter-31? 
Synthesis and Characterization of Steroidal Dimers: 
Dimeric and oligomeric steroids posses interesting micellular, detergent, and 
liquid crystal properties. Steroidal dimers have been used as catalysts for different 
types of reactions and many lead to enhance pharmacological activity. For example, 
the dimeric steroids cephalostatins are among the most potent natural cytotoxins. 
Here we are presenting new dimeric steroids namely that cholest-5-en-3-5p/ro-
[6'a,5'-oxa]-5'a-cholest-3'-one 68, cholest-5-en-7-5p/>o-[4'a,5'-oxa]-5'a-cholest-7'-one 
70 and 3/f-substitutedcholest-5-en-7-5/7/ro-[4'a,5'-oxa]-3'yff-substituted-5'a-cholestan-
7'-ones 72 and 74 which were prepared from cholest-5-en-3-one 67, cholest-5-en-7-
one 69 and 3)9-substituted-cholest-5-en-7-ones 71 and 73 respectively by amine 
catalysed dimerization using reducing agent DMAP and xylene. 
DMAP 
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Summary 
In the field of bio-organic research, steroids have been one of the most 
attractive areas for exploration due to the biological activities associated with such 
molecules. Organic chemists have reported a number of modifications in natural 
steroids resuhing in the promotion or loss of their biological activities. This still 
continues to be a fascinating field worldwide. Previous work from our laboratories 
described the preparation and study of a number of unknown steroidal derivatives in 
the cholestane series. These included azasteroids, oxasteroids, pyrazoles, pyrans etc. 
In continuation of the above work an attempt has been made to prepare new 
compounds with probable biological properties. In some cases, abnormal products 
have been obtained and this has offered scope for some mechanistic and 
stereochemical studies also. The resuhs are summarized as below. 
Chapter-3 
ThermaUy Induced One Step Synthesis Of Intermolecular 
Azacyclic Steroidal Derivatives; 
Azacyclic subunit has proved to be usefiil reactive intermediate in many 
organic synthetic strategies directed towards the synthesis of important natural 
products. Bicyclic and tricyclic derivatives have also been used as synthetic tool in 
organic chemistry especially in cycloaddition reaction. 
Initially the double Mannich reaction of ketone with methylamine was 
reported by Scheiber and Nemes in their synthesis of diamine which poses chiral 
architecture similar to sparteine which is a naturally occurring alkaloid extracted from 
plants such as Scotch Broom. 
The simplicity of this strategy has obvious advantages for accessing unusual 
methyl amine, and in the past few decades, a great deal of effort has been devoted 
towards developing asymmetric variants of the double Mannich reaction. 
Although some double Mannich reactions have been reported in recent years. 
The reports on the first asymmetric intermolecular as well as intramolecular reactions 
having external chiral induction have therefore attracted considerable interest. 
The formation of carbon-carbon multiple bonds rank among the most efficient 
methods for the new carbon-carbon bonds. We moved on to examine more usefiil 
electrophile trapping reactions that would allow the creation of new carbon-carbon 
(i) 
Summaty 
and carbon heteroatom bonds which are moderately more successful. We have 
synthesized azacyclic 47, 49, 51 and 53 of cholest-5-en-3-one and cholest-5-en-7-one 
and its analogue the mimic's of sparteine sufficiently. There have been no reports in 
the literature on the preparation of such azacyclic derivatives of cholesterol. Here we 
report the synthesis of some steroidal compounds with azacyclic moiety namely [2,4-
c,d]-A^-methylpiperidinocholest-5-en-3-one 47, [6,8-c,d]-iV-methylpiperidinocholest-
4-ene-7-one 49, [6,8-c,d]-A'-methylpiperidino-3^-chlorocholest-4-ene-7-one 51 and 
[6,8-c,d]-A^-methylpiperidino-3y?-acetoxycholest-4-ene-7-one 53 fi-om easily 
accessible steroidal ketones 46, 48, 50 and 52. 
In this part we have described the preparation of azacyclic cholesterol 
derivatives using the troublesome double Mannich reaction. Moreover we have been 
able to ache the first intermolecular synthesis of cholesterol derivatives. 
(CH2O) 
MeNH2 
AcOH. MeOH, 
46 47 
49, 51,53 
(ii) 
Svmmaty 
Chapter-M 
Synthesis and Characterization of Steroidal Derivatives having 
Thiazolidinone Rings: 
For a long time imines have been used successfully in the synthesis of 
nitrogen containing heterocycles. As part of ongoing project aimed at the synthesis of 
bioactive 4-thiazolidinone, we employed the Schiflf bases 93, 98, 103, and 108 
towards their synthesis. Furthermore, most of the 4-thia2olidinones and their 
benzylidene derivatives display a large variety of activities such as antibiotic, diuretic, 
organoleptic, tuberculostatic and antiparasitical. 
HC=N-CH2CH2-N 
6 93 N-"CH2CH2—N 
98 
103 
108 
R 
H 
CI 
OAc 
= C H - ^ 
The pharmacological properties of 4-thiazolidinones encouraged our interest 
in synthesizing several new compounds featuring various heterocyclic rings, attached 
to 4-thiazolidinone moieties. As a part of our aim to search for biologically active 
heterocycles containing sulfur and nitrogen, we have undertaken the synthesis of 
some steroidal 1,3,4-thiazolidinones, eg. cholest-5-en-(3/?)-5p/ro-3,3'-aminoethyl-
1 •,3',4'-thiazolidinone 92, cholest-5-en-(3i?>^/ro-3,3'-[2"-(2'"-phenyl-1 "',3"',4"'-
thiazolidinon-3'"-yl)ethyl]-1 •,3',4'-thiazolidinone 94, 5a-cholestan-(6/?)-5p/ro-6,3'-
aminoethyl-1 ',3',4'-thiazolidinone 97, 5a-cholestan-(6;?)-5p/ro-6,3'-[2"-(2'"-phenyl-
1 '",3"",4"'-thiazolidinon-3"'-yl)]ethyl-1 ',3',4'-thiazolidinone 99, 3^-chloro-5a-cholestan-
(6^)-5/7/>o-6,3'-aminoethyl-r,3',4'-thiazolidinone 102, 3^-chloro-5a-cholestan-(6^)-
5p/>o-6,3'-[2"-(2"'-phenyl-1 "•,3"',4'"-thiazolidinon-3"'-yl)]ethyl-1 •,3',4'-thiazolidinone 
104, 3^-acetoxy-5a-cholestan-(6i?)-^;>o-6,3'-aminoethyl-r,3',4'-thiazolidinone 107, 
3^-acetoxy-5a-cholestan-(6i?)-5/7;ro-6,3'-[2"-(2'"-phenyl-l"',3"',4'"-thiazolidinon-3"'-
yl)]ethyl-r,3',4'-thiazolidinonel09. 
(iii) 
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CIiapter-339 
Synthesis and Characterization of New Steroidal Pyrazole and 
1^,4-Oxadiazole Derivatives: 
The growing need for the compound libraries especially for biological 
evaluation, there is an increasing demand for clean and efficient synthesis of organic 
molecules. Recently, synthesis of steroidal pyrazoles and oxadiazoles have attracted 
the attention of organic chemists because they display remarkable and unusual 
physiological activity and material interest. Pyrazoles have been found in diverse 
application in pharmaceutical and agrochemical industries. The fusion of pyrazole 
ring to steroidal nucleus can act as potential drugs. The unusual anabolic activity 
observed in humans attached vital significance with such compounds in steroids. 
In addition, 1,3,4-oxadiazole constitute an important family of heterocyclic 
compounds. Since many of them display a remarkable biological activity, and are 
often used in drug discovery as potential agonists for cortical muscarinic, 
benzodiazepine histamine H3 receptors, antirhinoviral, growth hormone 
secretagogues. 
Thus, inspired by these results obtained by earlier workers, we have made an 
attempt to synthesize steroidal pyrazoles and oxadiazoles from steroidal hydrazide 
belonging to cholestane series. Here, we have synthesized 3yff-[(3'-methyl-5'-oxa-2'-
pyrazolin-l'-yl)carbonylmethoxy]cholest-5-ene 111, from cholest-5-en-3yS-0-acetyl 
hydrazide 110 using methyl acetoacetate. The treatment of compound 110 with 
benzoic acid or 4-chloro benzoic acid in presence of phosphorous oxychloride affords 
3^-[5'-phenyl-r,3',4'-oxadiazol-2'-yl]methoxycholest-5-ene 112 and 3y9-[5'-(4"-
chlorophenyl)-l',3',4'-oxadiazol-2'-yl]methoxycholest-5-ene 113. During the reaction, 
the acid was first converted to acid chloride, which subsequently reacted with 
compound 110 to give the corresponding acyl hydrazinocarbonyl compound, which 
underwent cyclodehydration to yield final products 112, 113. The compounds 3^-[5'-
(4"-ethylphenyl)-l',3',4'-oxadiazole-2'-yl)methoxycholest-5-ene 114 and 3)ff-[5'-
phenyl-l',3',4'-oxadiazole-2'-yl]methoxycholest-5-ene 112 are synthesized via 
cyclodehydration of diacylhydrazine. The cyclodehydration reaction condition was 
promoted by heat and anhydrous reagent POCI3. The compound 110 was obtained 
from easily assessable ethyl-5-cholesten-3yS-0-acetate 109 which was obtained by 
(V) 
Summary 
treating cholest-5-en-3^-ol (cholesterol) 108 with ethyl chloroacetate. The structures 
of new compounds were established on the basis of analytical and spectral studies. 
108 
Ethyl chloroacetate 
o r^V 
•*" H5C2-0-C-H2C-0' ^ ^v^^"^^ 
109 
NH2NH2.H2O 
- N H - C - C H 7 - 0 ' \ X ' ' ' S ^ > 
O O 
H3C 
N-C-CH2-
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N 
CH3COCH2CO2CH3 
o-kA^ 
111 
110 
a COCI 
POCI3 \ CeHgCOOH 
POCI3 
N N 
CsHs-^n^^^^-O 
112 
(vi) 
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113 
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114 
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Chapter-3(1? 
Synthesis and Characterization of Steroidal Dimers: 
Dimeric and oligomeric steroids posses interesting micellular, detergent, and 
liquid crystal properties. Steroidal dimers have been used as catalysts for different 
types of reactions and many lead to enhance pharmacological activity. For example, 
the dimeric steroids cephalostatins are among the most potent natural cytotoxins. 
Here we are presenting new dimeric steroids namely that cholest-5-en-3-5/7;ro-
[6'a,5'-oxa]-5'a-cholest-3'-one 68, cholest-5-en-7-5p/ro-[4'a,5'-oxa]-5'a-cholest-7'-one 
70 and 3y9-substitutedcholest-5-en-7-J5p;/-o-[4'a,5'-oxa]-3'^ -substituted-5'a-cholestan-
7'-ones 72 and 74 which were prepared from cholest-5-en-3-one 67, cholest-5-en-7-
one 69 and 3yff-substituted-cholest-5-en-7-ones 71 and 73 respectively by amine 
catalysed dimerization using reducing agent DMAP and xylene. 
DMAP 
67 
R 
70 H 
72 CI 
74 OAc 
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Introduction 
Steroids are compounds of natural origin and play an important role in 
biological systems. Cholesterol is a component of cell membranes in Eucaryotes, and 
serves as substrate for production of bile acids and steroid hormones. In cells, steroids 
are recognised by antibodies and enzymes. Synthetic receptors of steroids have been 
also reported. Some resorcinne are hosts have shov^ n capability of complexation of 
bile acids derivatives, cholesterol and corticosteroids, while cellophanes have been 
tested for recognition of androsterone and estrogens. Water-soluble cyclophane 
receptors are found effective for complexation of bile acid salts. Steroids themselves 
have been used as building blocks for designing and construction of molecular 
receptors which serve for recognition of guest molecules of diverse chemical nature. 
Some excellent review papers have been published. The first attempts to synthesize 
artificial receptors of steroid type have been reported by groups of Guthrie and Ueda 
and McKenna et al. The major types of cyclic host structures derived fi"om steroids 
are cyclocholates made of up to four bile acid units, cholaphanes which incorporate 
two or more bile acid residues joined together by spacer groups of diverse chemical 
character, and steroid cyclophanes. Other bile acid-based artificial receptors are 
molecular clefts and molecular tweezers. Cholesterol is one of the main constituents 
of membrane lipids and has been considered to govern the membrane fluidity and 
permeability of solutes. 
Cholest-5-en-3yff-ol (cholesterol) is a biomolecule essential to animals for 
membrane integrity and biosynthesis of steroid hormones, bile saUs, and Vitamin D. 
Structurally, cholesterol is a 17 carbon carbocylclic ring with an eight-member chain, 
branched at C25 and C20, attached at Ci? to the carbocyclic ring, a methyl group at Cio, 
a double bond at Cs-Ce, and one hydroxyl group attached at C3. The carbocyclic ring 
is a four ring structure that is a modified form of cyclopentenophenanthrene. The 
modified cycolophenanthrene ring and hydrocarbon chain produce cholesterol's 
highly hydrophobic nature. The hydroxyl group at C3 is cholesterol's lone source of 
hydrophilicy. The hydrophobic carbocyclic ring portion of cholesterol facilitates 
cholesterol's ability to insert into the hydrophobic portion of the cell membrane and 
stabilize it, as well as serving as the main structure in the synthesis of steroid 
hormones, bile salts, and Vitamin D. 
We report here on the synthesis of a new type of cholesterol derivatives, in 
chapter I, II, III and IV 
1 
Introduction 
In chapter I, I have been interested in synthesis of cholesterol derivatives with 
the help of double Mannich reaction of ketone with methylamine was reported by 
Scheiber and Hemes. Although some double Mannich reactions have been reported in 
recent years. This novel method allows the synthesis of azacyclic ketone 
functionalized alkylidene cyclopentanes in good to excellent yields and selectivities. 
We moved on to examine more useful electrophile trapping reactions that would 
allow the creation of new carbon-carbon and carbon heteroatom bonds which are 
moderately more successful. I have synthesized azacyclic [2,4-c,d]-iV-
methylpiperidinocholest-5-en-3-one 47, [6,8-c,d]-A'^ methylpiperidinocholest-4-ene-7-
one 49 and its analogue 51, 53 from easily accessible steroidal ketones 46, 48, 50 and 
52 which is the mimic's of sparteine sufficiently. 
In chapter II encouraged our interest in synthesizing several new compounds 
featuring various heterocyclic rings, attached to 4-thiazolidinone moieties. As a part 
of our aim to search for biologically active heterocycles containing sulfur and 
nitrogen, we have undertaken the synthesis of some steroidal 1,3,4-thiazolidinones, 
eg. cholest-5-en-(ii?)-j/?/>'o-3,3'-aminoethyl-l',3',4'-thiazolidinone 92, cholest-5-en-
(3i?)-5p7ro-3,3'-[2"-(2"'-phenyl-l"',3"',4"'-thiazolidinon-3"'-yl)ethyl]-l',3',4'-
thiazolidinone 94, 5a-cholestan-(6JR)-5/77ro-6,3'-aminoethyl-r,3',4'-thiazolidinone 97, 
5a-cholestan-(6i?)-5p/ro-6,3'-[2"-(2"'-phenyl-l'",3"',4"'-thiazolidinon-3"'-yl)]ethyl-
l',3',4'-thiazolidinone 99, 3yff-chloro-5a-cholestan-(6^)-^/w-6,3'-aminoethyl-I',3',4'-
thiazolidinone 102, 3^-chloro-5a-cholestan-(6/?)-5p/>o-6,3'-[2"-(2"'-phenyl-1 "•,3"',4"'-
thiazolidinon-3"'-yl)]ethyl-1 ',3',4'-thiazolidinone 104, 3y?-acetoxy-5a-cholestan-(6i?)-
5p/>-o-6,3'-aminoethyl-r,3',4'-thiazolidinone 107, 3y?-acetoxy-5a-cholestan-(6i?)-5/?/ro-
6,3'-[2"-(2"'-phenyl-l'",3'",4"'-thiazolidinon-3'"-yl)]ethyl-l',3",4'-thiazolidinonel09. 
In addition, oi chapter III 1,3,4-oxadiazole constitute an important family of 
heterocyclic compounds. Since many of them display a remarkable biological activity. 
Thus, inspired by these resuhs obtained by earlier workers, we have made an 
attempt to synthesize steroidal pyrazoles and oxadiazoles from steroidal hydrazides 
belonging to cholestane series. Here, we have synthesized 3^-[(3'-methyl-5'-oxa-2'-
pyrazolin-r-yl)carbonylmethoxy]cholest-5-ene 111, from cholest-5-en-3y5-0-acetyl 
hydrazide 110 using methyl acetoacetate. The treatment of compound 110 with 
benzoic acid or 4-chloro benzoic acid in presence of phosphorous oxychloride affords 
3yff-[5'-phenyl-l',3',4'-oxadiazol-2'-yl]methoxycholest-5-ene 112 and 3y5-[5'-(4"-
Introduction 
chlorophenyl)-r,3',4'-oxadiazol-2'-yl]methoxycholest-5-ene 113. During the reaction, 
the acid was first converted to acid chloride, which subsequently reacted with 
compound 110 to give the corresponding acyl hydrazinocarbonyl compound, which 
underwent cyclodehydration to yield final products 112, 113. The compounds of 3^-
[5'-(4"-ethylphenyl)-r,3',4'-oxadiazole-2'-yl)methoxycholest-5-ene 114 and 3^-[5'-
phenyl-r,3',4'-oxadiazole-2'-yl]methoxycholest-5-ene 112 are synthesized via 
cyclodehydration of diacylhydrazine. The cyclodehydration reaction condition was 
promoted by heat and anhydrous reagent POCI3. The compound 110 was obtained 
fi-om easily asseccible ethyl-5-cholesten-3y9-0-acetate 109. Compound 109 was 
obtained by treating cholest-5-en-3^-ol (cholesterol) 108 with ethyl chloroacetate. The 
structures of new compounds were established on the basis of analytical and spectral 
studies. 
It might be expected that polymers of steroidal ketones (or ketone derivatives) 
would readily be formed in reaction media of high acidity or basicity. There seems, 
however, to be only two instances of an aldol type of product having been isolated in 
sufficient quantity and purity to have merited reporting in the literature. 
Here in chapter IV, I am presenting new dimeric steroids namely that cholest-
5-en-3-5p;ro-[6'a,5'-oxa]-5'a-cholest-3'-one 68, cholest-5-en-7-j5p;ro-[4'a,5'-oxa]-5'a-
cholest-7'-one 70 and 3yff-substitutedcholest-5-en-7-J5p/ro-[4'a,5'-oxa]-3'^ -substituted-
5'a-cholestan-7'-ones 72 and 74 which were prepared fi^om cholest-5-en-3-one 67, 
cholest-5-en-7-one 69 and 3^-substituted-cholest-5-en-7-ones 71 and 73 repectively 
by amine catalysed dimerization using reducing agent DMAP and xylene. 
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Azacyclic subunit has proved to be useful reactive intermediate in many 
interesting stereospecific transformations making the derivatives powerful building 
block in organic synthetic strategies directed towards the synthesis of important 
natural products. Tricyclic derivatives have also been used as synthetic tool in organic 
chemistry especially in cycloaddition reaction. ^ '^  
In this part we reported the related work available in the literature. 
House et al} reported the hydroxy diketone 2 by the treatment of 
cyclohexane-l,2-dione 1 with methyl vinyl ketone in the presence of triethyl amine. 
CH2=CH-COCH3 
EtaN 
P^^ COCH3 
h 
1 2 
Anderson et al.'* described the flexible method for the synthesis of chromene 
precursor especially for an efficient synthesis of 2,4-disubstituted chromenes 4 which 
could incorporate a variety of substituent in the aromatic ring. 
Meyer et al. reported that oxidation and direct cyclization of alcohol 5 to the 
aldol product 6. 
Cdapterl 
PCC, NaOAc 
CH2CI2, rt 
Coates et al^ reported the synthesis of endo-bridged diketone 9 and exo-
bridged diketone 11 from the complete cyclization of 8 and 10 by using chromic acid. 
Compound 8 and 10 were prepared from compound 7 respectively. 
Break et al^ proposed the synthesis of chiral bispidine ligands 19-23 from 
cyclic ketone 12-14 via keto bispidine intermediate 18 which were reduced using 
Wolff-Kishner conditions. The diaza[3.3.1] skeleton was constructed using a double 
Mannich reaction with chiral amines 15-17. 
Cfutpterl 
12. X = NMe 
13.X = 0 
14. X = N^Ph 
Me 
(CH20)n, AcOH 
R2 
> - N H 2 
15. Ri = Ph, R2 = Me 
16. Ri = Cyclohexyl, R2 = Me 
17. Ri = Et, R2 = CH2OH 
19. R1 = Ph, R2 = Me, X = Me 
20. RI = Cyclohexyl, R2 = Me, X = NMe 
21. Ri = Et, R2 = CH2OH, X = NMe 
22. Ri = Ph, R2 = Me, X = O 
23. Ri = Ph, R2 = Me,X=N Ph 
Me 
Rlv-N 
H2NNH2 
tBuOK, BuOH 
R2 19-23 
The first domino reaction of a natural product was performed by Schopf and 
Robinson^ putting together a mixture of succindiaidehyde 24, methylamine and 
acetone dicarboxylic acid 25 to give the bicyclic tropinone 26 which is a structural 
component of several alkaloids such as cocaine and atropine. 
^ C H O 
CHO 
24 
^COsH 
C02H 
25 
H2N—Me 
26 
The key step in this synthesis is a double Mannich reaction. However, even 
the normal Mannich reaction' combining an aldehyde, generally formaldehyde, a 
ketone, and a secondary amine is a domino reaction and presumably the first domino 
reaction described in literature. In contrast, the well knovm Diels-Alder reaction may 
not be attributed as a domino reaction, although two bonds are usually formed in a 
sequence. 
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Brien et al}^ prepared an tricyclic icetone 28. The reaction performed by 
double Mannich reaction by using ketone 27 with methylamine, paraformaldehyde 
and acetic acid in methanol. 
27 
Me, 
MeNH2, 
(CH20)n, AcOH, MeOH, reflux 
28 
Peter O' Brien'' also reported the single diasteroisomer of 30 by double 
Mannich reaction of ketone 29 using methyl amine and paraformaldehyde. 
MeNHj, 
(CHjOjn, AcOH, MeOH 
Brien and Whitwood'^  reported the Mannich reaction precedented in the work 
of Scheiber and Nemes.^^ On the basis of that, they reported the synthesis of 
diazatricyclic ketones 32 and 33 by refluxing amino ketone 31, methylamine, 
paraformaldehyde and acetic acid in methanol. 
H 
ca° 
31 
i = MeNH2, (CH20)n, AcOH, MeOH. reflux. 
32 n = 1 (58%) 
33 n = O (29%) 
Hudgson et al}^ prepared 3,7-dibutyl-3,7-dia2abicyclo[3,3,l]nonane (also 
called dibutyl-bispidine, DBB) 36, via a Wolff-Kishner reduction of bispidinone 35, 
which itself was obtained from a double Mannich reaction with 4-butylpiperidone 34. 
Clupterl 
BuNH2 
(CH20)n, ACOH 
EtOH, 
34 
N-Bu 
35 
I.NH2NH2.H2O 
2. KOH, reflux 
N-Bu 
Flemming et al.'' synthesized (±)-spartein 39 with stereochemistry control in 
such a way as to make the route agreeable to an efficient synthesis of either 
enantiomers. The bislactam 37 gave the bispiperidine diol 38 on reduction with 
lithium aluminium hydride, THF and the diol 38 gave on treatment with carbon 
tetrachloride and triphenylphosphine provide spartein 39. 
Me02C C02Me 
H U - ^ H 
• NH HN, 
37 
LiAIH4, THF 
reflux 
EtaN, MeCH 
CCI4. PhaP 
6 
39 
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Peter 0 ' Brien et al}^ constructed a reactivity series and the results indicated 
that the s-BuLi/(+)-sparteine surrogate complex is more reactive than s-BuLi /(-)-
spateine. 
Peter 0 ' Brien^^ later synthesized triducterated diamine 45 through modified 
strategy and a more convoluted synthetic sequence. 
0 
MeO N ^ 
M 
D 3 C . ^ ^ 
M 
0 
40 
^ . 
-^ O 
45 
^'^T^ _ 
41 
0 
U ^ ^ H 
^ N J 
44 
i) Pt02, Hz, MeOH 
ii) EtjN, PhCOCl, CH2CI2 
iii) PtOz, Hz, MeOH 
iv) PdCOHVC NH^HCOz" 
0 
ii ^ f'^  N " ^ > \ ^ ^ ^ 
iv 
EtOH 
42 0 
iii 
1' 
^ ^ ' ^ v ^ 
43 

Ctuipterl 
Introduction 
Azacyclic subunit has proved to be useful reactive intermediate in many 
organic synthetic strategies directed towards the synthesis of important natural 
products. Bicyclic and tricyclic derivatives have also been used as synthetic tool in 
organic chemistry especially in cycloaddition reaction.''^  
Initially the double Mannich reaction of ketone with methylamine was 
reported by Scheiber and Nemes^^ in their synthesis of diamine which poses chiral 
architecture similar to sparteine which is a naturally occurring alkaloid extracted from 
plants such as Scotch Broom. It is commercially available and has been widely used as 
chiral diamine ligand in asymmetric synthesis and for a wide range of asymmetric 
reactions over last 30 years.'^ "^ * 
The high synthetic potential of this structure found in important natural and 
unnatural compounds is well illustrated by numerous examples, in which this tricyclic 
framework is always valuable reactive intermediate playing a significant role in many 
synthetic pathways. The same cyclization strategy was also followed in the synthesis 
of tricyclic lactone.^ '^^ ' 
The simplicity of this strategy has obvious advantages for accessing unusual 
methyl amine, and in the past few decades, a great deal of effort has been devoted 
towards developing asymmetric variants of the double Mannich reaction. 
Although some double Mannich reactions have been reported in recent years. 
The reports on the first asymmetric intermolecular'" as well as intramolecular '^ 
reactions having external chiral induction have therefore attracted considerable 
interest. 
" % 
Figure 1 
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This novel method allows the synthesis of azacyclic ketone functionalized 
alkylidene cyclopentanes in good to excellent yields and selectivities. 
The formation of carbon-carbon multiple bonds rank among the most efficient 
methods for the new carbon-carbon bonds.^ ^ We moved on to examine more useful 
electrophile trapping reactions that would allow the creation of new carbon-carbon 
and carbon heteroatom bonds which are moderately more successful.^ '^•''* We have 
synthesized azacyclic 47, 49, 51 and 53 of cholest-5-en-3-one and cholest-5-en-7-one 
and its analogue the mimic's of sparteine sufficiently. There have been no reports in 
the literature on the preparation of such azacyclic derivatives of cholesterol. Here, we 
report the synthesis of some steroidal compounds with azacyclic moiety namely [2,4-
c,d]-iV-methylpiperidinocholest-5-en-3-one 47, [6,8-c,d]-A^-methylpiperidinocholest-
4-en-7-one 49, [6,8-c,d]-iV^methylpiperidino-3y?-chIorocholest-4-en-7-one 51 and 
[6,8-c,d]-A/-methylpiperidino-3^-acetoxycholest-4-en-7-one 53 from easily accessible 
steroidal ketones 46, 48, 50 and 52. 
In this part we have described the preparation of azacyclic cholesterol 
derivatives using the troublesome double Mannich reaction.^' Moreover we have been 
able to ache the first intermolecular synthesis of cholesterol derivatives. 
11 
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Reaction of cholest-S-en-S-one 46 with methvlamine, 
paraformaldehyde in methanol: [2,4-c,d1-N-methylpiperidinocholest-
5-en-3-one 47: 
(CH20)n, 
MeNH2 
AcOH, MeOH, 
46 
Methylamine (in MeOH) was added drop wise to a stirred solution of cholest-
5-en-3-one 46, paraformaldehyde and acetic acid in MeOH at room temperature under 
nitrogen. The resulting solution was heated under reflux for 17 h. After cooling at 
room temperature, the solvent was evaporated under reduced pressure. The residue 
was taken in diethyl ether, worked up and dried over anhyd. K2CO3. Solvent was 
evaporated under reduced pressure to give an oily residue, which was purified by 
column chromatography to give compound 47 as pale yellow oil in 62% yield. 
Characterization of compound 47 as f2,4-c,dl-N-methvlpiperidino 
cholest-5-en-3-one: 
The compound 47 was correctly analysed for C30H49NO. Its IR spectrum 
exhibited characteristic absorption bands at Vmax 1745 (C=0), 1616 (C^C) and 1315 
cm'* (C-N).^ ^ The *H-NMR spectrum of compound 47 displayed two doublets for two 
protons each at 5 2.03 {J = 7.42 Hz) for C2-//2 and 2.1 (J = 6.95 Bz) for Ce-Ht. One 
triplet and one multiplet for single proton each were seen at S 2.81 and 3.49 for C^-H 
and C2-H, respectively. Another singlet for three protons was shown at 5 2.30 for -
NMe. A single-proton appeared as double doublet at d 5.05 (J= 7.9, 5.4 Hz) for C6-
olefinic proton. Angular and side-chain methyl protons were observed at 5 1.15 (Cjo-
CH3), 0.73 (Ci3-C/fj), 0.90 and 0.82 (other steroidal side-chain methyl protons).'"' 
The '^ C NMR spectrum of compound 47 showed characteristic peaks at S 
211.04 for carbonyl carbon atom (C3), 56.77 (€2-), 56.68 (Ce-), 49.99 (C2), 56.13 (C4) 
and 39.53 for methyl carbon atom of azacyclic ring. Other carbon atoms of steroidal 
skeleton appeared at expected region. The Mass spectrum of compound 47 showed 
12 
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molecular ion peaks at m/z 439 (M^', C30H49NO) along with M+2. Some other 
characteristic fragment ion peaks were recorded at m/z 424 (C29H46NO), 411 
(C28H45NO), 397 (C27H43NO), 384 (C27H44O), 327 (C22H33NO), 312 (C21H30NO) 
along with other usual fragment ion peaks. 
Thus, on the basis of above evidence, the non-crystallisable pale yellow oily 
compound 47 was characterized as [2,4-c,d]-A'-methylpiperidinocholest-5-en-3-one. 
Mechanism for the formation of Compound 47: 
Generation of Electrophile: 
Me—NH2 + H 2 C = 0 
H 
I 
H 
Me-N* C—O 
+ H* 
H 
I 
Me-N-C—OH 
+ H* 
H 
+ I 
Me-N=C 
I I 
H H 
H 
I . 
Me-N-C"^ 
I I 
H H 
-H2O 
H 
I + 
Me-N-C—OH2 
I I 
H H 
13 
Attack of Electrophile: 
CfutpUrl 
- ^ Me" ' 
+ H* -H2O 
C H z ^ ^ . ^ C H 2 
Me 
Me" ' H 
Q A J O •• 
Me 
c ^ r V ^ 
/ 
H 
Me-N' 
I 
H 
CH, 
-H* 
Me' 
TXXJ 
H2 
-H* 
Me' 
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Reaction of cholest-5-en-7-one 48 with methvlamine, 
paraformaldehyde in methanol: f6,8-c,d1-N-methvlpiperidinocholest-
4-en-7-one 49: 
48 
A solution of methylamine in methanol was added drop wise to a stirred 
solution of cholest-5-en-7-one 48, paraformaldehyde and acetic acid in methanol, at 
room temperature under nitrogen. The resulting solution was heated under reflux for 
18 h. After completion of reaction, reaction mixture was cooled to room temperature, 
the solvent was evaporated under reduced pressure. Residue was taken in diethyl 
ether, washed with water and dried over anhyd. K2CO3. Evaporation of solvent under 
reduced pressure gave crude product as light yellow oil which was purified by column 
chromatography over silica gel column to afford compound 49 as an oil in 66 % 
yields. 
Characterization of compound 49 as f6,8-c.d1-N-
methvlpiperidinocholest-4-en-7-one: 
The compound 49 was correctly analysed for C30H49NO. Its IR spectrum 
exhibited characteristic absorption bands at Vmax 1754 (C=0), 1621 (C=C) and 1314 
cm"' (C-N).^ ^ The 'H-NMR spectrum of compound 49, displayed two triplets for one 
proton each at ^ 5.21 (C4-//) and 3.13 (Ce-//) and two singlets integrating for two and 
three protons at 2.23 and 2.73 for C6-//2 and N-Me respectively. A two-proton 
doublet (J = 6.5 Hz) for Cr-Hi appeared at S 2.43. Angular and side-chain methyl 
protons were observed at S 1.17 (C10-CH3), 0.71 (Cu-CHs), 0.93 and 0.80 (other 
steroidal side-chain methyl protons).^' 
'^ C NMR spectrum of compound 49 showed characteristic peaks at 3 209.04 
for carbonyl carbon atom (C7), along with 55.89 (Cx), 56.05 (Cs-), 57.71 (Ce), 47.08 
(Cg) and at 38.53 for methyl carbon atom of azacyclic ring. Other carbon atoms of 
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steroidal skeleton appeared at the expected region; the mass spectrum of compound 
49 showed molecular ion peak at m/z = 439 (M""^  C30H49NO) along with M+2. 
Thus on the basis of above evidence non-crystalli sable oily compound 49 has 
been characterized as [6,8-c,d]-iV-methylpiperidinocholest-4-en-7-one. 
Reaction of 3^-Chlorocholest-5-en-7-one 50 with methylamine, 
paraformaldehyde in methanol: f6,8-c.d1-N-methylpiperidino-3^-
chlorocholest-4-en-7-one 51: 
50 
A solution of methylamine in methanol was added dropwise to a stirred 
solution of 3^-chlorocholest-5-en-7-one 50, paraformaldehyde and acetic acid in 
MeOH at room temperature under nitrogen. The resulting solution was heated under 
reflux for 15 h. After cooling to room temperature, the solvent was evaporated under 
reduced pressure. After usual workup and evapouration of solvent a yellowish oily 
compound was obtained which was purified by colunm chromatography over silica 
gel column to afford compound 51 as an oil in 59 % yields. 
Characterization of compound 51 as r6^-c,d1-JV-methylpiperidino-3^-
chlorocholest-4-en-7-one: 
The compound 51 was correctly analysed for C30H48CINO. Its IR spectrum 
exhibited characteristic absorbption bands at v^ ax 1740 (C=0), 1624 {C=C) 1321 (C-
N) and 738 cm"' (C-Cl).^ * The 'H-NMR spectrum of compound 51 displayed a 
doublet for single proton at 6 5.26 {J= 5.8 Hz) for C^-H, and a broad muhiplet for one 
proton at 4.12 (^/2 18.3 Hz, axial) for Csa-Zf. Two singlets integrating for two and 
three protons at ^ 2.13 and 2.63 for Ce-Hi and N-Me respectively. A two-proton 
doublet (J = 6.2 Hz) for Cx-Hi appeared at 5 2.23. A single proton triplet was 
observed at S 3.09 for Ce-H. Angular and side-chain methyl protons were observed at 
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1.18 (C10-CH3), 0.72 (C13-CH3), 0.91 and 0.84 (other steroidal side-chain methyl 
protons). ^ ^ 
The ^^ C NMR spectrum of compound 51 showed a characteristic peak at d 
210.07 for carbonyl carbon atom (C7), some other important peaks appeared at S 
56.08 (C2-), 56.25 (Ce-), 50.02 (Cs), 49.08 (Cg) and 39.89 for methyl carbon atom of 
azacyclic ring. Other carbon atoms of steroidal skeleton appeared at expected region. 
Thus, on the basis of above evidence, non-crystallizable oily compound 51 has 
been characterized as [6,8-c,d]-A'-methylpiperidino-3yS-chlorocholest-4-en-7-one. 
Reaction of 3^-acetoxycholest-5-en-7-one 52 with methylamine. 
paraformaldehyde in methanol: f6,8-c,d1-JV-methylpiperidino-3jg-
acetoxycholest-4-en-7-one 53: 
_ AcO 
AcO^ ^ " 
52 53 
Methylamine was added dropwise to a stirred solution of 3/9-acetoxycholest-5-
en-7-one 52, paraformaldehyde and acetic acid in methanol, at room temperature 
under nitrogen. The resuking solution was heated under reflux for 16 h. After 
completion of reaction, reaction mixture was cooled to room temperature and it was 
usually worked up. The crude product was purified by column chromatography over 
silica gel column to afford compound 53 as yellowish oil in 61% yields. 
Characterization of compoiind 53 as f63-c,d1-N-methylpiperidino-3^-
acetoxycholest-4-en-7-one: 
The compound 53 was correctly analysed for C32H51NO3. Its IR spectrum 
exhibited characteristic absorption bands at Vmax 1739 (C=0), 1732 (OAc), 1620 
(C=C), 1238 cm"' (C-N).^ ^ The 'H NMR spectrum of compound 53 displayed a 
doublet for C4 olefmic proton at (5 5.24 (J = 5.86 Hz), a broad multiplet for one proton 
at d 4.83 (J^/2 18.5 Hz, axial) for Csa-B and two singlets integrating for three protons 
17 
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each at 2.70 (N-C//3) and 2.01 (OCOCH3). Methylene protons of azacyclic ring as a 
doublet {C2-H2, y = 6.1 Hz) at (5 2.14 and as a singlet (C6-//2) at 2.26. Ce-protons 
appeared as a triplet sXd 3.\\. Angular and side-chain methyl proton were observed 
at 1.19 (Cio-C//j), 0.76 {Cu-CHi), 0.93 and 0.80 (other steroidal side-chain methyl 
protons).^' 
The '^ C NMR spectrum of compound 53 showed characteristic peak at S 
212.21 for carbonyl carbon atom (C7), some other important peaks appeared at 5 
55.48 (Cz), 57.15 (Ce'), 49.23 (Ce), 52.68 (Cg) and 40.19 for methyl carbon atom of 
azacyclic ring. Carbonyl carbon of acetate group appeared at S 169.42. Other carbon 
atoms of steroidal skeleton appeared at expected region. 
Thus, on the basis of foregoing discussion, non-crystallizable yellow oil 
compound 53 has been characterized as [6,8-c,d]-^-methylpiperidino-3^-
acetoxycholest-4-en-7-one. 
Mechanism of Compound; 
Generation of Electrophile: 
H H ^^ H 
I I *^ I 
Me-NH2 + CH2=0 »• Me-N* C—O" • Me-N—C—OH 
O I I u. I I 
H H -H H H 
+ H* 
^ H H H 
• • " I I I + 
Me^-=C . Me-N—C+ - • Me-N—C—OH, 
' A I I -H2O I I 
H H H H H H 
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Attack of Electrophile: 
" H 
48,50,52 
H2C. , y-^ 
j:t—CH2-^0H 
H 
„XJX.„ 
Me 1 + 
H 
+H* PjA^#**k^o 
"^'^]^-cHr°-
Me^  \ 
+ H* -H2O 
H2C.^ . . ^ L - C H 2 
N-
I 
Me 
49,51, S3 
R = H, CI, OAc 
H2C. ^ 
Me 
- H * 
^/L^LAQ 
H2C, 
'6"' Me 
,N-H 
19 
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All melting points were observed in the capillary tube and are uncorrected, 
infrared (IR) spectra were recorded in (neat) with spectrolab interspec 2020 FT-IR 
spectrometer and values are given in cm'\ H^ NMR spectra were measured on a 300 
MHz instrument and '^ C NMR spectra on a Bruker Avance II400 spectrometer at 100 
MHz, using TMS as internal standard and CDCI3 as solvent. Chemical shift (S) were 
expressed in ppm downfield from internal standard TMS. Mass spectra were obtained 
on a Jeol spectrometer SX-102 (FAB). The abbreviation s, d, dd, m, br denote 
"singlet, doublet, double doublet, multiplet and broad respectively. Thin layer 
chromatography (TLC) plates were coated with silica gel G and exposed to iodine 
vapours. Pet-ether refers to a fraction of b. p. 60 - 80 °C. Anhyd. Na2S04/K2C03 was 
used as drying agent. 
3^-Hydoxv-5A. 6^-dibromocholestane: 
To a solution of cholesterol (5 g) in ether (30 ml) was added bromine solution 
(0.9 ml of bromine in 20 ml of glacial acetic acid containing 0.2 g of anhydrous 
sodium acetate) with stirring. The solution turned yellow and promptly set to a stiff 
paste of bromide. The mixture was cooled in an ice bath and stirred with a glass rod to 
ensure complete crystallization. The product was then collected by filtration under 
suction and washed with cold diethyl ether-acetic acid mixture (3: 7) until the filtrate 
was completely colourless (6.9 g), m. p. 112-113 °C (reported^* m. p. 113 °C). 
5a, 6^-Dibromocholestan-3-one: 
3yff-Hydoxy-5a, 6yff-dibromocholestane (6.9 g) was suspended in acetone (150 
ml) in a three-necked round bottom flask fitted with a stirrer and dropping fiinnel. The 
suspension was stirred for 5 min. and Tone's reagent^' (10 ml) was then added in 
drops from dropping funnel in 15 min. The temperature of reaction mixture, during 
oxidation was maintained between 0-5 °C by external cooling. After the complete 
addition, stirring was continued for 15 min. and cold water (200 ml) was added. The 
product was collected on a Buchner funnel and washed thoroughly with water and 
methanol and air-dried (5 g), m. p. 73-75 °C (decomposed) (reported^* m. p. 73-75 
"C). 
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Cholest-5-en-3-one 46; 
The moist 5a, 6y9-dibromocholestan-3-one (5.0 g, 9.22 mmol) was dissolved 
in ether (100 ml) and glacial acetic acid (2.5 ml), zinc dust (7.5 g) was added in small 
portions during 30 minutes with continous shaking. After the complete addition, the 
ethereal solution containing suspended zinc dust was filtered, washed with water, 
sodium bi carbonate solution (5%) and water and dried (anhydrous sodium sulphate). 
The oily residue thus obtained after the evaporation of the solvent was crystallized 
from methanol to give the desired product 46 (3.3 g), m. p. 126-127 °C (reported^^ m. 
p. 129 °C). 
r2.4-c.dl-N-methvlpiperidmocholest-5-en-3-one47: 
Methylamine (1.35 ml of a 2.0 M solution in MeOH) was added dropwise to a 
stirred solution of cholest-5-en-3-one 46 (1 g, 2.6 mmol), paraformaldehyde (0.32 g, 
10.5 mmol) and acetic acid (0.2 ml) in methanol (40 ml), at room temperature under 
nitrogen. The resulting solution was heated under reflux for 17 h. After cooling to 
room temperature, 2 M hydrochloric acid was added and the aqueous layer was 
washed with diethyl ether. The aqueous layer was basified to pH 14 by addition of 
20% aqueous sodium hydroxide solution and extracted with diethyl ether. The organic 
extract was dried over anhyd. K2CO3 and evaporated under reduced pressure to give 
the crude product as yellow oil. Purification by column chromatography over silica 
gel with CHCI3 - MeOH (20:1) as eluant gave [2,4-c,d]-A'-methylpiperidinocholest-5-
en-3-one 47 as a pale yellow oil, yield 62 %. 
Analysis found : C, 81.97; H, 11.20; N, 3.21 
C30H49NO requires : C, 82.00; H, 11.16; N, 3.19 %. 
IR (neat) : v„ax 1745 (C=0), 1616(C=C), 1315 cm' (C-N). 
*H NMR (CDCI3) : S 5.05 (dd, J= 7.9 Hz, 5.4 Hz, IH, Cfi-olefinic proton), 
3.49 (m, IH. C2-H), 2.81 (t, IH, C^-H), 2.30 (s, 3H, -
mde), 2.1 (d, J = 6.95 Hz, 2H, C(,'-H2), 2.03 (d, J = 
7.42 Hz, 2H, Cr-Hi), 1.49 (d, J = 6.03 Hz, 2H, Ci-
21 
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Mass (m/z) 
Cholest-5-ene: 
CfiapUrl 
H2), 1.15 (s, 3H, C10-C//3), 0.73 (s, 3H, Cis-C/fs), 
0.90, 0.82 (other side-chain methyl protons). 
: ^211.04 (C=0), 142.11 (Cj), 121.67 (Ce), 39.53 (C of 
CH3-N<), 56.77 (C2), 56.68 (C&X 36.20 (Ci), 49.99 
(C2), 56.13 (C4), 31.80 (C7), 31.60 (Cg), 45.03 (C9), 
35.82 (Cio), 24.32 (Cu), 22.03 (Cn), 42.25 (C13), 
69.63 (CM), 23.85 (C15), 28.27 (Cie), 42.32 (Cn), 
19.44 (Cig). 21.10 (C19), 31.90 (C20), 18.74 (C2,), 
36.57 (C22), 28.04 (C23), 36.52 (C24), 29.26 (C25), 
22.87 (C26), 22.61 (C27) 
: m/z 439 (IVT", C30H49NO), 424 (C29H46NO), 411 
(C28H45NO), 397 (C27H43NO), 384 (C27H44O), 327 
(C22H33NO), 312 (C21H30NO). 
3^-Chlorocholest-5-ene (40 g) was dissolved in warm amyl alcohol (920 ml) 
and sodium metal (80 g) was added to the solution with continuous stirring over a 
period of 8 h. The reaction mixture was warmed occasionally. When all the sodium 
metal was dissolved, the reaction mixture was poured into water, acidified with 
hydrochloric acid and then allowed to stand overnight. A white crystalline solid thus 
obtained was fihered under suction and washed thoroughly with water and air-dried. 
The crude material was recrystallized from acetone to provide cubic crystals of 
cholest-5-ene (34 g), m. p. 94 °C (reported'*" m. p. 89-91 °C). 
Cholest-5-en-7-one 48: 
A solution of t-butyl chromate [t-butyl alcohol (60 ml), Cr03 (20 g), acetic 
acid (84 ml) and acetic anhydride (10 ml)] were added at 0 °C to a solution of cholest-
5-ene (8 g) in CCI4 (150 ml), glacial acetic acid (30 ml) and acetic anhydride (10 ml). 
The contents were refluxed for 3 h and then diluted with water. The organic layer was 
washed with NaHC03 solution (5 %) and water, and dried over anhyd. Na2S04. 
Evaporation of the solvents under reduced pressure provided an oil which was 
crystallized from methanol to give cholest-5-en-7-one 48 (3.1 g), m.p. 128 °C 
(reported'*" m. p. 125 - 129 °C). 
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[6.8-c,d1-iV-methvlpiDeridinocholest-4-en-7-one49; 
Methylamine (1.5 ml of 2.0 M solution in MeOH) was added dropwise to a 
stirred solution of cholest-5-en-7-one 48 (1 g, 2.6 mmol), paraformaldehyde (0.32 g, 
10.5 mmol) and acetic acid (0.2 ml) in MeOH (40 ml) at room temperature under 
nitrogen. The resulting solution was heated under reflux for 18 h. After cooling to 
room temperature, 2 M hydrochloric acid was added and the aqueous layer was 
washed with diethyl ether (60 ml). The aqueous layer was basified to pH 14 by 
addition of 20% aqueous sodium hydroxide solution, and extracted with diethyl ether 
(5x20 ml) and washed with water. The combined organic extracts were dried over 
anhyd. K2CO3 and evaporated under reduced pressure to give the crude product. 
Purification by column chromatography on silica gel with CHCI3 - MeOH (40:1) as 
eluant gave [6,8-c,d]-iV^methylpiperidinocholest-4-ene-7-one 49 as an oil, yield 66 %. 
Analysis found 
C30H49NO requires 
m (neat) 
H^ NMR (CDCI3) 
" C NMR (CDCI3) 
MS (m/z) 
: C, 81.98; H, 11.27; N, 3.18. 
: C, 82.00; H, 11.26; N, 3.19. % . 
: Vmax 1754 (C=0), 1621 (C=C), 1314 cm'* (C-N). 
: S 5.21 (t, IH, C4-olefmic proton), 3.13 (t, IH, Ce-H), 
2.73 (s, 3H, -NMe), 2A3 (d, J= 6.5 Hz, 2H, C2-H2), 
2.23 (s, 2H, C6-//2), 1.17 (s, 3H, Co-C/Zs). 0.71 (s, 
3H, Cn-CHi), 0.93, 0.80 (other steroidal side-chain 
methyl protons). 
: S 209.04 (C=0), 140.17 (C5), 121.03 (C4), 57.71 (Ce), 
38.53 (C of CH3-N<), 55.89 (C2O, 56.05 (Ce), 36.78 
(Ci). 29.09 (C2), 30.82 (C3), 47.08 (Cg), 41.09 (C9), 
36.02 (Cio), 19.39 (Cn). 32.45 (C12X 43.15 (C,,), 
58.03 (C14), 23.55 (Cn), 19.07 (Cis), 43.12 (C,,), 
20.44 (Cs), 21.17 (C19). 32.07 (C20X 18-93 (C2,), 
36.77 (C22), 29.04 (C23), 36.84 (C24X 30.06 (C25X 
22.57 (C26X 22.69 (C27X 
: 439 (M"" C30H49NO). 
23 
Cdapterl 
3^-Chlorocholest-5-ene; 
Freshly purified thionyl chloride (20 ml) was added gradually to cholesterol 
(25 g) at room temperature. A vigorous reaction ensued with the evolution of gaseous 
products. When the reaction slackened, the mixture was gently heated at a 
temperature of 50-60 °C on a water bath for 1 h, and then poured into cold water with 
stirring. The yellow solid thus obtained was fihered under suction, washed 
thouroughly with cold water and air-dried. Recrystallization from acetone gave 3y9-
chlorocholest-5-ene (23.5 g), m. p. 95 °C (reported'*' m. p. 96-97 °C). 
3^-Chlorocholest-5-en-7-one 50: 
A solution of t-butyl chromate [t-butyl alcohol (60 ml), CrOa (20 g), acetic 
acid (35 ml) and acetic anhydride (10 ml)] was added at 0 °C to a solution of 3^-
chlorocholest-5-ene (8 g) in CCI4 (150 ml), acetic acid (30 ml) and acetic anhydride 
(10 ml). The contents were refluxed for 3 h. and then it was washed with NaHCOa 
solution (5 %) and water and dried (anhyd. Na2S04). Evaporation of the solvents 
under reduced pressure furnished the ketone as oil which was crystallized from 
methanol to give 3y9-chlorocholest-5-en-7-one (3.3 g), m.p. 144 °C (reported'*^ m.p. 
144-145 °C). 
[6,8-c,d1-N-methvlpiperidino-3^-chlorocholest-4-ene-7-one51: 
Solution of methylamine (1.6 ml of 2.0 M solution in MeOH), was added 
dropwise to a stirred solution of 3^-chlorocholest-5-ene-7-one 50 (1 g, 2.3 mmol), 
paraformaldehyde (0.285 g, 9.5 mmol) and acetic acid (0.18 ml) in MeOH (40 ml) at 
room temperature under nitrogen. The resulting solution was heated under reflux for 
15 h. Completion of reaction was monitored by TLC. After cooling to room 
temperature 2 M HCl was added and aqueous layer was washed with diethyl ether. 
The aqueous layer was basified to pH 14 by addition of 20% aqueous sodium 
hydroxide solution and extracted with diethyl ether. The combined organic extracts 
were dried over anhyd. K2CO3 and solvent were evaporated under reduced pressure to 
give the crude product. Purification by column chromatography over silica gel with 
CHCI3 - MeOH (30:1) as eluant gave [6,8-c,d]-A'^ -methylpiperidino-3y9-chlorocholest-
4-en-7-one 51 as oil, yield 59 %. 
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Analysis found 
C30H48CINO requires 
m (neat) 
^H N M R (CDCI3) 
^^CNMR(CDCl3) 
: C, 75.98; H, 10.18; N, 2.97. 
: C, 76.02; H, 10.13; N, 2.95%. 
: v,„ax 1740 (C=0), 1624 (C=C), 1321 (C-N), 738 cm-' 
(C-Cl). 
: 6 5.26 (d, y = 5.8 Hz, IH, C4-oIefmic proton), 4.12 (br 
m, IH, W/z, 18.3 Hz, Caa-//), 3.09 (t, IH, Ce-H), 2.63 
(s, 3H, -NMe), 2.13 (s, 2H, Ce-H^), 2.23 (d, J = 6.2 
Hz, 2H, C2-H2), 1.18 (s, 3H, C10-CH3), 0.72 (s, 3H, 
Cu-CHj), 0.91, 0.84 (other steroidal side-chain 
methyl protons). 
: d 210.07 (C=0), 142.13 (Cj), 121.54 (C4), 39.89 
(CH3-N<), 56.08 (C2O, 56.25 (Ce-), 37.07 (Ci), 34.12 
(C2), 57.65 (C3), 50.02 (Cg). 49.08 (Cg), 38.18 (C9), 
36.22 (Cio), 19.34 ( d ) , 33.16 (C12), 40.94 (Co), 
55.09 (CM), 24.52 (C15), 19.65 (Cis), 43.31 (Cn), 
21.41 (Cig), 21.92 (C,9), 32.58 (C20), 19.76 (C21), 
36.95 (C22), 29.01 (C23), 35.04 (C24), 30.72 (C25), 
22.59 (C26), 22.65 (C27). 
3)g-Acetoxvcholest-5-ene: 
A mixture of cholesterol (100 g), pyridine (150 ml) and acetic anhydride (100 
ml) was heated on a water bath for 2 h. The reaction mixture was poured into ice-
cooled water and the solid thus obtained was filtered under suction, washed 
thoroughly with water and air-dried. Recrystallization of the crude product from 
acetone gave 3^-acetoxycholest-5-ene (95 g), m. p. 113-114 °C (reported'*^ m. p. 
115-116 °C). 
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3jg-Acetoxycholest-5-en-7-one 52; 
To a solution of 3yS-acetoxycholest-5-ene (8 g) in carbon tetrachloride (150 
ml), acetic acid (30 ml) and acetic anhydride (10 ml) was added at 0 °C a solution of 
tert-h\x\.y\ chromate [from ter/-butyl alcohol (60 ml), chromium trioxide (20 g), acetic 
acid (84 ml) and acetic anhydride (10 ml)]. The reaction mixture was heated under 
reflux for 4 h and then it was diluted with cold water. The organic layer was taken in 
diethyl ether, washed with water, sodium bicarbonate solution (5 %) and again with 
water and dried over anhyd. sodium sulphate. Evaporation of the solvent under 
reduced pressure gave an oil which was crystallized from methanol to give the ketone 
52 (3.5 g), m. p. 156 °C (reported'*^ m. p. 156-158 °C). 
f6,8-c,d1-N-methylpiperidino-3^-acetoxvcholest-4-ene-7-one53: 
Methylamine (1.2 ml of 2.0 M solution in MeOH) was added dropwise to a 
stirred solution of 3^-acetoxycholest-5-en-7-one 52 (1 g, 2.2 mmol), 
paraformaldehyde (0.279 g, 9.2 mmol) and acetic acid (0.17 ml) in MeOH (50 ml) at 
room temperature under nitrogen. The resulting solution was heated under reflux for 
16 h. After completion of reaction (monitored by TLC), followed by cooling to room 
temperature, 2 M HCl was added and aqueous layer was washed with diethyl ether. 
The aqueous layer was basified to pH 14 by addition of 20% aqueous sodium 
hydroxide solution and extracted with diethyl ether. The combined organic extracts 
were dried over anhyd. K2CO3 and solvents were evaporated under reduced pressure 
to give the crude product. Purification by column chromatography over silica gel with 
CHCls-MeOH (23:1) as eluant gave [6,8-c,d]-iV-methylpiperidino-3y5-acetoxycholest-
4-en-7-one 53 as a yellow oil, yield 61 %. 
Analysis found 
C32H51NO3 requires 
m (neat) 
C, 77.25; H, 10.29; N, 2.83. 
C, 77.26; H, 10.26; N, 2.81. % . 
Vmax 1739 (C=0), 1732 (OAc), 1620 (C=C), 1238 
cm-' (C-N). 
H^ NMR (CDCb) : S 5.24 (d, J = 6.4 Hz, IH, C4-olefmic proton), 4.83 
(m, IH, m/2, 18.5 Hz, Caa-ZT), 3.11 (t, IH, Ce-H), 
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2.70 (s, 3H, -NMe), 2.26 (s, 2H, C6-H2), 2.14 (d,J = 
6.1 Hz, 2H, C2-//2), 1.19 (s, 3H, C10-C//3), 0.76 (s, 
3H, C13-C//3), 0.93, 0.80 (other steroidal side-chain 
methyl protons). 
" C N M R (CDCI3) : d 212.21 (C=0), 169.42 (C=0 of acetate), 141.29 
(C5), 120.95 (C4), 40.19 (C of CH3-N<), 55.48 (Cr), 
57.15 (Ce-), 36.57 (Ci), 31.69 (Cj), 67.94 (C3), 49.23 
(Ce), 52.68 (Cg), 41.63 (C9), 37.05 (Cio), 18.19 (Cn), 
32.53 (C,2), 36.84 (C13), 49.86 (CM), 23.88 (C15), 
19.89 (C16), 43.08 (C17), 20.54 (Cig), 21.64 (C19), 
33.21 (C20), 19.93 (C21), 36.73 (C22), 29.24 (C23), 
36.54 (C24), 31.01 (C25), 22.85 (C26), 22.64 (C27), 
17.86 (C of acetate). 
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4-thiazolidinones and their benzylidene derivatives display a large variety of 
activities such as antibiotic, diuretic, organoleptic, tuberculostatic, antileukemik and 
antiparasitical.^ '^  To our knowledge, little is known on fused thiazolidines known to 
possess these activities. 
Thiazolidinones are classified as doubly unsaturated five membered 
heterocyclic compounds contain one nitrogen, one sulphur and three carbon atoms 
including a carbonyl group. Our continuous interest in the preparation and study of 
reactions of 4- thiazolidinones prompted us to examine under varied conditions to 
determine their cyclization reactions for new steroidal thiazolidinone compounds. 
HN-
0 
Here we are giving some recent methods reported by different workers for the 
preparation of thiazolidinone derivatives. 
Moawad et al^ reported that reaction of SchifF base 2 with mercaptoacetic 
acid in dry benzene afforded thiazolidinone 3. SchifF base 2 was obtained by the 
condensation of 3,4-xylene sulphonate ester of p-hydroxy benzaldehyde 1 with p-
aminobenzoic acid. 
CH3 
S03-{^ VcHO 
1 
Thioglycolic acid 
Amino benzioc acid 
• 
^^^"iX^^^'^'C /"COOH 
COOH 
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Gursoy et al.^ prepared new compounds 4 and 5 incorporating the quinazoline 
moiety. Compounds 5 showed promising anticonvulsant activity. 
CeHs 
N SCH2CONHNH-C-NH-R' ^ SCH2CONHN=^ 
N-
Ansari et al.^ synthesized 4-thiazolidinone 8 starting from chalcone 6, by two 
different route as shown in the following scheme. 
""(D~«"^=''""0"° 
HSCH2C00H 
(NH4)2C03 
HSCHjCOOH 
-TT^C-CH^-CH-HQ^-
^—^ S NH 4 ^— 
^ i ^—COOH 
8 
HSCH2C00H 
(NH4)2C03 
CI-(Vc-CH2-CH O CI 
COOH 
El-masry et al. reported that condensation of compound 9 with aromatic and 
heterocyclic aldehydes in absolute ethanol afforded the corresponding Schiff s bases 
10. The cyclocondensation of some substituted SchifFs bases with thioglycolic acid 
and thiolactic acid afforded the corresponding thiazolidinone 11 and 12. 
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N J RCHO 
N 
CH2CH2CONHNH2 
N J 
R = 
N 
CH2CH2CHONH2-N f 
11 
-©-N(CH3)2 
N 
ji 
N 
CH2CH2CONHN=CHR 
10 
Thiolactic acid 
07 
CH2CH2CHONH2-N—r' 
CH3 12 
R 
Anthonsen et al7 synthesized 2-imino-3-(4-arylthiazol-2-yl)-thiazolidin-4-
ones 15 via the key intermediates, 2-amino-4-arylthia2oles 13 which were reacted 
with chloroacetyl chloride to produce the corresponding 2-chloro-acetamido-4-
arylthiazoles 14. The latter was treated with potassium thiocyanate in refluxing 
acetone to afford the related product 15. 
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0 S 
JL + A 
Ar'^^CHa H2N NH2 
I2 
NH3. H2O 
' ^ / ^ 
L J ^ N H , CICOCHzCI^  
13 
i + A 
Ar^^CHsX H2N NH2 
X = CI, Br, 1 
14 
KSCN 
ATV 
HN Ui 
15 
Ocal et al^ synthesized substituted 4-thiazolidinones 17 by the reaction of 
mercaptoacids with aldimines 16 which were obtained by the condensation of pyrrole-
2-carbaldehyde with different aromatic amines. 
'^J^^»-^-{^^ 
H 
R= H, CH3 
16 
SH 
CH 
R'' COOH 
Abbady et al^ obtained 4-acetyhhiosemicarba2one-4'-acetyl diphenyl 
sulphone 18 and 4-acetylthiosemicarbazone-4'-acetyldiphenyl sulphide 19 which on 
further reaction with ethylchloroacetate in the presence of fiised AcONa gave 4-
(4"-thiazolidinone-2"-acety]azino)-4'-acetyldiphenyl sulphone 20 and 4-(4"-
thiazolidinone-2"-acetyla2ino)-4'-acetyldiphenyl sulphide 21, respectively. 
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o 
\ CH3 
0 
18 
0 
H 3 C - C H Q - S ^ - C = N - r 
CH3 
19 
s 
II 
-NH—C—NH2 
^ Ethyl chloroacelae 
>sAcONa 
X 0 
H3C 
CH-. 
^ Ethyl chloroacetae 
AcONa 
II 
gH-C-NH2 
21 
x-s,s 1 
0 
HN C*° 
-^v 
9,21 
Parekh et al.^° prepared that substituted SchifFs bases 23 by the treatment of 
2-amino-4-(a-methoxyiminocarbomethoxymethyl)-thiazole 22 with different aromatic 
aldehydes, which on cyclocondensation with mercaptoacetic acid and 
mercaptopropionic acid in dry benzene furnished desired thiazoUdinones of type 24 
and 25 respectively. The products were evaluated for their in vitro growth inhibiting 
activity against several microbes. Some of them showed significant anti-tubercular 
and antifungal activity. 
CH3 
CH3 n ' 
I %^0 
CH3 
H2N 
N 
22 " 23 
HSCH2COOH/ \ CH-SH 
COOH 
CH3 ; l CH3 
V° Y° 
N - ^ N ^ N 
24 " 25 
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Monforte et al}^ reported the synthesis of 2,3-diaryl-l,3-thiazolidin-4-ones 28 
by reacting an aromatic aldehyde 27 with an equimolar amount of (hetero)aromatic 
amine 26 in the presence of an excess of mercaptoacetic acid. The microwave-
irradiation dramatically shortened the reaction times, affording the desired products in 
high yields. 
R2 
X 
Y ^ N H 2 
26 
HSCH2COOH 
* -
27 
X = CH,N R'=Me,OMe,Br, R'* = H,Me 
Y = CH,N R^  = H,Me R5 = C1,F 
R^  = CI, F 
Terzioglu and his coworkers^^ synthesized the target compounds, 2-(3-ethyl-
4(3H)-quinazolinone-2-ylmercaptoacetylhydrazono)-3-alkyl/aryl-5-methyl-4-
thiazolidinones 30 and 2-arylimino-3-(3-ethyl-4(3H)-quinazolinone-2-
ylmercaptoacetylamino)-5-methyl-4-thiazolidinones 31 by the cyclization of 3-ethyl-
4(3H)-quinazolinone-2-ylmercaptoacetyl)-4-alkyl/arylthiosemicarbazides 29 with 
ethyl 2-bromopropionate in presence of anhydrous sodium acetate in absolute 
ethanol. 
O 
CHaBrCHCOOEt 
CHaCOONa 
abs. ethanol 
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Altintas et al}^ synthesized by refluxing of 4-carbethoxymethyl-2-[(a-
chloropropionyl/a-bromobutyryl/a-chloro-(a-phenyl)acetyl)amino]thiazoles 33 with 
ammonium thiocyanate to obtain 4-thiazoIidinone 34. 
5-(N,N-disubstituted aminomethyl-2-[(4-carbethoxymethyhhiazol-2-yl) imino]-
4-thiazolidinones 34 was evaluated as antibacterial and antifungal activities. 
C2H5OCOH2C 
r •N •NH: 
32 
-HX 
C2H5OCOH2C 
R-CHX-CO-X 
•N 
.X R I NHCOCHX 
33 
NH4SCN 
CH2O + R'-H 
C2H5OCOH2C 
a-o-" 
s 
34 
CH2R' 
R - CH3, C2H5, CgHs 
X = CI, Br 
Sriram et al.^'* reported that the synthesis of the 2,3-diaryl-l,3-thiazondin-4-
ones 37 was accomplished by reacting substituted benzaldehyde 36 with equimolar 
amount of an appropriate substituted aromatic amine 35 in the presence of an excess 
of mercaptoacetic acid in toluene under microwave irradiation. Unlike the 
conventional methods (reaction time 48 h and yields of 30-70%), microwave-assisted 
reactions were very facile (6-8 min.) and provided very good yields (64-82%). [Ar = 
4-F-C6H4-,R = 4-Cl,2-Cl] 
Ar-NH2 + 
35 
HSCH2C00H 
» 
Toluene 
MWI 
37 
Arya et al.^^ prepared J5p/ro[indole-thiazolidines] 40 by the multicomponent 
condensation between indole-2,3-dione 38, amines 39 and marcaptoacetic acid using 
37 
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montmorillonite KSF as solid support in 85-90% yield in 4-5 min under MW reaction 
conditions. 
I HSCH2COOH I \ ^ 
38 39 40 
X = H, 5-CI, 5-CH3; Y = H, OCH3; Z = 4-N(CH3)2, 4-OCH3, 3-OCH3, 4-CH3 
Desai et al.^^ synthesized 4-thiazolidinones 42 in a good yields from the 
heterocyclization reaction of 2-(benzothiazol-2-ylthio)-N'-ben2ylideneacetohydrazide 
41 with mercaptoacetic acid in DMF in the presence of catalytic amount of anhydrous 
ZnCh under microwave irradiation and compared with conventional methods. 
N H 
12C( 
41 
SHCH2C00H 
%—SCH2CONHN ^ ~ \ ^ / 
S O^^s^^ 
42 R = 4-NO2, CH3 
-Y 
\—SCH2C0NHN=C—^\ /) 
Nagarajan et al.^^ synthesized £"-thiazolidinone 45 by the cyclization of 
acetylene dicarboxylic ester 43 with thiocarbamoyl derivatives 44. 
C02Me 
+ RHN-C-NHR 
C02Me 
43 44 
38 
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Sahu et al.^^ reported that condensation of substituted benzaldehydes 46 with 
primary aryl amines 47 gave a series of Schiff bases 4S which, on reaction with 
mercaptoacetic acid, resulted in the formation of the corresponding 4-thiazolidinones 
49 
^ 
46 
CHO + Ar-NH2 
47 
EtOH i^ ^—CH=N-Ar 
48 
HSCH2C00H 
Ar = 4-NO2, Phenyl, 4-CI Phenyl and Naphthyl 
R = 2-OH, 4-N(CH3)2, 4-N02, 4-CI and 4-OCH3 i \—CH—N—Ar 
49 
Desai and shah'' synthesized series of 2-(substituted phenyl)-3-[4-(2,4-
dichloro-5-fluorophenyl)-6-(2-thienyl)pyrimidine-2-yl-ureido]5///methyl/carboxy 
methyl-4-thiazolidinones 53. It starting with compound 50 and employing the 
following reaction scheme. 
F 
RCHO Methyl chloroformate 
• II 1 
Hydrazine hydrate ^ ' N N 
NH. .NHNH2 
51 Y 
O 
HS-CH-COOH 
NH^ ,NH-N 
53 
V^^-Vx 
R=aryl; X= H, CH3, CH2COOH 
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Terzioglu etal.^° synthesized a series of 5-nitro-3-[(5-nonsubstituted/inethyl-4-
thiazolidinone-2-yli(iene)hydrazono]-l//^-2-indolinones 55 by cyclization of 5-nitro-
l//-indole-2,3-dione-3-thiosemicarbazones 54 with ethyl bromoacetate or ethyl 2-
bromopropionate. 
N-NH 
H-N 
R2 
y 
N - N 
54 
Cacic et al^^ reported the cyclization of thiosemicarbazide 56 with 
chloroacetylchloride in chloroform which afforded thiazolidinone derivative 57. 
Mir et al^^ reported a rapid and easy solvent free one-pot synthesis of 5-
arylidene-2-imino-4-thiazolidinones 60 by condensation of the thioureas 58 with 
chloroacetic acid and an aldehyde 59 under microwave-irradiation. 
R2 
S 
X 
RiHN NHPh 
58 
Ry = Ph, 4-Methylpyridin-2-yl 
R2CHO 
59 
CICH2COOH 
R2 = 
OMe N^  N^ 
Me ^Me Me' Me 
40 
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Cao et al^^ reported the reaction of l,4,5,6-tetrahydro-6-pyridazinone-3-
carboxylic acid hydrazides 61 with aromatic aldehydes which afforded 1,4,5,6-
tetrahydro-6-pyridazinone-3-carbonyl aromatic aldehyde hydrazones 62. Hydrazones 
62 cyclized with mercaptoacetic acid in DMF in the presence of anhydrous ZnCb to 
afford 1,3-thiazolidinone derivatives 63. 
O J—y O 
o=C\o-mm2 ^^^° > o=< >-c-NHN=cH-R 
61 
62 
HSCH2COOH 
0.> 
0=< y - C - N H — N — ( 
HN-N R 
63 
R = CeHs, p-MeOC6H4, p-NMe2C6H4, 0-NO2C6H4, m-N02C6H4, m-OMe-p-OHCeHs 
Rollas and Kucukguzel '^' synthesized 4-thiazoIidinones 65 by reacting 
hydrazones 64 reacted with mercaptoacetic acid/thiolactic acid. 
,0 
A r - C - N H - f 
A r - C - N H - N = C H — R • 11 
11 O . 
O R S 
N f 
.JkJ 
«" 65 
Turgut et al^^ prepared 4-thiazolidinones 68 by the Katti carbodiimide (DCC) 
mediated one-pot three component condensation reaction of an aromatic amine 67, an 
aldehyde 66 and mercaptoacetic acid. 
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" ^ ^ ^ O H 
H3CO 
• • -
DCC/THF 
66 67 
68 
X = CH3, CI, OCgHs, OCH3, OC2H5 
Shiradkar^ ^ reported that various aryl-thioureas 69 on treatment with ethyl 
chloroacetate 70 and fused sodium acetate in absolute ethanol gave 2-arylimino-4-
thiazolidinones 71. 
Ar 
s o \y^o 
69 70 7j 
Ameta et al. reported a fast and facile procedure for the synthesis of 
pyridothiazolidinone 75 starting from dihydropyridine 72. Oxidation of 72 with 
nitrating mixture (HNO3/H2SO4) produced the anticipated 2,6-dimethylpyridine 
derivatives 73, which were subsequently condensed with thiosemicarbazide in ethanol 
to produce the key intermediate 2,2-[4-(4-substitutedphenyl)-2,6-dimethylpyridine-
3,5-diyl]dicarbonyldihydra2ine carbothioamides 74. Compound 74 finally provided 
75 on reacting with CICH2COOH and CHaCOONa. 
All the reactions were carried by conventional as well as microwave method. 
The potent antimicrobial effects of the synthesized compounds were also investigated. 
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Thiosemicarbazide I jf ° HNO3 H2S04^  J l J 
H 3 C " H " CH3 ^ ~ " " ^ ^ N \ H 3 8-10 min 
72 73 
H 3 C ^ N ^ C H 3 6-8 3 min ^ HaC^ N CH3 
74 75 
AT = 4-F-C6H4, 4-CI-C6H4, 4-OCH3C6H4, 4-NO2-C6H4, C6H5 
Yan et al^^ reported the construction of 4-thiazolidinone ring 78 by a three 
component reaction of fluorous benzaldehydes 77, an amine and mercaptoacetic acid. 
Compound 77 was readily prepared from 76. 
HO' 
o 
76 77 
R^  = H. OMe; R^ = n-Butyl, n-Me-Ph; R^ = H, Me 
Talesara et al}^ also synthesized 2-amino-5-(4'-pyridyl)-l,3,4-thiadiazole 80 
by cyclization of isonicotinoylthiosemicarbazide 79 with cone, sulphuric acid. When 
80 was refluxed with various aldehydes, it gave the corresponding arylidene 
derivatives 81 which on further treatment with mercaptosuccinic acid furnished 
thiazolidinone derivative 82. Another thiazolidinone derivative 2-
isonicotinoylhydrazido-I,3-thiazolidinone 83 was obtained by the successive 
treatment of isonicotinoylthiosemicarbazide 79 with chloroacetic acid in the 
presence of sodium acetate. [Ar = 4-OCH3C6H4, 4-CIC6H4, 3,4,5-OCH3C6H2, 3-
NO2C6H4, 4-NO2C6H4, 4-(CH3)2NHC6H4, C6H5, C4H30(2-furyI)]. 
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/ = \ N-N 
cy H'V ^^^ .Q^x^.^^ ,Q<-^ jL^  
79 
CICH2COOH 
° M H 
83 
80 
I 
81 Ar 
Mercaptosuccinic acid 
^ ^ N-N 
82 
0 ' \ ( ^ OH 
b 
Literature has revealed that very few steroidal thiazolidinones have been 
prepared and studied so far. 
Shafiullah and Ali''° reported the synthesis and mass spectral studies of the 
spiro (cyclocholestane) thiazolidinones 84 and 85. Steroidal extranucleo 
thiazolidinones^^ of cholestane series 86 and 87 were also prepared by cyclising the 
respective thiosemicarbazones with CICH2COOH. 
p8Hl7 
85 
AcO 
CsHi? 
HN ]=:N-N 
87 
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r32 1 _ Siddiqui et al. prepared C-24 thiazolidinone derivatives 89 [R = H, OH, R = 
>2 -H] of bile acids from esters 88 [R = OMe] in three steps involving hydrazinolysis 
with NH2NH2 to give 88 [R^  = NHNH2], reaction with potassium or ammonium 
thiocynate to give 88 [R = NHNHC(S)NH2] and finally cyclocondensation with 
chloroacetic acid in presence of anhydrous sodium acetate and AcOH. 
C 0 R 2 
88 
CHONH=T -NR^ 
S v > ^ o 
45 
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Introduction 
Thiazolidinones have been reported to show versatile pharmacological 
activities. They have been reported as COX-1 inhibitor,''^  anti-inflammatory,'''* 
antiproliferative,^ ''^ ^ antihistaminic,^ ^ anti-HIV,''^ '''' hypnotic,'*" anaesthetic,'*' 
antifungal,'*^ anthelmintic'*^ and antiviral'*'* agents as well as CNS"*' stimulants. 4-
Thiazolidinones and their derivatives'*^ exhibit unusually high activity against 
Mycobacterium tuberculosis. Recently, a number of 2-pyridyl substituted 4-
thiazolidinones have been synthesised and found to exhibit highly potent and selective 
anti-Platelet Activating factor activity both in vitro and in v/vo.'*' 
2-Arylimino-4-thiazolidinone derivatives have also showed antibacterial,'**''*' 
antifungal,'" anticonvulsant ''"'^ and anticancer'^  activities. 
For a long time imines have been used successfully in the synthesis of 
nitrogen containing heterocycles.''* As part of ongoing project aimed at the synthesis 
of bioactive 4-thiazolidinone, we employed the SchifF bases 93, 98, 103, and 108 
towards their synthesis. 
H C = N - C H 2 C H 2 - N ' ^ ' ' ' ' ^ ^ ^ 
6 N-CH2CH2-N=CH-/~^ R 
98 H 
103 CI 
108 OAc 
Furthermore, most of the 4-thiazolidinones and their benzylidene derivatives 
display a large variety of activities such as antibiotic, diuretic, organoleptic, 
tuberculostatic, antileukemik and antiparasitical.""'^  
The pharmacological properties of 4-thiazolidinones encouraged our interest 
in synthesizing several new compounds featuring various heterocyclic rings, attached 
to 4-thiazolidinone moieties. As a part of our aim to search for biologically active 
heterocycles containing sulphur and nitrogen, we have undertaken the synthesis of 
some steroidal 1,3,4-thiazolidinones, eg. cholest-5-en-(ii?)-^/>o-3,3'-aminoethyl-
l',3',4'-thiazolidinone 92, cholest-5-en-(3i?)-5p/ro-3,3'-[2"-(2"'-phenyl-l"',3"',4"'-
thiazolidinon-3"'-yl)ethyl]-l',3',4'-thiazolidinone 94, 5a-cholestan-(6i?)-5/7/ro-6,3'-
46 
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aminoethyl-1 ',3',4'-thiazolidinone 97, 5a-cholestan-(6i?)-^/ro-6,3'-[2"-(2'"-phenyl-
l"',3"',4"'-thiazolidinon-3*"-yl)]ethyl-r,3',4'-thiazolidinone 99, 3^-chloro-5a-
cholestan-(6i?)-^/ro-6,3'-aminoethyl-r,3',4'-thiazolidinone 102, 3^-chloro-5a-
cholestan-(6i?)-^/ro-6,3'-[2"-(2'"-phenyl-r",3'",4"'-thia2olidinon-3'"-yl)]ethyl-l',3',4'-
thiazolidinone 104, 3y9-acetoxy-5a-cholestan-(6i?)-5/7/>o-6,3'-aminoethyl-1 ',3',4'-
thiazolidinone 107, 3^-acetoxy-5a-cholestan-(67?)-5p7>o-6,3'-[2"-(2"'-phenyl-
r",3'",4'"-thiazolidinon-3"'-yl)]ethyl-r,3',4'-thiazolidinonel09. 
° °^>-o 
94 
H ^ '''''N-CH2CH2-NH2 
R 
97 H 
102 CI 
107 oAc 
R 
99 H 
104 CI 
109 OAc 
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Reaction of cholest-5-en-3-one 90 with ethylenediamine; 3-
faminoethylimino)cholest-5-ene 91: 
A solution of cholest-5-en-3-one 90 (in methanol) was refluxed with 
ethylenediamine in equimolar ratio for 1 h. After completion of reaction (monitored 
by TLC), excess of solvent was removed under reduced pressure and the residue thus 
obtained was purified over silica gel column. Recrystallization from ethanol provided 
compound 3-(aminoethylimino)cholest-5-ene 91 as solid having m.p. 125 °C in 79 % 
yields. 
NH2-H2CH2C 
90 91 
Characterization of compound 91 having m.p. 125 "C as 3-(aminoethvl 
imino)cholest-5-ene: 
The compound 91 was correctly analysed for C29H50N2. The IR spectrum of 
compound 91 displayed important characteristic peaks at 3516 (NH2), 1626 (C=C), 
1613 (C=N) and 1229 cm'' for C-N." The ' H N M R spectrum of compound 91 
showed two singlets integrating for two protons each at S 8.65 and 2.91 for -NH2 
(exchangeable with deuterium) and C4-//2 respectively, and a double doublet for Cs-
olefmic proton at S 5.37 {J = 8.1, 6.4 Hz). Two fiised triplets for two protons each 
appeared at S 2.39 (C//2-NH2) and 2.08 (C=N-C/f2) of aminoethyl group. Angular and 
side-chain methyl protons appeared at ^ 1.14 (C10-C//3), 0.74 (C13-C//3), 0.93, 0.82 
(other steroidal side-chain methyl protons).'* 
Thus on the basis of above evidence, solid compound 91 has been 
characterized as 3-(aminoethylimino)cholest-5-ene. 
48 
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Reaction of 3-(aminoethvlimino)cholest-5-ene 91 with mercaptoacetic 
acid; Cholest-5-en-(3R)-spi>o-3^'-aminoethvl-l',3',4'-thiazolidinone 
92: 
A solution of 3-(aminoethylimino)cholest-5-ene 91, in dioxane was refluxed 
with mercaptoacetic acid and few drop of cone. H2SO4 for 6 h. After completion of 
reaction (monitored by TLC), excess of the solvent was removed under reduced 
pressure and the resulting residue was poured in excess of ice cooled water. After 
usual workup, purification and subsequent recrystallization of the product from 
ethanol provided compound cholest-5-en-(ii?)-5/7/'ro-3,3'-aminoethyl-r,3',4'-
thiazolidinone 92 as solid having m.p. 133 °C in 71 % yields. 
I I HS-CH2COOH 
in dioxane H2N-H2CH2C 
91 
Characterization of compound 92 having m.p. 133 "C as cholest-5-en-
(3RVspi>o-33'-aminoethvl-l'3',4'-thiazolidinone; 
The compound 92 was correctly analysed for C31H52N2OS. Its IR spectrum 
displayed important characteristic peaks at 3510, 1649, 1624, 1223 and 666 cm'' for 
(NH2), (C=0), (C=C), (C-N) and (C-S) respectively.^ ^ The ' H N M R spectrum of 
compound 92 displayed three singlets integrating for two protons each at d 8.19 
(exchangeable with deuterium), 3.47 and 2.94 for N//2, CH2-S and C4-//2 and two 
triplets integrating for two protons each at d 2.26 and 2.08 for C1-//2 and Ci^-Hi, 
respectively. One proton double doublet was seen at 6 5.22 {J= 6.8, 4.9 Hz) for Ce-
olefinic proton. Angular and side-chain methyl protons appeared at (5 1.16 (C10-C//3), 
0.70 (C13-C//3), 0.91, 0.80 (other steroidal side-chain methyl protons).^ * 
'•'C NMR spectra of compound 92 showed characteristic peaks ZAS 171.59 and 
37.36 for carbonyl and methylene carbon atoms of thiazolidinone ring, respectively. 
Other important peaks were at 6 58.9 (C3), 48.53 and 42.61 for two carbon atoms of 
aminoethyl group. Other carbon atoms of steroidal skeleton appeared at expected 
regions. 
49 
Ckapterll 
Thus on the basis of above evidence, solid compound 92 has been 
characterized as cholest-5-en-(5i?)-5p/>o-3,3'-aminoethyl-1 ',3',4'-thiazoHdinone. 
MECHANISM OF REACTION; 
J CH2--H2C-NH2 
92 
-H2O 
H O / ) " " 
t ^ "CH2-H2C-NH2 
Scheme 1 
Stereochemistiy of 3-spiro thiazolidinone 92: 
Steroidal thiazolidinone 92 has C3-S bond axially and C3-N bond as 
equatorially oriented. It could be explained on the basis that during cyclization 
(Scheme 1) the lone pair of sulphur of mercaptoacetic acid attack preferentially from 
axial (a) side and pushes the bulky (NCH2CH2NH2) group to be equatorial iP) side to 
avoid the 1,3-diaxial interactions. Therefore the obtained product 92 has R geometry 
at C3 in which C3-S and C3-N bond are axially (a) and equatorial {fi) oriented 
respectively. 
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Reaction of 3-(ammoethvlmimo)cholest-5-ene 91 with benzaldehyde: 
3-(2^-N-benzylidinethvDiminocholest-5-ene 93: 
A solution of 3-(aminoethylimino)cholest-5-ene 91 in methanol was refluxed 
with benzaldehyde for 3 h 20 min. The completion of reaction was monitored by 
TLC, excess of solvent was removed under reduced pressure and the residue thus 
obtained was purified over silica gel column. Recrystallization from ethanol provided 
compound 3-(2'-A'-benzylidinethyl)iminocholest-5-ene 93 as needle like solid, having 
m.p. 120 °C in 82% yields. 
H r S r ceH.cHo , M J C U 
K i t f : ^ ^ ^ J * " HC=N-CH2CH2 
0 91 93 
Characterization of compound 93 having m.p. 120 °C as 3-l2'-N-
benzylidinethvl)iminocholest-5-ene: 
The obtained product 93 was correctly analysed for C36H54N2. Its IR spectrum 
exhibited characteristic absorption bands at 1624 (C=C), 1616, 1610 (C=N), 1580, 
1542, 1498 (aromatic ring) and 1230, 1190 cm'' (C-N)." The 'H N M R spectrum of 
compound 93 displayed two singlets integrating for one and two protons respectively 
at S 6.02 (CH-Ai) and 3.12 (C4-H2). Five aromatic protons were observed at S 7.13-
6.94. A one proton double doublet appeared at S 5.41 (J= 7.1, 5.2 Hz) for Ce-olefmic 
proton. Methylene protons of benzylidinethylimino group appeared at S 2.83 and 2.42 
as two fused triplets. Angular and side-chain methyl protons appeared at <5 1.15 (Cio-
CHj), 0.72 (C13-CH3), 0.92, 0.84 (other steroidal side-chain methyl protons).^ ^ 
In its '^ C NMR spectrum characteristic signals were observed at ^ 151.80 for 
benzylidine carbon atom and 50.56, 52.66 for the two carbon atoms of iminoethyl 
group. Carbon atoms of aromatic ring appeared at S 137.6-129.7. Other signals at S 
31.28, 167.86, 32.91, 151.08 and 129.9 were attributed to C2, C3, C4, C3 and Ce of 
steroidal skeleton respectively. 
Thus, on the basis of above discussion compound 93 has been characterized as 
3-(2'-A'-benzylidinethyl)iminocholest-5-ene. 
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Reaction of 3-(2^-N-ben2ylidinethyl)iminocholest-5-ene 93 with 
mercaptoacetic acid: Cholest-5-en-(3R)-s;ytro-3^'-r2''-(2"'-phenyl-
1^^^^^^^4^^^-thiazolidinon-3^^^-vl)ethvn-1^^^4^-thiazolidinone94: 
A mixture of compound 93, mercaptoacetic acid and few drops of cone. 
H2SO4 in dioxane was refluxed with continuous stiring for 10 h. After completion of 
reaction, usual workup and purification of the product by column chromatography, a 
non-crystallizable semi-solid compound 94 was obtained in 64 % yields. 
HC=N-CH2CHr^^^- ' ' ' ^^ ^"-^^^^^^i 
93 
'^>-0 
94 
Characterization of compoiind 94 as cholest-5-en-(3R)-spfro-3^^-f2''-
(2"^-phenvl-1^^^3''^4^^^-thiazolidinon-3^^^-vl)ethvn-1^^^4^-
thiazolidinone: 
The compound 94 was correctly analysed for C4oH5gN202S2. Its IR spectrum 
exhibited characteristic absorption bands at 1690, 1656 (two C=0 of thiazolidinone 
rings), 1622 (C=C), 1584, 1530, 1492 (aromatic ring), 1240, 1232 (C-N) and 681, 677 
cm"' (C-S-C).'' The 'H N M R spectrum of compound 94 displayed two singlets 
integrating for two protons each at ^ 3.78 (C5-//2) and 3.69 (CS-^HT). The methine 
proton CH-AT of second thiazolidinone ring appeared as another singlet for one 
proton at S 5.23. Five aromatic protons were observed as multiple! at S 7.25-7.15 and 
C6-olefinic proton appeared as double doublet at S 5.79 (J= 8.04, 6.3 Hz). Methylene 
protons {Cr-Hj and Cx^-Hi) appeared at <5 3.55 and 3.40 as fused triplets. Angular and 
side-chain methyl protons were observed at ^ 1.12 (Cio-Ci/3), 0.71 (C13-C//3), 0.91, 
0.83 (other steroidal side-chain methyl protons).'^ 
In its '^ C NMR spectrum, characteristic signals were observed at d 170.02 and 
168.53 for two carbonyl carbons, 36.59 and 35.81 for the methylene carbon atoms of 
thiazolidinone rings. Other important peaks were S 51.46 (Cr), 52.60 (C2") of ethyl 
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group and 46.52 for CH-Ar. Carbon atoms of aromatic ring were observed at S 138.7-
132.1. Signals at S 31.42, 169.06, 31.81, 153.28 and 127.41 were assigned for C2, C3, 
C4, C5 and Ce of steroid skeleton respectively which were in the expected regions. 
Thus, on the basis of above evidence the semi-solid product 94 has been 
characterized as cholest-5.en-(3.R)-5p//'o-3,3'-[2"-(2"'-phenyl-l"',3"',4'"-thiazolidinon-
3"'-yl)ethyl]-r,3',4'-thiazolidinone. 
MECHANISM OF REACTION; 
94 
2H2O 0 4 H2C-CH2 
H2 
HO^ 
^ 
Scheme 2 
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Stereochemistry of 3-spiro thiazolidinone 94: 
Stereochemistry of thiazolidinone 94 as 3R has been assigned similarly 
established as was done in the case of thiazolidinone 92. 
The formation of thizolidinone 94 from steroidal 
benzylidinethyl)iminocholest-5-ene 93 can be explained on the basis of the proposed 
mechanism (Scheme 2). 
Reaction of 5g-cholestan-6-one 95 with ethylenediamine: 6-
(aminoethylimino)-5«-cholestane 96: 
A solution of 5a-cholestan-6-one 95 in methanol was refluxed with 
ethylenediamine for 1 h 40 min. After completion of reaction (monitored by TLC), 
excess of solvent was removed under reduced pressure and the residue thus obtained 
was purified over silica gel column. Recrystallization from ethanol provided 6-
(aminoethylimino)-5a-cholestane 96 as soHd having m.p. 118 °C in 74 % yields. 
u 
N—CH2CH2-NH2 
96 
Qiaracterization of compound 96 having m.p. 118 °C as 6-
(aminoethvlimino)-5g -cholestane: 
The obtained compound 96 was correctly analysed for C29H52N2. Its IR 
spectrum exhibited characteristic absorption bands at 3513 (NH2), 1610 (C=N) and 
1219 cm"' (C-N)." The ' H N M R spectrum of compound 96 displayed a two-proton 
broad singlet at d 8.96 for N/f^  (exchangeable with deuterium). Four methylene 
protons of aminoethyl group appeared as two fiased triplets at 6 2.25 and 2.16. 
Angular and side-chain methyl protons were observed at (51.13 (Cio-C/6), 0.76 (Co-
CH3), 0.90 and 0.84 (other side-chain methyl protons).'^ 
Thus, on the basis of above evidences the solid compound 96 has been 
characterized as 6-(aminoethylimino)-5a-cholestane. 
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Reaction of 6-(aminoethylimino)-5g-cholestane 96 with mercapto 
acetic acid: 5«-Cholestan-(6R)-spt^ro-6^^-aminoethyl-1^^^4^-
thiazolidinone 97: 
A mixture of 6-(aminoethyIimino)-5a-cholestane 96, mercaptoacetic acid and 
few drops of cone. H2SO4 in dioxane was refluxed with stirring for 6 h. After 
completion of reaction (monitored by TLC), excess of the solvent was removed under 
reduced pressure and the resuhing residue was poured in excess of ice cooled water. 
Usual workup, purification by column chromatography and recrystallization of the 
crude product from ethanol provided the compound, 5a-cholestan-(6/?)-^/>-o-6,3'-
aminoethyl-r,3',4'-thia2olidinone 97 as solid having m.p. 129 °C in 68J^Q yi^ JjjIj-
HS-CH2COOH 
»-
dioxane 4? 
^ N-CH2CH2-NH2 
96 Characterization of compound 97 having m.p. 129 "C as 5«-cholestan-
f6R)-spiro-6^^-aminoethvl-1^^^4^-thiazolidinone: 
The product 97 was correctly analysed for C31H54N2OS. Its IR spectrum 
exhibited characteristic absorption bands at 3522 (NHj), 1642 (C=0 of thiazolidinone 
ring), 1227 (C-N) and 670 cm'' (C-S)." The 'H NMR spectrum of the compound 97 
displayed two singlet integrating for two protons each at 6 8.11 (exchangeable with 
deuterium) for N//2 and ^3.33 assigned to methylene protons of thiazolidinone 
moiety. Two fused triplets appeared at 5 3.12 and 3.08 for methylene protons of 
aminoethyl group. Angular and side-chain methyl protons were observed at ^ 1.17 
(C10-C//3), 0.71 (C13-C//3), 0.92, 0.83 (other steroidal side-chain methyl protons).^ ^ 
'^ C NMR spectra of compound 97 showed characteristic peaks at 6 173.15 
(carbonyl carbon), 38.64 (methylene carbon of thiazolidinone ring) and 65.76 for Ce. 
Other important peaks were at 6 44.28 and 41.35 for two carbon atoms of aminoethyl 
group, 63.52 (C5) and 47.08 (C7). Other carbon atoms of steroidal skeleton appeared 
at expected regions. 
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Thus, on the basis of above evidence, solid compounds 97 has been 
characterized as 5a-cholestan-(6i?)-5p//-o-6,3'-aminoethyI-1 ',3',4'-thiazoIidinone. 
Stereochemistry of 6-spiro thiazolidinone 97: 
Steroidal thiazolidinone 97 has been assigned as 6R geometry at Cs. It might 
be explained on the basis that nucleophilic attack of sulphur is preferably from axial 
(^) side and the bulky group is moved towards less crowded equatorial (a) side to 
avoid 1,3-diaxial interactions mainly due to the Cio-yS-CHa. Therefore, the product 
(thiazolidinone) 97 has R geometry at Ce and this arrangement provides the greater 
stability to the molecule. 
Reaction of 6-(aminoethvlimino)-5g-cholestane 96 with benzaldehyde 
; 6-f2^-N-benzvlidinethvnimino-5a-cholestane 98: 
A solution of 6-(aminoethylimino)-5a-cholestane 96 and benzaldehyde in 
methanol was refluxed for 3 h. After completion of reaction (monitored by TLC), 
excess of solvent was removed under reduced pressure and the residue thus obtained 
was purified over silica gel column and recrystallization from ethanol provided 
compound 6-[2'-iV-benzylidinethyl]imino-5a-choIestane 98 as solid having m.p. 116 
°C in 74 % yields. 
CeHsCHO 
" N-CH2-CH2-NH2 N - C H 2 C H 2 - N = C H - ^ 
96 ofi 98 
Characterization of compound 98 having m.p. 116 °C as 6-F2^ -JV-
benzylidinethvl1imino-5«-cholestane: 
The product 98 was correctly analysed for C36H56N2. Its IR spectrum exhibited 
characteristic absorption bands at 1626, 1617 (C=N), 1583, 1549, 1497 (aromatic 
ring) and 1233, 1224 cm"^  (C-N)." The H^ NMR spectrum of the compound 98 
displayed a singlet for one proton at S 5.11 for CH-Ai and two fused triplets 
integrating for two protons each at d 2.73 and 2.61 for methylene protons of 
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benzylidinethyl group. Five aromatic protons were observed at S 7.10-6.96. Angular 
and side-chain methyl protons were observed at ^ 1.11 (C10-CH3), 0.73 (C13-C//3), 
0.91, 0.82 (other steroidal side-chain methyl protons).^ ^ 
In its ^^ C NMR spectrum, characteristic signals were observed at S 167.01 
(C=N of benzylidine group). Carbon atoms of aromatic ring appeared at S 133.2-
128.71 and 49.06, 44.31 for two methylene carbons of iminoethylene chain. Signals at 
3 25.36, 39.31, 168.91 and 29.63 were ascribed to C4, C5, Ce and C? of steroidal 
skeleton, respectively. 
Thus, on the basis of above evidence the solid product 98 has been 
characterized as 6-[2'-A^-benzylidinethyl]imino-5a-cholestane. 
Reaction of 6-f2^-N-benzylidinethynimino-5g-cholestane 98 with 
mercaptoacetic acid: 5a-Cholestan-f6JR)-spt'ro-6J^-f2"-(2'''-phenyl-
1^^^^^^^4^^^-thiazolidinon-3^^^-vl)^ethvl-1^3^4Mhiazolidinone99: 
To a solution of 6-[2'-A^-benzylidinethyl]imino-5a-cholestane 98 and 
mercaptoacetic acid in dioxane, few drops of cone. H2SO4 were added. The reaction 
mixture was refluxed with continuous stirring for 7 h. After completion of reaction 
(monitored by TLC), excess of the solvent was removed under reduced pressure. 
Organic layer was usually worked up and purification of the crude product by column 
chromatography provided 5a-cholestan-(6i?)-5p//-o-6,3'-[2"-(2'"-phenyl-1 "',3"',4"'-
thiazoUdinon-3"'-yl)]ethyl-r,3',4'-thiazolidinone 99 as a non-crystallizable semi-solid 
in 63 % yields. 
HS-CHjCOOH 
9 
dioxane 
N-CH2CH2-N=CH-^3 
98 
^ S I CH2-CH2 
^v4 
99 
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Characterization of compound 99 as 5g-cholest-f6R)-s;ww-6^'-r2''-(2'''-
phenyl-1^^^^^^^4^^^-thiazolidinon-3^^^-vl)^ethvl-1^^^4^-thiazolidinone: 
The compound 99 was correctly analysed for C40H60N2O2S2. Its IR spectrum 
exhibited characteristic absorption bands at 1690, 1677 (two C=0 of thiazolidinone 
rings), 1581, 1551, 1494 (aromatic), 1228, 1223 (C-N) and 669, 659 cm"' (C-S-C)." 
H^ NMR spectrum of compound 99 displayed two singlets integrating for two protons 
each at S 3.81 and 3.68 which were assigned for 2 x S-CH2 of thiazolidinone rings 
and another one proton singlet at 6 5.91 for CH-Ai. Five aromatic protons were 
observed at S 7.09-6.93 and two fused triplets appeared at S 3.03 (C2-//2) and 2.82 
(CV-HT) for two methylene group protons. Angular and side-chain methyl protons 
were observed aX S 1.16 (C10-CH3), 0.70 (Cu-CH^), 0.95, 0.83 (other steroidal side-
chain methyl protons).'^ 
In its '^ C NMR spectrum, characteristic signals were observed at 6 172.53 (C4~ 
= O), 170.16 (C4 = O), 37.56 (C5-H2) and 38.14 (C5-H2) of two thiazolidinone rings, 
and 58.93 for CH-Ar. Carbon atoms of aromatic ring appeared at 6 128.01-138.40 and 
two methylene carbon atoms (Cr and C2") at 49.28 and 43.11. Signals at 3 21.54, 
64.41, 61.73 and 46.09 were ascribed to C4, C5, Ce and C? of steroidal skeleton, 
respectively. 
Thus, on the basis of above evidence the semi-solid product 99 was characterized 
as 5a-cholestan-(6i?)-5p/ro-6,3'-[2"-(2'"-phenyl-l"',3"',4"'-thiazolidinon-3"'-yl)]ethyl-
r,3',4'-thiazolidinone. 
Stereochemistry of thiazolidinone 99 as 6R was similarly established as was 
done in the case of thiazolidinone 97. 
The formation of thizolidinone 99 from steroidal 6-[2'-A'-
benzylidinethyl]imino-5a-cholestane 98 can be explained on the basis of the proposed 
mechanism (Scheme 4). 
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Reaction of 3jg-chloro-5g-cholestan-6-one 100 with ethylenediamine; 
3^-Chloro-6-(aminoethvlimino)-5g-cholestanel01: 
A solution of 3^-chloro-5a-cholestan-6-one 100 and ethylenediamine in 
methanol was refluxed for 2 h 30 min. After completion of reaction, excess of solvent 
was removed under reduced pressure and the residue thus obtained was purified over 
silica gel column. Recrystallization of the crude product from ethanol provided 3^-
chloro-6-(aminoethylimino)-5a-cholestane 101 as solid having m.p. 136 °C in 68 % 
yields. 
c i ^ ^ - ^ ^ 
H O 
100 
N-CH2CH2--NH2 
101 
Characterization of compoimd 101 having m.p. 136 °C as 3)g-chloro-6-
faminoethylimino)-5g-cholestane: 
Compound 101 was correctly analysed for C29H51CIN2. Its IR spectrum 
showed important absorption bands at 3440 (NH2), 1599 (C=N), 1221 (C-N) and 731 
cm'^  (C-Cl).^'ln the H^ NMR spectrum of compound 101 a two-proton broad singlet 
(exchangeable with D2O) appeared at 6 8.06 which can be assigned for N//2 and a 
broad multiplet integrating for one proton at J 4.16 (WA 17 Hz, axial) which was 
assigned for Caa (axial) proton. Two fused triplets were seen at d 3.02 and 2.92 for 
C1-H2 and C2-/6, respectively. Angular and side-chain methyl protons were observed 
at 1.12 (C10-C//3), 0.70 (Cn-C/fa), 0.91, 0.80 (other steroidal side-chain methyl 
protons)." 
Thus, on the basis of above characteristic evidences, the solid product 101 has 
been characterized as 3>9-chloro-6-(aminoethylimino)-5a-cholestane. 
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Reaction of 3^-chloro-6-faminoethylimino)-5g-cholestane 101 with 
mercaptoacetic acid: 3^-Chloro-5g-cholestan-(6R)-spf'ro-6^^-amino 
ethvl-1^^^4^-thiazolidinone 102: 
A solution of 3^-chloro-6-(aminoethylimino)-5a-cholestane 101, 
mercaptoacetic acid and few drops of cone. H2SO4 in dioxane was refluxed for 8 h. 
After completion of reaction, excess of the solvent was removed under reduced 
pressure and the resulting residue was usually workedup, purified and recrystallized 
fi^om ethanol to provide 3yff-chloro-5a-cholestan-(6/?)-5/7/>*o-6,3'-aminoethyl-r,3',4'-
thiazolidinone 102 as solid having m.p. 142 °C in 81 % yields. 
HS-CH2C00H^ 
H N-CH2CH2-NH2 H 4''/N-CH2CH2-NH2 
'U. 
101 102 
Characterization of compoxmd 102 having m.p. 142 °C as 3^-chloro-
5a-cholestan-(6R)-5plro-63^-aminoethyl-1^^^4^-thiazolidinone: 
The compound 102 was correctly analysed for C31H53CIN2OS. Its IR spectrum 
exhibited characteristic absorption bands at 3489 (NH2), 1638 (C=0 of thiazolidinone 
ring), 1231 (C-N), 721 (C-Cl) and 674 cm'' (C-S-C)." The ' H N M R spectrum of 
compound 102 displayed two singlets integrating for two protons each at S 8.98 
(exchangeable with deuterium) and 3.12 for N//2 and methylene protons of 
thiazolidinone ring, respectively. A broad multiplet appeared at 6 4.12 iW^/2 17.3 Hz, 
axial) for Cza-H and two fused triplets at d 3.01 and 2.96 for Ci"-//2 and Cy-Hi of 
aminoethyl group. Angular and side-chain methyl protons were observed at (5 1.16 
(Cio-C/^ s), 0.74 (Ci3-C/f3), 0.91, 0.79 (other steroidal side-chain methyl protons).^ ^ 
In its '^ C NMR spectrum, characteristic signals were observed at (5173.15 and 
37.77 for the carbonyl and methylene carbon atoms of thiazolidinone ring, 
respectively. Other important signals were observed at d 59.23 (Ce), 51.72 (C3), 44.28 
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and 41.35 for two methylene carbon atoms of aminoethyl group. Signals at d 29.36, 
54.83 and 45.33 were ascribed to C4, C5 and C? of steroidal skeleton, respectively. 
Thus, on the basis of above evidences the solid compound 102 has been 
characterized as 3y9-chloro-5a-cholestan-(67?)-.^ />-o-6,3 -aminoethyl-1 ',3 ',4'-
thiazolidinone. 
Stereochemistry of thiazolidinone 102 as 6R might be similarly established as 
was done in the case of thiazolidinone 97 discuss earlier. 
Reaction of 3jg-chloro-6-faminoethvliinino)-5fl-cholestane 101 with 
benzaldehvde: 3^-Chloro-6-f2^-N-benzvlidinethvnimino-5g-
cholestane 103: 
A solution of 3>?-chloro-6-(aminoethylimino)-5a-cholestane 101 and 
benzaldehyde in methanol was refluxed for 2 h. After completion of reaction 
(monitored by TLC), excess of solvent was removed under reduced pressure and the 
residue thus obtained was purified over silica gel column. Recrystallization from 
ethanol provided 3^-chloro-6-[2'-A'^ benzylidinethyl]imino-5a-cholestane 103 as solid 
having m.p. 140 °C in 66 % yields. 
CsHsCHO^  
N-CH2CH2-NH2 
101 
N - C H 2 C H 2 - N = C H - ^ ^ 
103 
Characterization of compound 103 having m.p. 140 °C as 3jg-chlom-6-
f2^-N-benzvlidinethvnimino-5g-cholestane; 
The product 103 was correctly analysed for CaeHjsClNi. Its IR spectrum 
exhibited characteristic absorption bands at 1624, 1620 (C=N), 1586, 1542, 1498 
(aromatic ring), 1231, 1221 (C-N) and 729 cm '^ (C-Cl)." The 'H N M R spectrum of 
the compound 103 displayed a singlet for one proton at d 5.89 for CH-Ai. A broad 
muhiplet integrating for one proton at 6 4.08 (WA 16.8 Hz, axial) for Cza-H. Five 
aromatic protons were observed at d 7.16-6.99. Two fused triplets appeared at 6 2.70 
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(CX'-HT) and 2.46 (C2' -H2) for two methylene protons of benzylidiniminoethyl group. 
Angular and side-chain methyl protons were observed at ^ 1.13 (C10-C//3), 0.75 (C13-
CH3), 0.94, 0.83 (other steroidal side-chain methyl protons).^ ^ 
In its ^^ C NMR spectrum, characteristic signals were observed at S 140.34 
(CH-Ar), 137.3-126.04 (carbon atoms of aromatic ring), 168.11 (Ce), 50.62 (C3), 
44.83 and 49.12 for two carbon atoms of benzylidiniminoethyl group. Signals at d 
29.66, 32.71, and 30.26 were ascribed to C4, C5, and C? of steroidal skeleton, 
respectively. 
Thus, on the basis of above evidences the solid product 103 was characterized 
as 3^-chloro-6-[2 '-A'-benzylidinethyl]imino-5a-choIestane. 
Reaction of 3^-chloro-6-f2^-N-benzylidinethvl1imino-5g-cholestane 
103 with mercaptoacetic acid: 3jg-Chloro-5g-cholestan-(6R^-sptro-6^^-
[2"-(r"-phenvl-1^^^^^^^4^^^-thiazolidinon-3^^^-vl)^ethvl-l^J^4^-
thiazolidinone 104: 
A solution of 3^-chloro-6-[2-A^-benzylidinethyl]imino-5a-cholestane 103, 
mercaptoacetic acid and few drops of cone. H2SO4 in dioxane was refluxed with 
continuous stirring for 9 h. After completion of reaction (monitored by TLC), excess 
of the solvent was removed under reduced pressure. Usual work-up and purification 
of crude product by column chromatography provided 3yff-chloro-5a-cholestan-(6i?)-
.^/ro-6,3'-[2"-(2"'-phenyl-r",3"',4'"-thiazolidinon-3"'-yl)]ethyl-r,3',4'-thiazolidinone 
104 as a non-crystallizable semi-solid in 64 % yields. 
HS-CH2COOH 
^ N - C H 2 C H 2 - N = C H - ^ ^ 
103 
N-CH2CH2 
104 
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Characterization of compound 104 as 3^-chloro-5g-choIestan-f6jR)-
spiro-63'-[2"-(r"-phenvl-l^^^;3^^^4^^^-thiazolidinon-3^^^-vmethvl-
l^;3^4^-thiazolidinone: 
The compound 104 was correctly analysed for C40H59CIN2O2S2. Its IR 
spectrum exhibited characteristic absorption bands at 1681, 1676 (C=0 of two 
thiazolidinone rings), 1586, 1577, 1499 (aromatic), 1231, 1225 (C-N), 736(C-Cl)and 
683, 673 cm"' (C-S-C)." 'H NMR spectrum of compound 104 displayed two singlets 
integrating for two protons each at 6 3.76 and 3.57 for methylene protons (C5-//2 and 
Cy"-H2) of thiazolidinone rings, a singlet for one proton appeared at S 5.65 for CH-Ar. 
A broad muhiplet for one proton appeared at d 3.82 (W^A 17.1 Hz, axial) for da-H 
and five aromatic protons were observed at 3 7.19-6.91. Two fused triplets appeared 
at 6 3.05 {C2-H2) and 2.89 (Ci"-//2). Angular and side-chain methyl protons were 
observed at 3 \AS (C10-CH3), 0.75 (C13-C//3), 0.92, 0.81 (other steroidal side-chain 
methyl protons).^ ^ 
In its ''C NMR spectrum, characteristic signals were observed at 3 176.03, 
171.76 (two C=0), 38.06 (C5~H2), 39.16 (C5-H2), 57.17 (CH-Ar), 62.75 (Ce) and 
29.54 (C3). Carbon atoms of aromatic ring appeared at 3 135.08-127.57 and two 
methylene carbon atoms (Ci"-H2 and C2'»H2) appeared at 3 51.72 and 44.69. Signals at 
3 20.50, 63.44 and 45.32 were ascribed to C4, C5 and C? of steroidal skeleton, 
respectively. 
Thus, on the basis of above evidences the semi-solid product 104 was 
characterized as 3y9-chloro-5a-cholestan-(6i?)-5p/ro-6,3'-[2"-(2"'-phenyl-1 '",3 '",4"'-
thiazolidinon-3"'-yl)]ethyl-r,3',4'-thiazolidinone. 
Stereochemistry of thiazolidinone 104 as 6R was similarly established as was 
done in the case of thiazolidinone 97 discuss earlier. 
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Reaction of 3^-acetoxv-5g-cholest-6-one 105 with ethylenediamine: 
3jg-Acetoxv-6-(aminoethvIimino)-5«-cholestanel06: 
A solution of 3;ff-acetoxy-5a-cholestan-6-one 105 in methanol was refluxed with 
ethylenediamine for 1 h 10 min. After completion of reaction (monitored by TLC), 
excess of solvent was removed under reduced pressure and the residue thus obtained 
was purified over silica gel column. Recrystallization from ethanol provided 3^-
acetoxy-6-(aminoethylimino)-5a-cholestane 106 as solid having m.p. 131 °C in 83 % 
yields. 
4^ H O 
105 
* Aco^-Jy 
N-CH2CH2-NH2 
106 
Characterization of compound 106 having m.p. 131 °C as 3^acetoxy-6-
faminoethylimino)-5g-cholestane: 
Compound 106 was correctly analysed for C31H54N2O2. The IR spectrum 
showed important absorption bands at 3443 (NH2), 1731 (OCOCH3), 1605 (C=N), 
1231 (C-N), 1135 cm"' (C-0)." A singlet in 'H NMR spectrum of compound 106 at 6 
8.11 (exchangeable with deuterium) integrating for two protons was assigned to N/fa 
and another singlet at d 2.01 for three protons for acetate group. A broad muhiplet for 
one proton {C^a-H) appeared at d 4.76 {WA 17.6 Hz, axial). Two fused triplets 
appeared at 6 2.79 and 2.61 for Ci-Z^ z and Cr-Hi of aminoethyl group. Angular and 
side-chain methyl protons were observed at 6 1.15 (Cio-C/fs), 0.74 (Cis-C/fa), 0.92, 
0.83 (other steroidal side-chain methyl protons).'* 
Thus, on the basis of above characteristic evidences, the solid product 106 has 
been characterized as 3^-acetoxy-6-(aminoethylimino)-5a-cholestane. 
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Reaction of 3^-acetoxv-6-faminoethvlimino)-5g-cholestane 106 with 
mercaptoacetic acid: 3^-Acetoxy-5g-cholestan-(6.R)-sp/ro-6,3^-amino 
ethvl-1^^^4^-thiazolidinone 107: 
A solution of 3y9-acetoxy-6-(aminoethylimino)-5a-cholestane 106, 
mercaptoacetic acid and few drops of cone. H2SO4 in dioxane was refluxed for 6 h 45 
min. After completion of reaction (monitored by TLC), excess of the solvent was 
removed under reduced pressure and the resulting residue was worked up usually, 
purified by column chromatography and subsequently recrystallized from ethanol to 
provide 3y5-acetoxy-5a-cholestan-(67?)-^/ro-6,3 -aminoethyl-l ',3 ',4'-thiazolidinone 
107 as solid having m.p. 139 °C in 70 % yields. 
HS-CH2COOH 
AcO' 
" N-CH2CH2-NH2 ^ ' 
106 
Characterization of compound 107 having m.p. 139 °C as 3^-acetoxy-
5g-cholestan-(6R)-5;?fro-6^^-aminoethvl-1^^^4^-thiazolidinone: 
The compound 107 was correctly analysed for C33H56N2O3S. Its IR spectrum 
exhibited characteristic absorption bands at 3465 (NH2), 1735 (OCOCH3), 1661 (C=0 
of thiazolidinone ring), 1236 (C-N), 1105 (C-0) and 678 cm"' (C-S)."The 'H NMR 
spectrum of compound 107 displayed two singlets integrating for two protons each at 
6 8.08 (exchangeable with deuterium) for N//2 and 3.34 for -CH2-S of thiazolidinone 
ring, and another sharp singlet for three protons of acetate group at 3 2.01. A broad 
multiplet for one proton appeared at 3 4.67 (W^/216.8 Hz, axial) for C^a-H. Two fused 
triplets appeared at 3 3.01 and 3.16 for C2--//2 and Ci"-/^ 2 of aminoethyl group. 
Angular and side-chain methyl protons were observed at J 1.18 (C\o-CH-i), 0.79 (Cn-
C//3), 0.90, 0.86 (other steroidal side-chain methyl protons)." 
In its ^^ C NMR spectrum, characteristic signals were observed at 3 170.65 
(C=0), 37.69 (CH2-S) of thiazolidinone ring, 52.70 (C3) and 59.37 (Ce). Other 
important signals appeared at 3 44.64 and 43.87 for two carbon atoms of aminoethyl 
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group. Signals at d 29.63, 54.91 and 44.89 were ascribed to C4, Cj and C? of steroidal 
skeleton, respectively. 
Thus, on the basis of above evidences the solid compound 107 has been 
characterized as 3y9-acetoxy-5a-cholestan-(6i?)-.53;>o-6,3'-aminoethyl-1 ',3 ',4'-
thiazolidinone. 
Stereochemistry of thiazolidinone 107 as 6R was similarly assinged as was 
done in the case of thiazolidinone 97. 
Reaction of 3^-acetoxv-6-(aminoethvlimmo)-5«-cholestane 106 with 
benzaldehyde: 3^-Acetoxy-6-f2^-N-benzylidinethynimino-5«-
cholestane 108: 
A solution of 3y9-acetoxy-6-(aminoethylimino)-5a-cholestane 106 and 
benzaldehyde in methanol was refluxed for 3 h. After completion of reaction 
(monitored by TLC), excess of solvent was removed under reduced pressure and the 
residue thus obtained was purified over silica gel column. Recrystallization from 
ethanol provided 3^-acetoxy-6-[2-A''-benzylidinethyl]imino-5a-cholestane 108 as 
solid having m.p. 134-136 °C in 67 % yields. 
AcO 
C6H5CHO 
AcO' 
N-CH2CH2-NH2 
106 
" N-CH2CH2-N=CH 
108 
Characterization of compound 108 having m.p. 134-136 °C as 3/g-
acetoxy-6-r2^-iV-benzvlidinethvlTimino-5a-cholestanel08; 
The product 108 was correctly analysed for C38H58N2O2. Its ER spectrum 
exhibited characteristic absorption bands at 1739 (OCOCH3), 1622 (C=N), 1588, 
1540, 1494 (aromatic ring), 1240 (C-N) and 1129 cm'' (C-0)." The 'H NMR 
spectrum of the compound 108 displayed two singlets integrating for one and three 
protons respectively at S 5.96 for CH-Ai and 2.02 for OAc. A broad multiplet 
appeared at 6 4.75 (WA 16.7 Hz, axial) for C^a-H and five aromatic protons were 
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observed at 6 7.14-6.97. Two fused triplets appeared at d 2.47 (C1-//2) and 2.37 (C2-
H2) of iminoethyl group. Angular and side-chain methyl protons were observed at d 
1.14 (C10-C//3), 0.71 (C13-C//3). 0.90, 0.82 (other steroidal side-chain methyl 
protons).^ ^ 
In its *^ C NMR spectrum, characteristic signals were observed at S 144.51 
(CH-Ar), 50.84 (C3), 169.24 (Ce) and 135.8-129.43 carbon atoms of aromatic ring. 
Methylene carbon atoms of iminoethyl group appeared at 6 45.67 and 48.92. Signals 
at 5 28.94, 32.86 and 31.45 were ascribed to C4, C5 and C? of steroidal skeleton, 
respectively. 
Thus, on the basis of above evidences the solid product 108 was characterized 
as 3/ff-acetoxy-6-[2 '-A'-benzylidinethyl]imino-5a-cholestane. 
Reaction of 3)g-acetoxv-6-r2^-N-benzylidinethyl1imino-5g-cholestane 
108 with mercaptoacetic acid: 3^-Acetoxy-5g-cholestan-(6R)-spt'ro-6^^-
r2"-rr"-phenvl-l^^^J^^^4^^^-thiazolidinon-3^^^-vnlethvl-1^3^4^-
thiazolidinone 109: 
A solution 3^-acetoxy-6-[2-A'-benzylidinethyl]imino-5a-cholestane 108, 
mercaptoacetic acid and few drops of cone. H2SO4 in dioxane was refluxed with 
stirring for 8 h 30 min. After completion of reaction (monitored by TLC), excess of 
the solvent was removed under reduced pressure. It was usually worked up, purified 
by silica gel column and subsequently recrystallized from ethanol to provide 3^-
acetoxy-5a-cholestan-(67?)-5p;>o-6,3*-[2"-(2'"-phenyl-l"',3'",4"'-thiazolidinon-3"'-
yl)]ethyl-r,3',4'-thiazolidinone 109 as semi-solid with 58 % yields. 
AcO 
HS-CH2COOH AcO' 
N-CH2CH2-N=CH 
H 4 'N-CH2CH2-N 
108 6 109 
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Characterization of compound 109 as 3^-acetoxv-5(z-cholestan-(6R)-
sptro-6^^-r2"-(r"-phenyl-1^^^^^^^4^^^-thiazoIidinon-3^^^-yl)Tethyl-
V3'A'- thiazolidinone: 
The compound 109 was correctly analysed for C42H62N2O4S2. Its IR spectrum 
exhibited characteristic absorption bands at 1738 (OCOCH3), 1668, 1654 (two C=0 
of thiazolidinone rings), 1588, 1561, 1494 (aromatic), 1236, 1230 (C-N), 1086 (C-0) 
and 683, 675 cm'* (C-S).'^ *H NMR spectrum of compound 109 displayed two 
singlets integrating for two protons each at (5 3.77 and 3.17 for (S-C5~//2-) and (S-C5-
H2-) of thiazolidinone rings and a sharp singlet for three protons appeared at S 2.02 
for acetate group. Another singlet for one proton appeared at 5 5.76 for CH-Ai. A 
broad multiplet for one proton appeared at S 4.71 (W^A 17.6 Hz, axial) for C^a-H. Five 
aromatic protons were observed at d 7.16-6.98. Two fused triplets were seen at 6 2.79 
iCi'-Hj) and 2.92 {Cy-Hj) for methylene protons. Angular and side-chain methyl 
protons were observed at <51.13 (C10-C//3), 0.77 (Cu-C/^s), 0.93, 0.82 (other steroidal 
side-chain methyl protons).'^ 
In its '^ C NMR spectrum, characteristic signals were observed at 6 173.03, 
170.74 for (C=0 of two thiazolidinone rings), 28.94 (C3), 61.92 (Ce), 38.32 (C5-H2) 
and 34.19 (C5—H2) for methylene carbon atoms of two thiazolidinone rings and 6 
56.16 for CH-Ar. Carbon atoms of aromatic ring were appeared at d 132.00-128.06. 
Two methylene carbon atoms appeared at d 51.93 and 43.65. Signals at 6 20.10, 63.65 
and 45.31 were ascribed to C4, C5 and C? of steroidal skeleton, respectively. 
Thus, on the basis of above evidences the semi-solid product 109 was 
characterized as 3)9-acetoxy-5a-cholestan-(6/?)-5p/ro-6,3'-[2"-(2"'-phenyl-1 "',3'",4"'-
thiazoIidinon-3"'-yl)]ethyl-r,3',4'-thiazolidinone. 
Stereochemistry of thiazolidinone 109 as 6R was similarly assinged as was 
done in the case of thiazolidinone 97. 
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The tentative mechanisms for the formation of thiazolidinones (97, 102 and 
107) from the respective precursors (96,101 and 106) (Scheme 3) and thiazolidinones 
99,104 and 109 from compound 98,103 and 108 respectively (Scheme 4), have been 
proposed. 
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cluster II 
All melting points were observed in the capillary tube and are uncorrected, 
infrared (IR) spectra were recorded in KBr pellets with spectrolab interspec 2020 FT-
IR spectrometer and values are given in cm'\ 'H NMR spectra were measured on a 
300 MHz instrument and '^ C NMR spectra on a Bruker Avance II 400 spectrometer at 
100 MHz, using TMS as internal standard and CDCI3 as solvent. Chemical shift (5) 
were expressed in ppm downfield from internal standard TMS. The abbreviation s, d, 
dd, m, br denote "singlet, doublet, double doublet, muhiplet, broad respectively. Thin 
layer chromatography (TLC) plates were coated with silica gel G and exposed to 
iodine vapours. Pet-ether refers to a fraction of b.p. 60 - 80 °C. Anhydrous sod. 
sulphate (Na2S04) was used as drying agent. 
3jg-Hydoxv-5a. 6/g-dibromocholestane: 
To a solution of cholest-5-en-3y9-ol (cholesterol) (5 g) in diehyl ether (30 ml) 
was added bromine solution (0.9 ml of bromine in 20 ml of glacial acetic acid 
containing 0.2 g of anhydrous sodium acetate) with stirring. The solution turned 
yellow and promptly set to a stiff paste of bromide. The mixture was cooled in an ice 
bath and stirred with a glass rod to ensure complete crystallization. The product was 
then collected by filteration under suction and washed with cold diethyl ether-acetic 
acid mixture (3:7) until the filtrate was completely colourless (6.9 g), m. p. 112-113 
°C (reported''m. p. 113 °C). 
5a, 6^-Dibromocholestan-3-one: 
3^-Hydoxy-5a, 6y9-dibromocholestane (6.9 g) was suspended in acetone (150 
ml) in a three-necked round bottom flask fitted with a stirrer and dropping funnel. The 
suspension was stirred for 5 min. and Tone's reagent^ " (10 ml) was then added in 
drops from dropping funnel in 15 min. The temperature of reaction mixture, during 
oxidation was maintained between 0-5 "C by external cooling. After the complete 
addition, stirring was continued for 15 min. and cold water (200 ml) was added. The 
product was collected on a Buchner funnel and washed thoroughly with water and 
methanol and air-dried (5 g), m. p. 73-75 °C (decomposed) (reported^' m. p. 73-75 
°C). 
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Cholest-5-en-3-one 90; 
The moist 5a, 6^-dibromocholestan-3-one (5.0 g) was dissolved in diethyl 
ether (100 ml) and glacial acetic acid (2.5 ml), zinc dust (7.5 g) was added in small 
portions during 30 min. with continous shaking. After the complete addition, the 
ethereal solution containing suspended zinc dust was filtered and the filtrate was 
washed with water, sodium bicarbonate solution (5%) and water and dried (anhydrous 
sodium sulphate). The oily residue thus obtained after the evaporation of the solvent 
was crystallized fi^om methanol to give the desired product 90 (3.3 g), m. p. 126-127 
°C (reported^%. p. 129 °C). 
3-faminoethylimino)cholest-5-ene 91: 
A solution of cholest-5-en-3-one 90 (4 g, 10.4 mmol) in methanol (40 ml) was 
refluxed with ethylenediamine (7 ml, 10.4 mmol) for 1 h. After completion of reaction 
(monitored by TLC), excess of solvents were removed under reduced pressure and the 
residue thus obtained was purified over silica gel colunm using light petroleum ether: 
diethyl ether (5:1) as eluant. Recrystallization fi-om ethanol afforded 3-
(aminoethylimino)cholest-5-ene 91 as solid having m.p. 125 "C in 79 % yields. 
Analysis found : C, 81.60; H, 11.83; N 6.55 
C29H50N2 requires : C, 81.62; H, 11.81; N 6.56 % 
IR(KBr) : Vmax 3516 (NH2), 1626 (C=C), 1613 (C=N), 1229 
cm-' (C-N). 
'H NMR (CDCI3) : 6 8.65 (br s, 2H, N/Tj. exchangeable with D2O), 
5.37 (dd, y= 8.1, 6.4 Hz, IH, Ce-ZO. 2.91 (s, 2H, 
C4-//2), 2.58 (t, 2H, Ct-Hi), 2.39, 2.08 (fijsed t, 2H 
each, C2-//2 and C1-//2), 1.14 (s, 3H, C10-CH3), 
0.74 (s, 3H, Ci3-CHs), 0.93, 0.82 (other steroidal 
side-chain methyl protons). 
Cholest-5-e^-(3JR)-spfro-33^-aminoethvl-1^3^4^-thiazolidmone92: 
To a solution of 3-(aminoethylimino)cholest-5-ene 91 (1 g, 2.3 mmol) in 
dioxane (40 ml), mercaptoacetic acid (0.2 ml, 2.3 mmol) and 4-5 drops of cone. 
H2SO4 were added and the reaction mixture was refluxed for 6 h. Completion of 
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reaction was monitored by TLC, excess of the solvent was removed under reduced 
pressure and the resulting residue was poured in excess of ice cooled water. Organic 
layer was taken in diethyl ether and washed with water, NaHCOs solution (5%) and 
again with water and dried over anhydrous sodium sulphate. Evaporation of solvent 
provided crude product which was purified by column chromatography using silica 
gel column and pet. ether- diethyl ether (2:1) as an eluant and subsequent 
recrystallization of the product from ethanol provided the compound cholest-5-en-
(3i?)-5/7/'/-o-3,3'-aminoethyl-r,3',4'-thiazolidinone 92 as solid having m.p. 133 °C in 71 
% yields. 
Analysis found 
C31H52N2OS requires 
IR(KBr) 
*H NMR (CDCI3) 
"C NMR (CDCI3) 
C, 74.32; H, 10.49; N 5.58 
C, 74.34; H, 10.47; N5.59% 
v ^ 3 5 1 0 (NH2), 1649 (C=0), 1624 (C=C), 1223 
(C-N), 666 cm-' (C-S). 
^8.19 (br s, 2H, N//2, exchangeable with D2O), 
5.22 (dd, J = 6.8, 4.9 Hz, IH, Ce-H), 3.47 (s, 2H, 
C//2-S), 2.26, 2.08 (t, 2H each, Cv-Hj and C2-//2), 
2.94 (s, 2H, C4-//2), 2.11 (t, 2H, C2-i/2), 116 (s, 
3H, Cio-CNj), 0.70 (s, 3H, Cu-CHs), 0.91, 0.80 
(other steroidal side-chain methyl protons). 
d 171.59 (C=0), 37.36 (CH2 of thiazolidinone 
ring), 48.53 (Cr), 42.61 (Cr), 30.06 (Ci), 41.07 
(C2), 58.9 (C3), 47.2 (C4), 154.9 (C5), 126.7 (Cs), 
31.3 (C7), 28.31 (Cg), 44.83 (C9), 39.56 (Cio), 
21.23 (Cu), 32.93 (Cn), 41.71 (Cu), 49.31 (CH), 
21.80 (C15), 21.16 (C16), 47.52 (Cn), 20.57 (Cig), 
21.08 (C19), 30.34 (C20X 19.15 (C2,), 36.73 (C22), 
26.81 (C23), 39.25 (C24), 29.63 (C25), 22.52 (C26), 
22.18 (C27). 
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3-r2^-N-benzylidmethyl|immocholest-5-ene93: 
A solution of 3-(aniinoethylimino)cholest-5-ene 91 (2 g, 4.6 mmol) in 
methanol (25 ml) and benzaldehyde (0.5 ml, 4.6 mmol) was refluxed for 3 h 20 min. 
After completion of reaction (monitored by TLC), excess of solvent was removed 
under reduced pressure and the resulting residue thus obtained was purified over silica 
gel column by using light petroleum ether: diethyl ether (4:1) as eluant. 
Recrystallization fi"om ethanol provided 3-[2'-A^-benzylidinethyl]iminocholest-5-ene 
93 as needle like solid having m.p. 120 °C in 82 % yields. 
Analysis found 
C36H54N2 requires 
IR(KBr) 
' H N M R (CDCI3) 
13, C NMR (CDCI3) 
C, 83.98; H, 10,60; N 5.42 
C, 83.99; H, 10,57; N5.44% 
Vmax 1624 (C=C), 1616, 1610 (C=N), 1580, 1542, 
1498 (aromatic ring), 1230, 1190 cm"^  (C-N). 
S 7.13-6.94 (m, 5H, Ar-H), 6.02 (s, IH, CH-Ar), 
5.41 (dd, J = 7.1, 5.2 Hz, IH, Ce-H), 3.12 (s, 2H, 
C4-H2), 2.83, 2.42 (fiised t, 2H each, C2-//2 and 
C1-H2), 2.26 (t, 2H, C2-H2), 2.13 (dd, 7 = 7.8, 6.2 
Hz, 2H, C7-//2), 1.15 (s, 3H, Cio-CHs), 0.72 (s, 
3H, Cn-CHs), 0.92, 0.84 (other steroidal side-
chain methyl protons). 
d 151.80 (-C=N), 137.6-129.7 (carbon atoms of 
aromatic ring), 50.56, 52.66 (two carbons of 
benzylidinethylimino group), 33.05 (Ci), 31.28 
(C2), 167.86 (C3), 32.91 (C4), 151.08 (Cj), 129.9 
(Cfi), 30.11 (C7), 30.53 (Cg), 44.19 (C9), 40.33 
(Co), 21.46 (Cn), 31.92 (C12), 42.61 (C13), 49.06 
(C14), 21.99 (C15), 21.63 (C16), 48.02 (Cn), 20.81 
(C18), 21.24 (C19), 30.17 (C20), 19.37 (C21), 36.78 
(C22), 26.14 (C23), 40.08 (C24), 29.16 (C25), 22.54 
(C26), 22.89 (C27). 
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Cholest-5-en>r3J?)-s;;/ro-3;3^-f2"Wr"-phenvl-l^^^J^^\4^^^-thiazolidmon-
3^^Wl)ethyl]-1^3^4^-thiazolidmone94: 
To a solution of 3-[2'-A'-benzylidinethyl]iminocholest-5-ene 93 (1 g, 1.94 
mmol) in dioxane (50 ml), mercaptoacetic acid (3.9 mmol) and few drops of cone. 
H2SO4 were added and the reaction mixture was refluxed with constant stirring for 10 
h. Completion of reaction was monitored by TLC, extra solvent was removed under 
reduced pressure and the resulting residue was poured in excess of ice cooled water. It 
was taken in diethyl ether and washed with water, NaHCOa solution (5%) and again 
with water and dried over anhydrous sodium sulphate. Purification of crude product 
by column chromatography provided cholest-5-en-(3i?)-^7'ro-3,3'-[2"-(2'"-phenyl-
l"',3"',4'"-thiazolidinon-3'"-yl)ethyl]-r,3',4'-thiazolidinone 94 as non- crystallizable 
semi-solid in 64 % yields. 
Analysis found 
C4oH5gN202S2 requires 
m (Nujol) 
H^ NMR (CDCI3) 
13. C NMR (CDCI3) 
C, 72.42; H, 8.85; N4.24 
C, 72.46; H, 8.82; N 4.23 % 
Vmax 1690, 1656 (C=0), 1622 (C=C), 1584, 1530, 
1492 (aromatic ring), 1240, 1232 (C-N), 681, 677 
cm-' (C-S). 
S 7.25-7.15 (m, 5H, Ax-H), 5.79 (dd, J = 8.04, 6.3 
Hz, IH, Cs-H), 5.23 (s, IH, CH-Ai), 3.78, 3.69 (s, 
2H each, 2 x CH2-S of thiazolidinone ring), 3.55, 
3.40 (fused t, 2H each, d - and C2-H2), 2.85 (s, 
2H, C4-H2), 2.10 (dd, J = 8.7, 6.4 Hz, 2H, C2-H2), 
1.12 (s, 3H, C10-CH3), 0.71 (s, 3H, Ci3-C^i), 0.91, 
0.83 (other steroidal side-chain methyl protons). 
S 170.02 and 168.53 (two carbonyl carbon of 
thiazolidinone rings), 138.7-132.1 (carbon atoms 
of aromatic ring), 51.46 (d-), 52.60 (€2-) carbon 
atoms of ethyl group, 36.59, 35.81 (2 x CH2-S of 
thiazolidinone rings), 46.52 (CH-Ar), 32.08 (Ci), 
31.42 (C2), 169.06 (C3), 31.81 (C4), 153.28 (C5), 
127.41 (Cfi), 31.13 (C7), 30.08 (Cg), 45.09 (C9), 
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41.36 (Cio), 22.66 (Cn), 32.05 (C12), 42.56 (C13), 
49.61 (CH), 20.97 (C15), 21.86 (Cis), 48.68 (Cn), 
20.73 (C18). 21.91 (C19), 31.41 (C20), 19.06 (C2,), 
37.18 (C22), 27.12 (C23), 41.16 (C24), 29.52 (C25), 
22.57 (C26), 22.48 (C27). 
Cholest-5-ene: 
3y9-Chlorocholest-5-ene (10 g) was dissolved in warm amyl alcohol (230 ml) 
and sodium metal (20 g) was added to the solution with continous stirring over a 
period of 8 h. The reaction mixture was warmed occasionally. When all the sodium 
was dissolved, the reaction mixture was poured into water, acidified with dilute 
hydrochloric acid and allowed to stand overnight. A white crystalline solid thus 
obtained was filtered under suction and washed thoroughly with water and air-dried. 
The crude material was recrystallized from acetone to provide cholest-5-ene, m. p. 88-
89 °C (reported '^ m.p. 89-91 "C), yield 83%. 
6-Nitrocholest-5-ene: 
A suspension of finely powdered cholest-5-ene (6.0 g), in glacial acetic acid 
(50 ml) was stirred at room temperature for 5 min. Fuming nitric acid (15 ml; d, 1.52) 
was rapidly added. Sodium nitrite (3 g) was added gradually over a period of 1 h. with 
stirring and stirring was continued for 2 h. The temperature of the reaction mixture 
was kept between 20-25°C by external cooling. Cold water was added a yellow solid 
thus obtained was filtered under suction, washed thoroughly with water and air dried. 
Recrystallization from methanol furnished 6-nitrocholest-5-ene, m.p. 119-120 °C 
(reported" m.p. 120-121 °C), yield 53%. 
5g-C3iolestan-6-one 95: 
6-Nitrocholest-5-ene (6 g) was dissolved in glacial acetic acid (200 ml) by 
heating and to this solution zinc dust (12.0 g) was added in small portions. After the 
initial exothermic reaction had subsided, the suspension was heated under reflux for 3 
h, and water (24 ml) was added now and then during the course of reaction. The 
solution was then filtered and the residue was washed with 40 ml warm acetic acid. 
To the filtrate was added a few ml of water till turbidity developed and it was allowed 
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to stand overnight at room temperature. The crystalline material thus separated was 
fihered under suction and washed thoroughly with water in order to remove zinc 
acetate. The organic solid was air dried and its recrystallization from ethanol afforded 
5a-cholestan-6-one 95, m.p. 96-98 °C (reported '^ m. p. 98-100 °C), yield 60%. 
6-(ammoethvlimmo)-5g-cholestane 96: 
A solution of 5a-cholestan-6-one 95 (4 g, 10.3 mmol) in methanol (45 ml) was 
refluxed with equimolar amount of ethylenediamine for 1 h 40 min. After completion 
of reaction (monitored by TLC), solvent was removed under reduced pressure and the 
residue thus obtained was purified over silica gel column using light petroleum ether: 
diethyl ether (7:1) as eluant. Recrystallization from ethanol afforded 6-
(aminoethylimino)-5a-cholestane 96 as solid having m.p. 118 °C in 74 % yidgs^wd t/|.'><' 
Analysis found 
C29H52N2 requires 
IR(KBr) 
H^ NMR (CDCI3) 
C, 81.23; H, 12.25; N 6.51 
C, 81.24; H, 12,22; N 6.53% 
v,nax3513 (NH2), 1610 (C=N), 12 
^8.96 (br s, 2H, NH2, exchangeable with D2O), 
2.71 (d, J = 7.6 Hz, 2H, C7-H2), 2.25, 2.16 (fused 
t, 2H each, C1-//2 and C2-H2), 1.13 (s, 3H, Cio-
CHs), 0.76 (s, 3H, C13-CH3), 0.90, 0.84 (other 
steroidal side-chain methyl protons). 
5fl-cholestan-(6R)-spifio-6^'-aminoethyl-1^3',4^-thiazolidmone 97 : 
To a solution of 6-(aminoethylimino)-5a-cholestane 96 (1 g, 2.3 mmol) in 
dioxane (40 ml), mercaptoacetic acid (2.35 mmol) and 5-6 drops of cone. H2SO4 were 
added and the reaction mixture was refluxed with stirring for 6 h. After completion of 
reaction (monitored by TLC), excess of the solvent was removed under reduced 
pressure and obtained residue was poured in excess of ice cooled water. Organic layer 
was taken in diethyl ether and washed with water, NaHCOa solution (5%) and again 
with water and dried over anhydrous sodium sulphate. Evaporation of solvent and the 
residue thus obtained was purified over silica gel column using light pet. ether: diethyl 
ether (6:1) as eluant. Recrystallization of crude product from ethanol gave 5a-
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choIestan-(6i?)-5p/ro-6,3'-aminoethyI-r,3',4'-thiazolidinone 97 as solid having m.p. 
129 °C in 68 % yields. 
Analysis found 
C31H54N2OS requires 
IR(KBr) 
H^ NMR (CDCI3) 
'^ C NMR (CDCI3) 
C, 74.02; H, 10.85; N5.58 
C, 74.05; H, 10.82; N5.57% 
Vmax 3522 (NH2), 1642 (C=0), 1227 (C-N), 670 
cm-' (C-S). 
(5 8.11 (br s, 2H, N//2, exchangeable with D2O), 
3.33 (s, 2H, C//2-S), 2.09 (d, J = 7.3 Hz, 2H, C7-
H2), 3.12, 3.08 (fused t, 2H each, Ci-i/2 and C2-
H2), 1.17 (s, 3H, Cio-CHs), 0.71 (s. 3H, Cn-CHj), 
0.92, 0.83 (other steroidal side-chain methyl 
protons). 
S 173.15 (C=0), 38.64 (CH2-S of thiazolidinone 
ring), 44.28 (d-), 41.35 (C2-), 37.59 (Ci), 28.72 
(C2), 26.09 (C3), 21.91 (C4), 63.52 (C5), 65.76 
(Cfi), 47.08 (C7), 28.93 (Cg), 57.71 (C9), 29.21 
(Co), 21.06 (Cn), 44.37 (Cn), 45.81 (CB), 59.68 
(CM), 29.51 (C15), 26.01 (Cis), 57.84 (Cn), 18.01 
(C,8), 18.09 (C19), 30.42 (C20), 19.96 (C21), 36.67 
(C22), 26.56 (C23), 40.39 (C24X 30.05 (C25), 22.35 
(C26), 22.22 (C27). 
6-(2'-N-benzylidinethvl)imino-5g-cholestane98; 
A solution of 6-(aminoethylimino)-5a-cholestane 96 (2 g, 4.6 mmol), in 
methanol (25 ml) was refluxed with benzaldehyde (4.7 mmol) for 3 h. After 
completion of reaction (monitored by TLC), excess of solvent was removed under 
reduced pressure and the residue thus obtained was purified over silica gel column by 
using light petroleum ether: diethyl ether (4:1) as eluant. Recrystallization from 
ethanol gave 6-(2'-A^-benzyIidinethyl)imino-5a-cholestane 98 as solid having m.p. 116 
°C in 74 % yields. 
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C36H56N2 requires 
IR(KBr) 
^H NMR (CDCI3) 
" C NMR (CDCI3) 
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C, 83.64; H, 10.96; N5.44 
C, 83.66; H, 10.92; N5.42% 
v™,x 1626, 1617 (C=N), 1583, 1549, 1497 
(aromatic ring), 1233, 1224 cm"' (C-N). 
5 7.10-6.96 (m, 5H, Ai-H), 5.11 (s, IH, C^-Ar), 
2.73, 2.61 (fused t, 2H each, Ci-i/2 and Cr-Hi), 
2.14 (d, J= 7.9 Hz, 2H, C7-//2), 111 (s, 3H, Cio-
CH3), 0.73 (s, 3H, C13-C//5), 0.91, 0.82 (other 
steroidal side-chain methyl protons). 
6 167.01 (C=N), 133.2-128.71 (carbon atoms of 
aromatic ring), 49.06 (Cr), 44.31 (C2) (two carbon 
atoms of benzylidinethylimino group), 34.31 (Ci), 
23.72 (C2), 26.59 (C3), 25.36 (C4), 39.31 (C5), 
168.91 (Ce), 29.63 (C7), 24.71 (Cg), 44.53 (C9), 
32.29 (Cio), 21.56 (Cn), 33.81 (C12), 41.59 (CB) , 
51.26 (CM), 26.06 (Cu), 27.11 (Cie), 47.21 (Cn), 
21.68 (Cs), 21.31 (C,9), 31.03 (C20), 19.26 (C21), 
36.01 (C22), 27.13 (C23X 40.06 (C24), 29.74 (C25), 
22.39 (C26), 22.70 (C27). 
5g-Cholestan-(6R)-5ptro-6^^-r2"-rr"-phenvl-l^^^-3^^^-4^^^-thiazolidmon-
3^^^-vl)lethvl-1^^^4^-thiazolidmone99: 
To a solution of 6-(2'-A^-benzylidinethyl)imino-5a-cholestane 98, (1 g, 1.9 
mmol) in dioxane (50 ml), mercaptoacetic acid (3.9 mmol) and 6-8 drops of cone. 
H2SO4 were added and the reaction mixture was refluxed with continuous stirring for 
7 h. After completion of reaction (monitored by TLC), excess of the solvent was 
removed under reduced pressure. The residue obtained was poured in excess of ice 
cooled water. Organic layer was taken in diethyl ether and washed with water, 
NaHC03 solution (5%) and again with water and dried over anhydrous sodium 
sulphate. Obtained crude product was purified by column chromatography by using 
light pet, ether: diethyl ether (7:2) as eluant and recrystallization from ethanol 
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provided 5a-cholestan-(6/?)-5p/ro-6,3'-[2"-(2"'-phenyl-r"-3"'-4'"-thiazolidinon-3'"-
yl)]ethyl-r,3',4'-thiazolidinone 99 as noncrystallizable semi-solid in 63 % yields. 
Analysis found 
C40H60N2O2S2 requires 
m (Nujol) 
^H NMR (CDCI3) 
13 C NMR (CDCI3) 
: C, 72.21; H,9.11; N4.25 
: C, 72.24; H, 9.09; N 4 . 2 1 % 
: Vmax 1690, 1677 (C=0), 1581, 1551, 1494 
(aromatic ring), 1228, 1223 (C-N), 669, 659 cm"' 
(C-S). 
: d 7.09-6.93 (m, 5H, Ax-H), 5.91 (s, IH, C//.Ar), 
3.81, 3.68 (s, 2H, 2 X S-C//2), 3.03, 2.82 (fused t, 
2H each, Cx-Hz and €2-^2), 2.06 (d, J = 6.9 Hz, 
2H, C7-//2X 1.16 (s, 3H, C10-CB3), 0.70 (s, 3H, 
C13-CH3), 0.95, 0.83 (other steroidal side-chain 
methyl protons). 
; S 172.53, 170.16 (carbonyl carbons of 
thiazolidinone rings), 128.01-138.40 (carbon 
atoms of aromatic ring), 58.93 (CH-Ar), 49.28 and 
43.11 (d - and C2" carbon atoms of ethyl group), 
37.56 and 38.14 (2xCH2-S) of thiazoHdinone 
rings, 39.72 (Ci), 24.07 (Cj), 29.13 (C3), 21.54 
(C4), 64.41 (C5), 61.73 (Ce), 46.09 (C7). 28.17 
(Cg), 57.51 (C9), 29.43 (Cio), 21.35 (Cn), 42.64 
(C12), 46.06 (C13), 59.16 (C14), 29.01 (Cu), 26.86 
(C16), 59.04 (Cn). 15.31 (Cig), 18.02 (C19), 30.16 
(C20), 19.79 (C21X 38.11 (C22), 28.10 (C23), 42.08 
(C24), 30.19 (C25), 22.33 (C26), 22.62 (C27). 
3^-Chlorocholest-5-ene: 
Freshly purified thionyl chloride (75 ml) was added gradually to cholesterol 
(100 g) at room temperature. A vigorous reaction ensued with the evolution of 
gaseous products. When the reaction slackened, the reaction mixture was gently 
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heated at a temperature of 50-60 °C on a water bath for one hour, and then poured into 
cold water with constant stirring. The yellow solid thus obtained was fihered under 
suction, washed several times with cold water and air-dried. Recrystallization from 
acetone gave 3^-chlorocholest-5-ene, m.p. 95 °C (reported^" m.p. 96-97 °C) yield 
97%. 
3^-Chloro-6-nitrocholest-5-ene: 
To a well stirred mixture of 3^-chlorocholest-5-ene (12 g), glacial acetic acid 
(100 ml) and fuming nitric acid (25 ml) at room temperature, was added sodium 
nitrite (3.6 g) gradually over a period of 1 h. After the complete addition of sodium 
nitrite, the mixture was further stirred for 1 h. The content was diluted by the addition 
of water (200 ml) and stirring was continued for 10 min. more. The yellowish solid 
thus separated was filtered, washed with cold water and air dried. The crude product 
was recrystallized from methanol to give 3y9-chloro-6-nitrocholest-5-ene, m.p. 150-
152 °C (reported" m.p. 153 °C) and yield 60 %. 
3^-Chloro-5«-cholestan-6-one 100: 
To a solution of 3y9-chloro-6-nitrocholest-5-ene (6 g) in hot glacial acetic acid 
(140 ml), zinc dust (12 g) was added gradually in small portions with constant 
shaking. The suspension was heated under reflux for 4 h and water (10 ml) was added 
at regular intervals during the course of heating. The hot solution was filtered to 
remove unreacted zinc powder and the fihrate was cooled to room temperature, 
followed by dilution with large excess of ice-cooled water. The organic matter was 
extracted with diethyl ether and ethereal solution was washed with NaHCOs solution 
(10%) and water, and dried (anhyd. Na2S04). Evaporation of the solvents gave an oil 
which was crystallized from methanol to give compound 100 m.p. 127-129 °C 
(reported" m.p. 127-128 °C), yield 63%. 
3^-Chloro-6-(aminoethvlimino)-5g-cholestanel01: 
A solution of 3^-chloro-5a-cholestan-6-one 100 (4 g, 9.5 mmol) in methanol 
(45 ml) was refluxed with ethylenediamine (9.6 mmol) for 2 h 30 min. After 
completion of reaction (monitored by TLC), solvent was removed under reduced 
pressure and the residue thus obtained was purified over silica gel column through 
light petroleum ether: diethyl ether (2:1) as eluant. Recrystallization from ethanol 
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afforded 3^-chloro-6-(aminoethyliniino)-5a-cholestane 101 as solid having m.p. 136 
X in 68 % yield. 
Analysis found 
C29H51CIN2 requires 
IR(KBr) 
*H NMR (CDCI3) 
C, 75.18; H, 11.14; N6.04 
C, 75.20; H, 11.10; N6.05% 
Vmax3440 (NH2), 1599 (C=N), 1221 (C-N), 731 
cm-' (C-Cl). 
^8.06 (br s, 2H, N//2, exchangeable with D2O), 
4.16 (br m, IH, W/2=17 Hz, Cja-H, axial), 3.02, 
2.92 (fused t, 2H each, C1-H2 and €2-//^), 1.78 (d, 
J = 7.6 Hz, 2H, C7-H2X 1.12 (s, 3H, Cio-CHs), 
0.70 (s, 3H, Cii-CHs), 0.91, 0.80 (other steroidal 
side-chain methyl protons). 
3^-Chloro-5«-cholestan-(6R)-sptro-6^'-aminoethvl-l^;3^4"-
thiazolidinone 102: 
To a solution of 3y9-chloro-6-(aminoethyIimino)-5a-cholestane 101, (1 g, 2.1 
mmol) in dioxane (40 ml), mercaptoacetic acid (2.15 mmol) and 4-5 drops of cone. 
H2SO4, were added and the reaction mixture was refluxed for 8 h. After completion of 
reaction (monitored by TLC), excess of the solvent was removed under reduced 
pressure and the resuhing residue was poured in excess of ice cooled water. Organic 
layer was taken in diethyl ether and washed with water, NaHCOa solution (5%) and 
again with water and dried over anhydrous sodium sulphate. Evaporation of solvent, 
purification by column chromatography and recrystallization of the crude product 
from ethanol provided 3y9-chloro-5a-cholestan-(6/?)-^//*o-6,3'-aminoethyl-r,3',4'-
thiazolidinone 102 as solid having m.p. 142 °C in 81 % yields. 
Analysis found 
C31H53CIN2OS requires 
IR(KBr) 
C, 69.26; H, 9.96; N5.18 
C, 69.30; H, 9.94; N 5.21 % 
Vmax 3489 (NH2), 1638 (C=0), 1231 (C-N), 721 
(C-Cl), 674 cm-' (C-S). 
82 
CHapterll 
*H NMR (CDCb) : S 8.98 (br s, 2H, NH2, exchangeable with D2O), 
4.12 (br m, IH, WA =17.3 Hz, da-K), 3.12 (s, 
2H, C//2-S), 3.01, 2.96 (fused t, 2H each, Cr-//2 
and C2-//2), 1.81 (d, J = 7.8 Hz, 2H, C7-//2), 1.16 
(s, 3H, C10-CH3), 0.74 (s, 3H, C13-CH3), 0.91, 0.79 
(other steroidal side-chain methyl protons). 
"CNMRCCDCb) : S 173.15 (C=0), 44.28, 41.35 (2xCH2 of 
aminoethyl group), 37.77 (CH2-S of thiazolidinone 
ring), 33.72 ( d ) , 30.31 (C2), 51.72 (C3), 29.36 
(C4), 54.83 (C5), 59.23 (Ce), 45.33 (C7), 28.51 
(Cg), 55.01 (C9), 27.88 (Cio), 21.62 (Cu), 41.78 
(C12), 44.11 (C13), 56.81 (Cu), 29.17 (C15), 25.67 
(Cie), 58.16 (CnX 18.06 (Cis), 18.13 (C,?), 30.51 
(C20), 19.89 (C21), 36.57 (C22), 26.14 (C23), 40.65 
(C24), 29.21 (C25), 22.39 (C26), 22.58 (C27). 
3^-Chlon)-6-r2^-N-benzvlidinethvnimino-5g-cholestanel03: 
A solution of 3^-chloro-6-(aminoethylimino)-5a-cholestane 101 (2 g, 4.3 
mmol), in methanol (30 ml) was refluxed with benzaldehyde (4.35 mmol) for 2 h. 
After completion of reaction (monitored by TLC), excess of solvent was removed 
under reduced pressure and the residue thus obtained was purified over silica gel 
column using light petroleum ether: diethyl ether (7:2) as eluant. Recrystallization 
from ethanol afforded 3^-chloro-6-[2'-jV-benzylidinethyl]imino-5a-cholestane 103 as 
solid having m.p. 140 °C in 66 % yields. 
Analysis found 
C36H55CIN2 requires 
IR(KBr) 
*H NMR (CDCla) 
: C, 78.40; H, 10.10; N5.05 
: C, 78.43; H, 10.06; N 5.08 % 
: vmax 1624, 1620 (C=N), 1586, 1542, 1498 
(aromatic ring), 1231, 1221 (C-N), 729 cm"' (C-
Cl). 
: 6 7.16-6.99 (m, 5H, Ai-H), 5.89 (s, IH, CH-Ai), 
4.08 (br m, IH, ^/2=16.8 Hz, C3a-H, axial), 
2.70, 2.46 (fused t, 2H each, C1-//2 and C2-//2), 
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2.31 (d, J= 7.6 Hz, 2H, Cn-Hi), 1.13 (s, 3H, Cio-
CHs), 0.75 (s, 3H, Cn-CHs), 0.94, 0.83 (other 
steroidal side-chain methyl protons). 
"C NMR (CDCI3) : d 140.34 (CH-Ar), 137.3-126.04 (carbon atoms of 
aromatic ring), 44.83, 49.12 (2xCH2 of iminoethyl 
group), 29.33 (Ci), 30.52 (C2), 50.62 (C3), 29.66 
(C4), 32.71 (C5), 168.11 (Ce), 30.26 (C7), 24.16 
(Cg), 44.91 (C9), 31.08 (Cio), 20.19 ( d ) , 32.37 
(C12), 41.57 (C,3), 50.01 (CH) . 21.95 (Cu), 21.76 
(C16), 46.68 (C17), 20.04 {CM), 20.29 (C19), 30.68 
(C20). 19.53 (C21X 36.41 (C22), 26.35 (C23), 40.03 
(C24), 29.72 (C25), 22.19 (Cze), 22.23 (C27). 
3^-Chloro-5«-cholestan-(6RV5piro-63^-[2"-(r"-phenvl-1^^^3^^^4^^^-
thiazolidmon-3^^^-vl)]ethvl-1^^^4^-thiazolidmonel04: 
A solution of 3^-chloro-6-[2'-iV-benzylidinethyl]imino-5a-cholestane 103 (1 g, 
1.8 mmol), mercaptoacetic acid (3.8 mmol) and 7-9 drops of cone. H2SO4 in dioxane 
(40 ml), was refluxed with constant stirring for 9 h. Completion of reaction has 
monitored by TLC and excess of the solvent was removed under reduced pressure. 
The resulting residue was poured in excess of ice cooled water. Organic layer was 
taken in diethyl ether and washed with water, NaHCOs solution (5%) and again with 
water and dried over anhydrous sodium sulphate. Evaporation of solvent, purification 
of crude product by column chromatography over silica gel column and subsequent 
recrystallization of the product from ethanol provided 3;ff-chloro-5a-cholestan-(6i?)-
5p/ro-6,3'-[2"-(2'"-phenyl-l"',3"',4'"-thiazolidinon-3"'-yl)]ethyl-r,3',4'-thiazolidinone 
104 as a non-crystallizable semi-solid in 64 % yields. 
Analysis found 
C40H59CIN2O2S2 requires 
m (Nujol) 
C, 68.65; H, 8.53; N 4.05 
C, 68.68; H, 8.50; N 4.00 % 
Vmax 
1681, 1676 (C=0 of thiazoHdinone rings), 
1586, 1577, 1499 (aromatic ring), 1231, 1225 (C-
N), 736 (C-Cl), 683, 673 cm'' (C-S-C). 
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: d 7.19-6.91 (m, 5H, Ar-//), 5.65 (s, IH, CH-Ax), 
3.76, 3.57 (s, 2H, IXS-CHT), 3.82 (br m, IH, 
W'/2=n.l Hz, Caa-H, axial), 3.05, 2.89 (fused t, 
2H each, C2-//2 and C1-H2), 2.15 (d, J = 6.6 Hz, 
2H, C7-//2), 1.18 (s, 3H, Cio-CHs), 0.75 (s, 3H, 
C13-C//5), 0.92, 0.81 (other steroidal side-chain 
methyl protons). 
: S 176.03, 171.76 (carbonyl carbons of 
thiazoHdinone rings), 135.08-127.57 (carbon 
atoms of aromatic ring), 57.17 (CH-Ar), 51.72, 
44.69 (2xCH2 of ethyl group), 38.06 (S-C"'-H2) 
and 39.16 (S-C'-H2) of thiazoHdinone rings, 40.71 
(Ci), 25.16 (C2), 29.54 (C3), 20.50 (C4), 63.44 
(C5), 62.75 (CeX 45.32 (C7), 29.15 (Cg), 58.29 
(C9), 29.54 (Cio), 21.86 (di), 43.04 (Cn), 45.49 
(C,3), 60.19 (CM), 28.74 (Cu), 26.09 (Ce), 59.84 
(C17), 17.33 (Cg), 18.68 (C19), 30.74 (C20), 19.48 
(C21), 37.56 (C22), 29.70 (C23). 43.75 (C24), 31.15 
(C25), 22.46 (C26), 22.68 (C27). 
3^-Acetoxycholest-5-ene: 
A mixture of cholesterol (100 g), pyridine (150 ml) and acetic anhydride (100 
ml) was heated on a water bath for 2 h. The reaction mixture was poured into ice-
cooled water and the solid thus obtained was fihered under suction, washed 
thoroughly with water and air dried. Recrystallization of the crude product from 
acetone gave 3)ff-acetoxychoIest-5-ene, m. p. 113-114 °C (reported^^ m.p. 117-118 "C) 
yield 95%. 
3jg-Acetoxy-6-nitrocholest-5-ene: 
3)ff-Acetoxycholest-5-ene (10 g) was covered with cone. HNO3 (200 ml; d, 
1.42), sodium nitrite (10 g) was gradually added over a period of 1 h with continous 
stirring, slightly cooling was also required during the course of reaction and the 
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stirring was continued for additional 2 h. A yellow spongy mass separated on the 
surface of the mixture, it was diluted with cold water (200 ml) then green coloured 
solution was obtained. The whole mass was extracted with diethyl ether. The ethereal 
layer was washed successively with water, NaHC03 solution (5%) (until washing 
become pink), water and dried (anhyd. Na2S04). Removal of solvents provided the 
nitro compound as an oil which was crystallized from methanol (with traces of 
acetone) m. p. 104 °C (reported^^ m.p. 102-104 °C), yield 70%. 
3^-Acetoxy-5g-cholestan-6-one 105: 
3^-Acetoxy-6-nitrocholest-5-ene (6.0 g) was dissolved in glacial acetic acid 
(250 ml) by warming the mixture and zinc dust (12 g) was added in small portions 
with shaking. The suspension was heated under reflux for 4 h and water (12 ml) was 
added at regular intervals during the course of reaction. The hot solution was filtered, 
cooled to room temperature and diluted with a large excess of ice-cooled water. The 
precipitate thus obtained was taken in diethyl ether and the ethereal solution was 
washed with NaHCOa solution (10%) and water, and then dried (anhyd. Na2S04). 
Evaporation of the solvents gave the acetoxy ketone 105 as an oil which was 
crystallized from methanol, m.p. 128-129 °C (reported '^ m. p. 127-128 °C), yield 
70%. 
3jg-Acetoxy-6-(aminoethvlimino)-5g-cholestanel06: 
A solution of 3^-acetoxy-5a-cholestan-6-one 105 (4 g, 9 mmol) in methanol 
(55 ml) was refluxed with ethylenediamine (9.1 mmol) for 1 h 10 min. After 
completion of reaction (monitored by TLC), excess of solvent was removed under 
reduced pressure and the residue thus obtained was purified over silica gel column 
using light petroleum ether: diethyl ether (3:1) as eluant. Recrystallization from 
ethanol provided 3yff-acetoxy-6-(aminoethylimino)-5a-cholestane 106 as solid having 
m.p. 131 °C in 83% yields. 
Analysis found 
C31H54N2O2 requires 
IR(KBr) 
C, 76.45; H, 11.15; N 5.73 
C, 76.49; H, 11.18; N5.75% 
Vmax3443 (NH2), 1731 (OCOCH3), 1605 (C=N), 
1231 (C-N), 1135 cm-'(C-0). 
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*HNMR(CDCl3) : J 8.11 (br s, 2H, N//2, exchangeable with D2O), 
4.76 (br m, IH, WA^M.t Hz, Csa-H), 2.79, 2.61 
(fused t, 2H each, Cy-H^ and C2-//2), 2.01 (s, 3H, 
OCOC//3), 1.84 (d, y = 7.0 Hz, 2H, C7-//2), 115 
(s, 3H, C1Q-CH3), 0.74 (s, 3H, Cn-CHs), 0.92, 0.83 
(other steroidal side-chain methyl protons). 
3^-Acetoxv-5g-cholestan-(6JR)-spfro-63'-aminoethvl-l'J',4'-
thiazolidinone 107: 
A solution of 3yff-acetoxy-6-(aminoethylimino)-5a-cholestane 106, (1 g, 2.05 
mmol) in dioxane (50 ml), mercaptoacetic acid (2.1 mmol) and 4-6 drops of cone. 
H2SO4 were added and the reaction mixture was refluxed with stirring for 6 h 45 min. 
Completion of reaction was monitored by TLC and solvent was removed under 
reduced pressure. The obtained residue was poured in excess of ice cooled water. It 
was taken in diethyl ether and washed with water, NaHCOs solution (5%) and again 
with water and dried over anhydrous sodium sulphate. Evaporation of solvent and 
purification of crude product by column chromatography and subsequent 
recrystallization of the product from ethanol provided 3^-acetoxy-5a-cholestan-(6/?)-
5p/>o-6,3'-aminoethyl-r,3',4'-thiazolidinone 107 as solid having m.p. 139 °C in 70 % 
yields. 
Analysis found 
C33H56N2O3S requires 
IR(KBr) 
H^ NMR (CDCI3) 
C, 70.63; H, 10.08; N4.97 
C, 70.67; H, 10.06; N4.99% 
v„^ 3465 (NH2), 1735 (OCOCH3), 1661 (C=0), 
1236 (C-N), 1105 (C-0), 678 cm"^  (C-S). 
: S 8.08 (br s, 2H, N//2, exchangeable with D2O), 4.67 
(br m, IH, ^/2=16.8 Hz, Caa-H, axial), 3.34 (s, 
2H, CH2-S), 3.16, 3.01 (fused t, 2H each, Cr-//2 and 
C2'-H2), 2.01 (s, 3H, 0C0C/^3X 1-92 (d, J = 7.6 Hz, 
2H, C7-H2), 1.18 (s, 3H, C10-CH3), 0.79 (s, 3H, C13-
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13 C NMR (CDCb) 
CHi), 0.90, 0.86 (other steroidal side-chain methyl 
protons). 
: d 170.65 (C=0), 44.64, 43.87 (2xCH2 of aminoethyl 
group), 37.69 (CH2-S of thiazolidinone ring), 34.12 
(Ci), 30.56 (C2), 52.70 (C3), 29.63 (C4), 54.91 (C5), 
59.37 (Cs), 44.89 (C7), 29.23 (Cg), 55.28 (C9), 27.97 
(Co), 21.73 (Cn), 41.94 (Cn), 45.17 (Co), 56.79 
(CM), 29.54 (C15), 25.84 (Cie), 59.19 (Cn), 18.19 
(Cig), 18.24 (C19), 30.67 (C20), 19.93 (C21), 37.63 
(C22), 25.98 (C23), 40.76 (C24), 29.48 (C25), 22.44 
(C26), 22.53 (C27). 
3^-Acetoxv-6-(2^-JV-benzylidmethyl]imino-5g-cholestanel08: 
A solution of 3^-acetoxy-6-(aminoethylimino)-5a-cholestane 106 (2 g, 4.11 
mmol), in methanol (25 ml) was refluxed with benzaldehyde (4.2 mmol) for 3 h. After 
completion of reaction (monitored by TLC), excess of solvent was removed under 
reduced pressure and the residue thus obtained was purified over silica gel column. 
Recrystallization from ethanol gave 3^-acetoxy-6-(2'-iV-ben2ylidinethyl]imino-5a-
cholestane 108 as solid having m.p. 134-136 °C in 67 % yields. 
Analysis found 
C38H58N2O2 requires 
IR(KBr) 
H^ NMR (CDCb) 
"C NMR (CDCb) 
: C, 79.35; H, 10.14; N4.86 
: C, 79.39; H, 10.17; N4.87% 
: v„„x 1739 (OCOCH3), 1622 (C=N), 1588, 1540, 
1494 (aromatic ring), 1240 (C-N), 1129 cm'' (C-0). 
: 6 7.14-6.97 (m, 5H, Ai-H), 5.96 (s, IH, C//-Ar), 
4.75 (br m, IH, »V2=16.7 Hz, da-H, axial), 2.47, 
2.37 (fused t, 2H each, C1-//2 and C2-//2), 2.67 (d, J 
= 7.9 Hz, 2H, C7-^2), 2.02 (s, 3H, OCOC//3), 114 
(s, 3H, CxQ-CHs), 0.71 (s, 3H, Cn-CHs), 0.90, 0.82 
(other steroidal side-chain methyl protons). 
: 3 144.51 (CH-Ar), 135.8-129.43 (carbon atoms of 
aromatic ring), 45.67, 48.92 (2xCH2 of 
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benzylidinethylimino group), 30.31 (Ci), 30.65 (Cj), 
50.84 (Cs), 28.94 (C4), 32.86 (C5), 169.24 (Ce), 
31.45 (C7), 24.52 (Cg), 43.89 (C9), 32.18 (Cio), 
20.32 (Cn), 31.65 (C12), 41.85 (C13), 50.34 (CM), 
21.90 (C15), 21.69 (C,6), 46.73 (C17), 20.15 (Cg), 
20.37 (C19), 30.87 (C20), 19.43 (C21), 36.49 (C22), 
27.41 (C23), 41.13 (C24), 29.54 (C25), 22.32 (Cze), 
22.46 (C27). 
3p-Acetoxv-5a-<holestan-(6R)-spirO'63'-\2''-(2'''-phenv\-r"3'''A'''-
thiazolidinon-3^^^-vl)^ethvl-1^^^4^-thiazolidinonel09: 
To a solution of 3^-acetoxy-6-(2'-A'^ benzylidinethyl]imino-5a-cholestane 108, 
(1 g, 1.74 mmol) in dioxane (40 ml), mercaptoacetic acid (3.6 mmol) and 9-10 drops 
of cone. H2SO4 were added, and then reaction mixture was stirred and refluxed for 8 h 
30 min and completion of reaction was monitored by TLC. Excess of the solvent was 
removed under reduced pressure and the resuhing residue thus obtained was poured in 
excess of ice cooled water. Organic layer was taken in diethyl ether and washed with 
water, NaHCOs solution (5%) and again with water and dried over anhydrous sodium 
sulphate. Evaporation of solvent, purification of the residue by column 
chromatography by silica gel column using pet. ether - diethyl ether (5:2) as an eluant 
and subsequent recrystallization of the crude product from ethanol gave 3^-acetoxy-
5a-cholestan-(6^)-5p/>o-6,3'-[2"-(2"'-phenyl-r",3'",4'"-thiazolidinon-3'"-yl)]ethyl-
r,3',4'-thiazolidinone 109 as non-crystalHzable semi-solid in 58 % yields. 
Analysis found 
C42H62N204S2 fcquires 
m (Nujol) 
*H NMR (CDCI3) 
C, 69.72; H, 8.67; N3.88 
C, 69.76; H, 8.64; N3.87% 
v™,x 1738 (OCOCH3), 1668, 1654 (C=0), 1588, 
1561, 1494 (aromatic ring), 1236, 1230 (C-N), 1086 
(C-0), 683, 675 cm*' (C-S). 
S 7.16-6,98 (m, 5H, Ar-^, 5.76 (s, IH, CKAr), 
3.77, 3.17 (s, 2H each, l^S-C-Hi), 4.71 (br m, IH, 
PF'/2= 17.6 Hz, Caa-H), 2.79, 2.92 (fiised t, 2H each. 
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C2-H2 and Ci--/^:), 2.02 (s, 3H, OCOCH3), 2.28 (d, 
J= 6.9 Hz, 2H, C7-/6), 1.13 (s, 3H, C10-CN3), 0.77 
(s, 3H, Ci3-CHs), 0.93, 0.82 (other steroidal side-
chain methyl protons). 
^^ C NMR (CDCI3) : S 173.03 and 170.74 (two carbonyl carbons of 
thiazolidinone rings), 132.00-128.06 (carbon atoms 
of aromatic ring), 56.16 (CH-Ar), 51.93, 43.65 
(2xCH2 of ethyl group), 38.32, 34.19 (2xCH2-S) of 
thiazolidinone rings, 41.11 (Ci), 25.34 (C2), 28.94 
(C3), 20.10 (C4), 63.65 (C5), 61.92 (Ce), 45.31 (C7), 
29.61 (Cg). 59.19 (C9), 29.75 (Co), 21.79 (Cn), 
42.83 (C12), 44.87 (C13), 59.11 (CH), 28.77 (C15), 
26.18 (C16), 58.13 (Cn), 18.04 (Cg), 18.87 (C19), 
30.07 (C20). 20.90 (C21), 36.52 (C22), 28.16 (C23), 
42.15 (C24), 31.75 (C25), 22.40 (C26X 22.79 (C27). 
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Synthesis and Cfidfdctetization 
ofO^ew Steroiddf(Fyrazole and 
l,3,4-O^QuCiazo(e (Derivatives 

CHapUrin 
Heterocyclic is a challenging field of study because of its importance in 
biological systems, chemical reactivity and molecular recognition. For this reason, it 
has been extensively studied over the past decades.' In particular, the problem of 
pyrazolinones has been the objective of a large number of studies.''^ Substituted 1,3,4-
oxadiazole are also considerable for pharmaceutical and material interest, which is 
documented by a steadily increasing number of publication and patent. For instance 
1,3,4-oxadiazole act as muscle relaxants,^  hypnotic and as a sedative.'* 
Some material synthetic application of pyrazolinone and 1,3,4-oxadiazole 
derivatives. 
Kepe et al.^ described the synthesis of l-acyl-3-hydroxy-l//-pyra2oles 4 and 
related derivatives from ethoxymethyleneoxazolone derivative 1 and hydrazides or 
related derivatives 2. The method includes a migration of an acyl group in the 
intermediary-formed pyrazolone derivative 3 to yield the rearranged l-acyl-3-
hydroxy-l.^-pyrazoles 4 in high yields. In contrast, in the reaction of the oxazolone 
derivative 1 with two equivalents of an appropriate hydrazine derivative the 
corresponding symmetrically A'^ iV'-disubstituted hydrazines 5 and oxazolone 
derivative 6 were obtained. 
EtO-HC R^CONHNH; (2) 
1,4-Dioxane 
COR^ 
I 
NH 
°t=/' 
PhOCHN 
2R'CONHNH2 
0.5-2h. reflux 
1,4-dioxane 
RiCONHNHCORi 
5 
t H 
P h O C H N ^ V , 
CORi 
u. PhOCHN OH 
4 
Kurth et al.^ reported the preparation of .jp/ro-fused isoxazolinopyrazolone 9. 
[R = Me, Et, Ph, 4-MePh, 4-MeOPh; R' = 2-ClPh, 4-MeOPh, 2-pyridyl, R" = Me, Ph, 
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H, 4-MeOPh] from ketoester 7 by hydrazone formation with concomitant 
cycloelimination. 
u w 
R NHNH, 
NHR" 
MeO' 
Wentrup et al^ reported that under flash vacuum thermolysis (FVT) 
conditions the ketenes 10 cyclized to pyrazolium oxides 11, which underwent 1,4-
migration of a methyl group to yield l,4,4-trimethyl-3-phenylpyrazole-5(4/0-one 12 
[R = H, CH3] and l,4-dimethyl-3-phenylpyrazole-5(4//)-one 14. 
X 
10 
FVT 
hv 
11 
500 °C 
-1,4-Me 
Ph^N 
14 
Me 
M e - V ^ 
I ^N-Me 
12 
[ ^N-Me 
Ph -^N ' 
13 
Saleh et al^ reported that the treatment of 15 with hydrazine hydrate or 
phenyl hydrazine in refluxing ethanol afforded the corresponding pyrazolin-5-one 
derivatives of 3H-quinazolin-4-one 16. Cyclization of 17 with hydrazine hydrate 
yielded the corresponding products 18. 
[X = H, Br; R = H, Ph.] 
96 
Cfiapterlll 
^^^x^--< ^/^^^ R-NH-NHg 'COOC2H5 
15 16 
H2N 
I^XAJ>""-"" -^^ —"€a:^ "V' 
17 
CH3 d 
18 
Park et al^ described that the majority of dyes belong to the chromophoric 
class known as donor-acceptor systems. The essential structural feature of such 
systems is the presence of one or more electron donating groups conjugated to one or 
more electron withdrawing groups via an unsaturated bridge. The pyrazolin-5-one 
system is an effective electron acceptor residue, and can also act as a weak electron 
donor. They reported the reaction of S-methyl-l-phenylpyrazolin-S-one with 4-N,N-
dimethylaminobenzaldehyde 19 and l,3,3-trimethyl-2-methylene-indolinealdehyde 21 
to the corresponding products 20 and 22. [R = H, OH] 
r ^ N - P h H3C 
Et^ NHQ-CHO ? ^ B ^ N - Q ^ C H K ^ J ; 
\ ^ R O ^ Nh 
19 20 
^3C .M 
] ^ ; N ' P ^ H3C CH3 H3C 
CH3 O 
22 
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Peesapati et al}^ prepared the corresponding pyrazole derivatives 24 via 
treatment of 2-[3-methyl-6-oxo-5,6,7,8,9,10-hexahydrobenzo-(a)-cycloocten-
5yl]ethano hydrazide 23 with methyl acetoacetate in presence of acidic medium. 
methyl acetoacetate 
^• 
R 
23 24 
Desai et al.^^ reported the reaction, which was carried out using different 
aromatic and heteroaromatic carboxylic acid, amine and carboxylic acid were mixed 
and irradiated under microwaves to yield 2,3-disubstituted-4-(3//)-quinazolinones 25. 
Good yields were obtained in less irradiation time as compared to the conventional 
procedure requiring 5-substituted anthranilic acid, acetyl chloride, pyridine and amino 
acids and long refluxing time. The hydrazide 27 from the corresponding acid was 
prepared by hydrazine hydrate and 6-bromo-2-methyl-3-[-4-(3-methyl-5-oxo-2,5-
dihydro-lH-pyrazol-lyl)carbonyl]phenylquinazoline-4(3H)-one 28 was obtained from 
4-(6-bromo-2-methyl-4-oxoquinazolin-3(4//)-yl) benzohydrazide 27 using different 
solid supports as neutral alumina and by conventional technique using ethyl 
acetoacetate in ethanol solvent. It gave new 3-methyl-lH-5-pyrazolone in good yield. 
[Y = Br, H; R = CH3, CgHj; X = 4-C6H4, CH2] 
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^ • "^^NHz 
OH 
r^" , X O ' " X / NH2 
N NHNH2 
27 
CH3COCH2COOC2H5 
.00' P ^ 
Hydrazine hydrate 
IM 
25 
SOCI2 
! . - - < 
Sacmaci et al.^^ reported that 4-(4-Methoxybenzoyl)-5-(4-methoxyphenyl)-
2,3-furandione 29 reacted with N-aryl substituted phenylhydrazones 31 via the p,p'-
dimethoxydibenzoylketene intermediate 30 giving the proponohydrazide derivatives 
32. In addition, compounds 32 were converted into corresponding pyrazolone 
derivatives 33 by the hydrolysis in acidic solution. [Ri= H, Ph; R2 = Ph, EtOPh, Cl-
Ph; R3 = Ph, Ph (2,4-di-Me); Ar = MeO-Ph] 
99 
Ar 
A r \ ^ 0 
Ar^C"° 
29 
Ar 
30 
^*5tr 
Rl 
31 ^ 
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A r " ^ 0 \ ^ ^ 
R2 
32 
N-R3 
33 
Eller and his coworker'^  reported that the fully unsubstituted pyrazolone 35 
(2-pyrazolin-5-one, which is tautomer to lJ¥-pyra2ol-3-ol and l//-pyrazol-5-ol) was 
prepared from hydrazine hydrate and methyl (2£)-3-methoxyacrylate 34 in almost 
quantitative yield. 
MeO 
NH2-NH2 X H2O 
OMe • 
34 
HN^  > 0 Nv > 0 N^ X 
N 
H 
35 a 
N 
H 
35 b 35 c 
Brugel et al.^'* reported that the aldol reaction between 4-fluorophenyl acetate 
36 and 2-methylsulfanyl pyrimidine-4-carbaldehyde 37 provided yff-hydroxyester 38. 
This was followed by oxidation with chromium trioxide to afford y?-ketoester 39. 
Cyclization of 39 with pyrazolidine dihydrogen chloride produced 2,3-
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bisarylpyrazolone 40, which on oxidation and amine displacement of the thiomethyl 
group furnished bicyclic pyrazolone analog 41. 
OCH3 
36 
OCH3 OCH. 
40 
d,e 
a. LDA, 2-methylsulphanyI-pyrimidine-4-carbaldehyde 37, THF; b. CrOs, CH2CI2, 
Pyridine; 
d. pyridine, pyrrolidine, dihydrogen chloride; d. Oxone, THF/MeoH; e. (S)-
Methylbenzylamine, toluene. 
They also reported that beginning with the differentially protected 
pyrazolidine 42 removal of the Boc protecting group was accomplished with 
SOCli/MeOH. This was followed by acylation with 4-fluorophenylacetyl chloride to 
give monoacylated pyrazolidine 43. Deprotection of the Cbz group under 
hydrogenation conditions followed by a subsequent second acylation with pyrimidine 
carbonyl chloride 44 gave bis-acylated pyrazolidine 45 in excellent yield. When 45 
was subjected to the cyclization conditions (NaH, DMF) bicyclic pyrazolone 48 was 
obtained. 
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Cbz^'^'^N 
O^'OS 
Boc 
42 
N 
I 
CbzN 
43 
3 
SMe 44 
c. d 
45 
S-Me 
46 47 
H2O 
48 
a. SOCI2, MeOH; b. 4-flourophenyl-acetylchloride, NaOH, H2O/CH2CL2; c. H2, Pd, 
methanol; 
d. acid chloride 
Ahasan et al}^ reported that pyrazolone heterocyclic compound, 3-niethyl-l-
phenyl-2-pyrazoline-5-one 51 was synthesized by condensation reaction between 
ethyl acetoacetate 49 and phenyl hydrazine 50. Their cytotoxicity effects were 
measured by brine shrimp lethality bioassay. 
H3C 
°'^OEt + 
O 
49 
NHNH2 
50 
H3C. 
l ^ o N 
51 52 
Padmavathi et al. '^  reported that the Michael adduct, ethyl 4-phenylsulfonyl-
2-(2'-phenylsulfonylethyl)-2-cyanobutyrate 53 was prepared by the addition of ethyl 
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cyanoacetate to vinyl sulfone in the presence of Trition-B in benzene. The 
cyclocondensation of 53, with hydrazine hydrate in the presence of piperidine in 
ethanol afforded 5-amino-4,4-bis-(2'-phenylsulfonylethyl)-pyrazol-3-one 54. 
EtO 
53 54 
Oxadiazoles 
Kaim et al}^ reported that when hydrazone 55 was subjected to react with 
EtONa /EtOH, no change was observed even after 4 h at room temperature but when 
the same solution was refluxed for 5 h the oxadiazole 56 was formed in 48% yields. 
O 
OEt 
EtO 
EtOH 
EtONa 
55 
56 
El-masry et al}^ reported that the reaction of 3-(2-methylbenzimidazol-l-yl) 
propanoic acid hydrazide 57 with CS2/KOH gave oxadiazole 58. 
CS2/KOH 
N 
CH2CH2CONHNH2 
57 
"N CH3 
I N-N 
CH2CH2-J J^sH 
58 O^ 
Lee et al}^ reported that the treatment of a suspension of salicylic hydrazide 
59 in toluene with acetic anhydride or an acid chloride in the presence of 
methanesulfonic acid at room temperature, and then heating to reflux temperature 
gave 1,3,4-oxadiazoles 61. 
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O 
NHNH2 
X^XH 
59 
N N 
61 
MeSOj/toluene 
RCOCl or Ac,0 k^XH 
o o 
NHNH^R 
60 
N NH 
I 
\ ^ X H 
60' 
Sage et al?^ reported the synthesis of 2-(3-vinylphenyl)-5-phenyloxadiazole 
65 starting from 5-Phenyltetrazole 63 and 3-bromobenzoyl chloride 65. 
Os^CI 
62 
H 
o\i Br, 
63 
Heat, -N2 
\ , N-N ^_^ 
64 
iMg.THF 
iiCH2=CHBr or 
,, Pd(PPh3)4. = v 
SnBu3 
65 
Baouid et al}^ reported one-step synthesis of new 3-mesityl-7-methyl-8,9a-
diphenyl-4,5,6,9a-tetrahydro-7H-[l,2,4]oxadiazolo[4,5-d][l,4]diazepines 68 from the 
reaction of 1,4-diazepines 66 and mesitonitrile oxide 67. 
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H,C 
H3C 
a PeHs Ar-CNO 67 
\ AH5 
N' 
66 
ether, r.t. 
CeHs 
^ N 
68 
Ar = - ^ ^ C H 3 
H3C 
Monge et al}^ reported the transformation of 7V'^ -(2-cyanoethyl)-iV-
methylindoIe-2-carbohydrazide 69 into oxadiazolone 71 and oxadiazolethione 70 [R = 
H, CH3; R ' = H, OCH3, 0CH2Ph, OH] by its reaction with triphosgene and 
thiophosgene, respectively. 
Rahman et al}^ synthesized 5-(benzothiazole-2-yl-thiomethyl)-2-
phenylamino-1,3,4-oxadiazole 74, 5-(benzothiazole-2-yI-thiomethyl)-2-amino-1,3,4-
oxadiazole 75 and 5-(benzothiazole-2-yl-thiomethyl)-l,3,4-oxadiazole-2-thione 76 by 
the oxidative cyclization of A^-(benzothiazole-2-yl-thioacetyl)-A^-phenyl-3-
thiosemicarbazide 73 and (benzothiazole-2-yl-thio)acetic acid hydrazide 72, with 
following sequences of reactions. 
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t ^ 
N S 
W 
I VSCH^-CONHNH-C ^^^^ 
S NHPh 
73 
PhNCS 
SCH2CONHNH2 
CS2 
KOH 
• N 
76 
N NH 
S 
CNBr 
KHCO3 
N N N 
74 
N N (;xy»A„A NH2 
75 
Hirata et al. synthesized substituted 5-[4-(benzy]oxy)phenyl]-3-(2-
cyanoethyI)-l,3,4-oxadiazoI-2(3//)-one 79 [X = H, 2-1, 3-1, 4-1; Y = H, I] from 
substituted-l-[4-(benzyloxy)benzoyl]-2-(2-cyanoethyl)hydrazide 78, which was 
prepared from substituted-l-[4-(benzyloxy)benzoyl]-2-(2-cyanoethyl)hydrazine 77. 
O - ^ /^-CONHNH' 
(CCl30)2CO 
- G^ 
X 
°A ^''-^' 
79 
u< 
,CN 
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Chande et al}^ synthesized 5-arylamino-2-mercapto-l,3,4-oxadiazoles 82 [R = 
CeHs, P-CH3C6H4, P-CIC6H4 etc.] by the reaction of sodium P-{N-
aryhhiocarbamyI)thiocarbazinates 81 with ethanolic NaOH. 
S S O 
" cos II II 
R - N H - C - N H - N H 2 * R _ N H - C - N H - N H - C - S - Na" 
NaOH 
80 
NaOH / Ethanol 
81 
N N 
82 
r26 Gadaginamath et al synthesized l-fiirfuryl-3-carbethoxy-5-(l,3,4-oxadiazol-
2-yl)methoxy-2-methylindole 84 and l-furfuryl-3-carbethoxy-5-(5-mercapto-l,3,4-
oxadiazol-2-yl)methoxy-2-methyIindole 85 by treating separately l-fiirfuryl-3-
carbethoxy-2-methylindol-5-yloxy acetic acid hydrazide 83 with acetonyl acetone and 
ethanolic KOH / CS2 respectively. 
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H2NHN 
/ ^ > ^ 0 
Acetonyl 
acetone 
OC2H5 
OC2H5 
CS2/KOH 
N — N H 
OC2H5 
84 85 
Mankhetkom et al?'' synthesized 5-aryl-3-(4-hydroxyphenyl)-l,3,4-
oxadiazole-2-(3//)-thiones 87 by cyclocondensation of l-(4-hydroxyphenyl)-2-
aroylhydrazines 86 with thiophosgene. [X = H, OMe; Y = H, Me OMe, N02; Z = H, 
OMe] 
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0 
H II CSCI, 
N-NH-C—Ar 
86 
H2O 
X 
Ar = Ar-C >-Y 
" - \ ^ ' 
Donawade ei al?^ synthesized l-flirfuryl-3-ethoxycarbonyl-5-(5-mercapto-
l,3,4-oxadiazol-2-yl)methoxy-2-methylbenz(g)indole 89 and l-furfuryl-3-
ethoxycarbonyl-5-(2,5-dimethylpyiTol-l-yl)aminocarboylmethoxy-2-methylbenz(^) 
indole 90 by the reaction of l-furfuryl-3-ethoxycarbonyl-2-methylbenz(^)indole-5-
yloxyacetic acid hydrazide 88 with CS2/KOH and acetonyl acetone respectively. 
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H2NHN 
OCH2CH3 
88 
CS2/KOH 
OCH2CH3 
89 
CH3-CO-(CH2)2-COCH3 
H3C, 
> ^ 
H2C 
OCH2CH3 
90 
Katritzky et al}^ reported the preparation of 1,2,4-oxadiazole 93 by the reaction 
of amidoxime 91 with aryi halide 92 in the presence of palladium catalyst. 
/ OH 
I + Ar-X 
R' NH2 
91 92 
N \ 
R- 'N 
93 
.Ar 
Demibras et al}^ synthesized 5-alkyl-2-[(5-{[(5-mercapto-l,3,4-oxadiazol-2-
yl)methyl]thio}-l,3,4-thiadia2ol-2-yl)methyl]-2,4-dihydro-3//-l,2,4-triazol-3-ones 95 
by treating 2-({[(3-allcyl-5-oxo-4,5-dihydro-l/^-l,2,4-triazol-]-yl)methyl]-l,3,4-
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thiadiazol-2-yl}thio)acetohydrazide derivatives 94 with CS2/KOH. [R = CH3, 
CHjCeHj, CsHs] 
N — N o N — N 
// W ^^ ,HNH, N-N 7 / W 
CS2/ KOH 
,,, -s" ^ // w r \ , / ^ s H 
N — N S r..o-/i^oM / - ^ J ^ S O 
'^• •^° A > o 
j ^ . - • N — N S 
N 
^ 94 ^ ^^' 
^^ H 95 
Khan e/ a/. '^ reported the synthesis of hydrazides 2,5-disubstituted-l,3,4-
oxadiazoles 98 from the reaction of available hydrzide 96 and substituted carboxylic 
acids 97 in the presence of phosphorous oxychloride. 
O O N N 
X ^ X ^^^ 1 1 
96 97 98 
Vishalakshi et al^^ reported 1,3,4-oxadizole 100 from acid hydrazide 99 on 
reaction with aryl acid chloride in presence of POCI3. 
F-fVc-NHNH2 R-^hcoCI Wo 
O POCI3 O 
R 
99 100 
Holla et al^^ synthesized 1,3,4-oxadiazole derivatives 102 from 2,4-dichloro-
5-fluoro benzoyl hydrazide 101 on reacting with aromatic acid in presence of POCI3. 
I l l 
chapter III 
- / \-C-NHNH2 
RCO2H 
POCI3 
101 
CI 
102 
Belkadi et al.^^ reported the synthesis of racemic compound 5-(2,2-dimethyl-
[l,3]dioxolan-4-yl)-3//-[l,3,4]-oxadiazol-2-thione 105 from racemic 2,2-dimethyl-
[l,3]dioxolan-4-carboxylic acid hydrazide 104 by its treatment with CSa/ethanolic 
KOH. 
HzNHN^^^^^O 
103 
CS2 
HN O 
KOH, EtOH V 
-O Me 
104 
K 
^%/° 
Me 
-O Me 
105 
Refaat et al^^ reportd the preparation of 3-[5-(4-nitrophenyl)-l,3,4-oxadiazol-
2-yl]-quinoxalin-2(lH)-one 107 from treatment of 3-hydrazinocarbonyl-quinoxalin-
2(lH)-one 106 with 4-nitrobenzoic acid in phosphorus oxychloride. 
N CONHNH2 
O ^ N - ^ ^ COOH 
P0CI3 
106 
.r^ -'V^ V 
KX 
107 
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Introduction 
The growing need for the compound libraries especially for biological 
evaluation, there is an increasing demand for clean and efficient synthesis of organic 
molecules. Recently, synthesis of steroidal pyrazoles and oxadiazoles have attracted 
the attention of organic chemists because they display remarkable and unusual 
physiological activity and material interest. Pyrazoles have been found in diverse 
application in pharmaceutical and agrochemical industries.'^ '^ ^ In particular they are 
known as potential antibiotic and antioxidant agents.^ ^ Many dyes also contain 
pyrazole nucleus. The fusion of pyrazole ring to steroidal nucleus can act as potential 
drugs. The unusual anabolic activity observed in humans '^ attached vital significance 
with such compounds in steroids. 
In addition, 1,3,4-oxadiazole constitute an important family of heterocyclic 
compounds.'*" Since many of them display a remarkable biological activity, and are 
often used in drug discovery as potential agonists for cortical muscarinic,'*''''^  
benzodiazepine"'' histamine H3 receptors,'*" antirhinoviral,'*' growth hormone 
secretagogues,'*^ anti-inflammatory'*^ and anti-tumor agents."** They also inhibit 
monoamine oxidase,'*' human neutrophil elastase'° and human DNA 
topoisomerases. '^ 
Thus, inspired by these results obtained by earlier workers, we have made an 
attempt to synthesize steroidal pyrazoles and oxadiazoles from steroidal hydrazides 
belonging to cholestane series. Here, we have synthesized 3^-[(3'-methyl-5'-oxa-2'-
pyrazolin-r-yl)carbonylmethoxy]cholest-5-ene 111, from cholest-5-en-3^-0-acetyl 
hydrazide 110 using methyl acetoacetate. The treatment of compound 110 with 
benzoic acid or 4-chloro benzoic acid in presence of phosphorous oxychloride affords 
3^-[5'-phenyl-l',3',4'-oxadiazol-2'-yl]methoxycholest-5-ene 112 and 3/ff-[5'-(4"-
chlorophenyl)-r,3',4'-oxadiazol-2'-yl]methoxycholest-5-ene 113. During the reaction, 
the acid was first converted to acid chloride, which subsequently reacted with 
compound 110 to give the corresponding acyl hydrazinocarbonyl compound, which 
underwent cyclodehydration to yield final products 112, 113. The compounds 3yff-[5'-
(4"-ethylphenyl)-l',3',4'-oxadiazole-2'-yl)methoxycholest-5-ene 114 and 3^-[5'-
pheny]-r,3',4'-oxadiazole-2'-yl]methoxycholest-5-ene 112 are synthesized via 
cyclodehydration of diacylhydrazine. The cyclodehydration reaction condition was 
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promoted by heat and anhydrous reagent POCI3. The compound 110 was obtained 
from easily asseccible ethyl-5-cholesten-3y9-0-acetate 109 which was obtained by 
treating cholest-5-en-3y9-ol (cholesterol) 108 with ethyl chloroacetate. The structures 
of new compounds were established on the basis of analytical and spectral studies. 
H3C 
O (I 
N-C-CH2-
I 
N 
111 112 
CI 
N N I I N N 
CH2-0 
113 114 
114 
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Reaction of cholest-5-en-3^-ol 108 with ethyl chloroacetate in the 
presence of K2CO3: Ethyl-5-cholesten-3^-0-acetate 109: 
* p ^ p V Ethyl chloroacetate 
H5CrO-C-H2C-0 ' \^^^5^ 
108 109 
Cholest-5-en-3/5-oI (cholesterol) 108 in 1,4-dioxane was subjected to treat 
with ethyl chloroacetate in the presence of K2CO3. The reaction mixture was refluxed 
for 25 h. Completion of reaction was monitored by TLC. Inorganic solid was fihered 
off and excess of solvent was distilled out under reduced pressure. After usual work 
up and chromatographic purification, a white powdered single product 109, m.p. 144 
°C, (reported'^  m.p. 145 °C) was obtained in 65 % yields. 
Characterization of compound 109 having m,p. 144 °C as ethvl-5-
cholesten-3^-0-acetate: 
The compound 109 was correctly analysed for C31H52O3. Its IR spectrum 
exhibited characteristic absorption bands at 1731 (C=0 ester), 1616 (C=C), 1218 (C-
O of -iU>c) and 1143 cm"' (C-0)." The 'H N M R spectrum of compound 109 
displayed a double doublet for single proton at S 5.62 (y = 8, 2 Hz) for Ce-H and one-
proton broad multiplet centred at 4.26 (W^/214.4 Hz, axial) for da-H, another singlet 
for two protons at 4.81 {-OCH2-CO), a quartet for two protons at 4.1 for {-O-CH2-
CH3) and a triplet for three protons at 1.41 (O-CH2-C/6). Angular and side-chain 
methyl protons were observed at ^ 1.14 (Cio-C//?), 0.73 (C13-C/6), 0.93 and 0.80 
(other steroidal side-chain methyl protons). ^ "^  
Thus, on the basis of above evidences, compound 109 having m.p. 144 °C has 
been characterized as ethyl-5-cholesten-3^-0-acetate. 
Ethyl-5-cholesten-3;J-0-acetate 109 has also been reported in the literature by 
other methods." 
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Reaction of ethvl-5-cholesten-3)g-0-acetate 109 with hydrazine 
hydrate: Cholest-5-en-3jg-0-acetvl hydrazide 110: 
O IN|-l2lNt-l2.|-l2U Q 
H5C20-C-CH2-0''^^«v--'' '%>^ H2N-NH-C-CH2-O 
1«^ 110 
To a suspension of 109 in absolute ethanol was added 99 % of hydrazine 
hydrate and pyridide (3-5 drops) and the reaction mixture was refluxed for 11 h on 
water bath. Completion of reaction was monitored by TLC and after completion of 
reaction it was concentrated to half its volume under reduced pressure. After usual 
work up, chromatographic purification over silica gel column and recrystallization 
from ethanol, a single compound 110, m.p. 153 °C (reported^^ m.p. 152 °C) was 
obtained in 69 % yields. 
Characterization of compound 110 having m.p. 153 °C as cholest-5-en-
3^-O-acetyl hydrazide: 
The obtained compound 110 was correctly analysed for C29H50N2O2. Its IR 
spectrum exhibited characteristic absorption bands at 3370 (NH2), 3232 (NH), 1642 (-
CO-NH-), 1620 (C=C), 1385 (C-N) and 1120 cm'' (C-0)." The ' H N M R spectrum of 
compound 110, displayed a broad peak for one proton at ^ 9.1 (N//), a singlet for two 
protons of N//2 at 6.5 (both exchangeable with deuterium), a double doublet for a 
single proton at 5.63 (J= 8.2, 5 Hz) for Ce-H, a one-proton broad multiplet centred at 
4.30 {W^A 14.6 Hz. axial) for da-H and another singlet for two protons at 4.9 (-
OCH2-CO). Angular and side-chain methyl protons were observed at 6 1.19 (Cio-
CH3), 0.72 (Cn-CHs), 0.92 and 0.83 (other steroidal side-chain methyl protons)." 
Thus, on the basis of above data, compound 110 having m.p. 153 °C has been 
characterized as cholest-5-en-3^-0-acetyl hydrazide. 
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Reaction of cholest-5-en-3^-0-acetvl hvdrazide 110 with methyl 
acetoacetate: 3^-[(3^-methvl-5^-oxo-2^-pyrazolin-l^-vl)carbonyl 
methoxykholest-5-ene 111: 
110 "^^ 111 
The mixture of compound 110 and methyl acetoacetate in ethanol containing 
2-3 drops of hydrochloric acid was refluxed for 5 h 30 min. The usual work up 
followed by recrystallization from ethanol provided compound 111 as a solid, m.p. 
138-141 °C in 71% yield. 
Characterization of compound 111 having m.p. 138-141 "C as 3^-[(3'-
methvl-5^-oxo-2^-pyrazolin-lWl)carbonvlmethoxv1cholest-5-ene: 
The compound 111 was correctly analyzed for C33H52N2O3. Its JR. spectrum 
exhibited characteristic absorption bands at 1719, 1674 (C=0), 1611 (C=N), 1627 
(C=C), 1393 (C-N), 1213, 1183 cm"' (C-0)." In the H^ NMR spectrum of compound 
111, a double doublet for one olefinic proton appeared at S 5.46 (J= 7.6, 4.2 Hz) for 
Ce-H and a singlet for two protons at 4.58 {CH2 of pyrazolinone ring). It also showed 
a two-proton singlet at S 4.86 for O-C//2-CO, another singlet for three protons (CH3 of 
pyrazolinone ring) at 1.56 and a broad multiplet integrating for one proton at S 3.49 
(W^/2 14.9 Hz, axial) for C^a-H. Angular and side-chain methyl protons were 
observed at ^ 1.17 (C10-CH3), 0.72 (C13-CH3), 0.91 and 0.83 (other steroidal side-
chain methyl protons).'^ 
In the '^C NMR spectrum of compound 111, characteristic peaks at S 176.3 
and 61.24 were assigned for carbonyl and methylene carbon atoms of pyrazolinone 
ring, respectively. Other important peaks were at S 149.25 (C=N), 169.52 (OCH2-
C=0) and 62.52 (OCH2). Some other signals were at d 78.35, 39.56, 141.36 and 
128.53 for C3, C4, C5 and Ce respectively. Remaining carbon atoms of steroidal 
skeleton appeared at expected regions. 
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Thus, on the basis of above discussion, compound 111 having m.p. 138-141 
C has been characterized as 3y5-[(3'-methyl-5'-oxo-2'-pyrazolin-r-
yl)carbonylmethoxy]cholest-5-ene. 
Reaction of cholest-5-en-3/^-0-acetyl hydrazide 110 with benzoic acid 
and POCI3 in acetonitrile: 3^-r5^-phenvl-1^^^4^-oxadiazol-2^-
yl]methoxycholest-5-ene 112: 
O I I C H COOH ^ ^ I I 
110 112 
A mixture of compound 110, benzoic acid and phosphorus oxychloride in 
acetonitrile was refluxed on an oil bath for 8 h. Completion of reaction was monitored 
by TLC. The excess of solvent was distilled off and crystallization of the crude 
product from ethanol gave compound 112 as a solid, m.p. 125-126 °C in 69 % yields. 
Characterization of compound 112 having m.p. 125-126 °C as 3^-[5'-
phenvl-1^^^4^-oxadiazol-2^-vnmethoxvcholest-5-ene: 
The compound 112 was correctly analyzed for C36H52N2O2. Its IR spectrum 
exhibited characteristic absorption bands at 1625, 1607 (C=N), 1620 (C=CX 1587, 
1490, 1445 (aromatic ring) and 1245, 1220 cm'' (C-0)." The ' H N M R spectrum of 
compound 112 displayed a two-proton singlet at 3 4.29 for (O-CH2-), a double 
doublet for a single proton at 5.41 (7= 8.1, 5.9 Hz) for Ce-H and a one-proton broad 
multiplet centred at S 3.54 (fPA 15.4 Hz, axial) for da-H. Five aromatic protons 
appeared at S 7.07-6.91. Angular and side-chain methyl protons were observed at d 
1.15 (C1Q-CH3), 0.74 (Cn-CHs), 0.90 and 0.85 (other steroidal side-chain methyl 
protons).^ " 
In its '•'C NMR spectrum, compound 112 showed characteristic peaks at S 
138.03-127.85 for aromatic ring and 72.51 for methylene carbon atom (OCH2). Other 
important peaks were at <5 111.53 (C2') and 123.92 (Cs-) of oxadiazole ring. Some 
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other signals appeared at d 76.11, 42.53, 148.17 and 126.98 for C3, C4, C5 and Ce 
respectively. Other carbon atoms of steroidal skeleton appeared at expected regions. 
Thus, on the basis of above data, compound 112 having m.p. 125-126 °C has 
been characterized as 3y9-[5'-phenyl-r,3',4'-oxadiazol-2'-yl]methoxycholest-5-ene. 
Reaction of choIest-5-en-3^-0-acetvl hvdrazide 110 with 4-
chlorobenzoic acid/POCb in acetonitrile: 3jg-r5'-(4^^-chlorophenyl)-
l'^'.4'-oxadiazol-2'-vnmethoxvcholest-5-ene 113 : 
A mixture of compound 110, 4-chloroben2oic acid and phosphorus 
oxychloride in acetonitrile was refluxed on an oil bath for 10 h. Completion of 
reaction was monitored by TLC. The excess of solvent was distilled off and 
crystallization of crude product from ethanol gave compound 113 as a solid, m.p. 136-
139 °C in 66 % yields. 
4-CI-C6H5COOH N N 
H2N-NH-C-CH2-0'^^^^'^*^ POCI3 * 1 X ^ 0 ^ ^ " ' " ° ' 
110 113 
Characterization of compound 113 havinp m.p. 136-139 °C as 3^\5'-
f4'^-chlo^ophenvl)-1^3^4^-oxadiazol-2Wnmethoxvcholest-5-ene: 
The compound 113 was correctly analyzed for C36H51CIN2O2. Its IR spectrum 
exhibited characteristic absorption bands at 1629, 1612 (C=N), 1622 {C=C), 1594, 
1495, 1457 (aromatic ring), 1226, 1210 (C-0) and 768 cm"' (C-Cl)." The 'H NMR 
spectrum of compound 113 displayed a two-proton singlet at (5 3.89 for O-CH2-, a 
double doublet for a single proton at 5.27 (J= 7.9, 4.8 Hz) for Ce-olefinic proton and 
a one-proton broad multiplet centered at S 3.76 (W^/2 16.2 Hz, axial) for Csa-H. Four 
aromatic protons appeared at ^ 7.16 - 6.98. Angular and side-chain methyl protons 
were observed at 3 1.13 (Cio-CHs), 0.76 (Cu-CHs), 0.93 and 0.82 (other steroidal 
side-chain methyl protons).''' 
In its '•'C NMR spectrum, compound 113 showed characteristic peaks at S 
135.97-128.15 for aromatic ring, 71.85 for methylene carbon atom (O-CH2), 113.03 
and 126.14 for Cr and Cs' of oxadiazole ring. Some other signals appeared at S 76.29, 
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41.50, 144.75 and 122.48 for C3, C4, C5 and Ce respectively. Other carbon atoms of 
steroidal skeleton appeared at expected regions. 
Thus, on the basis of above data, compound 113 having m.p. 136-139 °C has 
been characterized as 3y9-[5'-(4"-chlorophenyl)-r,3',4'-oxadiazol-2'-
yl]methoxycholest-5-ene. 
Reaction of cholest-5-en-3^-0-acetyl hydrazide 110 with 4-ethvl 
benzoyl chloride in presence of POCb: 3^-r5'-r4''-ethvlphenvl1-l'^\4'-
oxadiazole-2Wl)methoxvcholest-5-ene 114: 
110 114 
A mixture of compound 110, 4-ethyI benzoyl chloride and phosphorous 
oxychloride in dichlomethane, was refluxed for 7 h on oil bath. After completion of 
reaction it was concentrated under reduced pressure and then residue was poured onto 
crushed ice and left overnight. The precipitated solid on recrystallization from 
ethanol, provided a single compound 114 as a solid, m.p. 131-133 °C in 69 % yields. 
Characterization of compound 114 having m.p. 131-133 °C as 3^-f5'-
f4^^-ethvlphenvl)-l^J^4^-oxadiazole-2Wnmethoxvcholest-5-ene: 
The compound 114 was correctly analyzed for C38H56N2O2. Its IR spectrum 
exhibited characteristic absorption bands at 3061 (aromatic C-H stret.), 1618 (C=C), 
1578, 1488, 1420 (aromatic ring), 1625, 1611 (C=N) and 1196 cm"' (C-0)." The ^ H 
NMR spectrum of compound 114, showed a double doublet for a single proton at d 
5.28 (J= 9.1, 5.8 Hz) for Ce-olefmic proton, a one-proton broad muhiplet centred at 6 
3.81 {WA 16.5 Hz, axial) for C^a-H and another singlet for two protons at 6 4.68 for 
O-CH2. A triplet for three protons and a quartrate for two protons appeared at S 1.43 
and 2.52 which could be assigned for methyl and methylene protons of ethyl group 
which is attached at para position of aromatic ring. Four aromatic protons appeared at 
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d 7.11-6.94. Angular and side-chain methyl protons were observed at S 1.17 (Cio-
CHs), 0.74 (Ci3-C//i), 0.93 and 0.84 (other steroidal side-chain methyl protons).'" 
In its '^C NMR spectrum, compound 114 showed characteristic peaks at S 
136.98-129.15 for aromatic ring, 69.25 for methylene carbon atom (O-CH2), 118.72 
and 125.4 for Cx and Cs' of oxadiazole ring respectively. Other important peaks were 
at S 29.62 (CHj), 19.15 (CH3), 76.03 (C3), 39.72 (C4), 146.09 (Cj) and 126.65 (Ce). 
Remaining carbon atoms of steroidal skeleton appeared at expected regions. 
Thus, on the basis of foregoing discussion and spectral values, compound 114 
having m.p. 131-133 °C has been characterized as 3^-[5'-(4"-ethylphenyl)-l',3',4'-
oxadiazole-2'-yl]methoxycholest-5-ene. 
Reaction of cholest-5-en-3^-0-acetvl hvdrazide 110 with benzoyl 
chloride in presence of POCb; 3^-r5'-phenvl-l^^'.4'-oxadiazole-2'' 
yl]methoxycholest-5-ene IIZ* 
r\^ a COCI 
H 2 N - N H - C - H 2 C - 0 ' ' ^ — ^ ^ ^ ^ 
110 
POCI3 CeHsK^J-^^2-^ 
N N I T 
112 
A mixture of compound 110, benzoyl chloride and phosphorous oxychloride 
in dichlomethane, was refluxed for 9 h on oil bath. After completion of reaction 
(monitored by TLC), it was concentrated under reduced pressure and then residue was 
poured onto crushed ice and left overnight. The precipitated solid on recrystallization 
from ethanol, provided a single compound 112 as a solid, m.p. 125-126 °C in 71 % 
yields. 
Characterization of compound 112 having m.p. 149-152 °C as 3^-f5'-
phenyl-l^^',4^-oxadiazole-2^-vl1methoxycholest-5-ene: 
The compound has been found identical with compound 112. It has similar 
m.p., mixed m.p., mol. formula, elemental analysis and spectral studies (IR, ' H NMR, 
'^C NMR). 
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All melting points were observed in the capillary tube and are uncorrected, 
infrared (IR) spectra were recorded in KBr pellets with spectrolab interspec 2020 FT-
IR spectrometer and values are given in cm'V 'H NMR spectra were measured on a 
300 MHz instrument and '^'C NMR spectra on a Bruker Avance II400 spectrometer at 
100 MHz, using IMS as internal standard and CDCI3 as solvent. Chemical shift (6) 
were expressed in ppm dovmfield from internal standard TMS. The abbreviation s, d, 
dd, m, br denote "singlet, doublet, double doublet, multiplet, broad respectively. Thin 
layer chromatography (TLC) plates were coated with silica gel G and exposed to 
iodine vapours. Pet-ether refers to a fraction of b.p. 60 - 80 °C. Anhydrous sod. 
sulphate (Na2S04) was used as drying agent. 
Ethvl-5-cholesten-3^>0-acetate 109: 
To the solution of cholest-5-en-3^-ol (cholesterol) 108 (5g, 12.9 mmol) in 
dioxane (50 ml), K2CO3 (10 g) was added followed by the addition of ethyl 
chloroacetate (11 ml) and the mixture was refluxed for 25 h. The progress of the 
reaction was monitored by TLC, After completion of the reaction, the inorganic solid 
was fihered off and filtrate was concentrated under reduced pressure. The residue was 
taken in diethyl ether and washed with water. The organic layer was separated, dried 
over anhyd. sodium sulphate and crystallized from methanol to give compound 109 
as an off white powdered compound, m.p. 144 °C (reported^^ m.p. 145 °C), yield 65 
%. 
Analysis found 
C31H52O3 requires 
IR(KBr) 
'H NMR (CDCI3) 
C, 78.72; H, 11.11. 
C, 78.76; H, 11.09%. 
Vmax 1731 (C=0 ester), 1616 (C=C), 1218 (C-0 of 
o 
- ^ ) , ]143cm-^(C-0-C). 
8 5.62 (dd, y= 8, 2 Hz, IH, Ce-H), 4.81 (s, 2H, -
OCH2-CO-), 4.26 (br m, IH, W/i 14.4 Hz, axial, 
C^a-H), 4.1 (q, 2H, -O-CH2-CH3), 1.41 (t, 3H, -
0-CR2-CH3\ 1.14 (s, 3H, C10-CH3), 0.73 (s, 3H, 
Ci3 'CH3), 0.93, 0.80 (other steroidal side-chain 
methyl protons). 
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Cholesten-5-en-3^-O-acetylhydrazidell0; 
A mixture of compound 109 (4.23 mmol), hydrazine hydrate (4.23 mmol), 
pyridine (3-5 drops) in absolute ethanol (40 ml), was heated at reflux on a boiling 
water bath for 11 h. The completion of reaction was monitored by TLC. The reaction 
mixture was concentrated to half its original volume under reduced pressure. The 
separated solid was fihered and taken in diethyl ether and dried over anhydrous sod. 
sulphate. The obtained compound was chromatographed over silica gel column (Pet. 
ether - diethyl ether, 20:2) to afford compound 110 which was recrystallized from 
ethanol, m.p. 153 °C, (reported" m.p. 152 °C), yield 69 %. 
Analysis found 
C29H50N2O2 requires 
IR(KBr) 
H^ NMR (CDCb) 
C, 75.96; H, 11.05; N, 6.06. 
C, 75.93; H, 10.99; N, 6.11%. 
Vmax 3370 (NH2), 3232 (NH), 1642 (-CO-NH-), 
1620 (C=C), 1385 (C-N), 1120 cm'' (C-0). 
d 9.1 (br s, IH, N/f, exchangeable with 
deuterium), 6.5 (s, 2H, N//2, exchangeable with 
deuterium), 5.63 (dd, 7 = 8.2, 5 Hz, IH, Ce-H), 
4.9 (s, 2H, O-CH2-CO), 4.30 (br m, IH, W V2 
14.6 Hz, axial, Caa-ZO, 119 (s, 3H, Cio-C/6), 
0.72 (s, 3H, Ci3-C//i), 0.92, 0.83 (other steroidal 
side-chain methyl protons). 
3^-f(3^-methvl-5^-oxo-2^-pvrazolm-l^-yl)carbonvlmethoxy]cholest-5-
ene 111 : 
A mixture of compound 110 (1.08 mmol) and methyl acetoacetate (1.1 mmol) 
was heated under reflux in ethanol (50 ml) containing 2-3 drops of hydrochloric acid 
for 5 h 30 min. Completion of reaction was monitored by TLC. The reaction mixture 
was concentrated under reduced pressure. Residue was taken in diethyl ether, washed 
with water and dried over anhyd. sod. sulphate. Evaporation of solvent gave a solid 
crude product which was recrystallized from ethanol to afford compound 111, m.p. 
138-141 °C, yield 71 %. 
123 
Cdapterlll 
Analysis found 
C33H52N2O3 requires 
IR(KBr) 
*H NMR (CDCI3) 
" C NMR (CDCI3) 
C, 75.48; H, 9.96; N, 5.36. 
C, 75.53; H, 9.99; N, 5.34 %. 
Vmax 1719, 1674 (C=0), 1627 (C=C), 1611 (C=N), 
1393 (C-N), 1213, 1183 cm-' (C-0). 
S 5.46 (dd, J = 7.6, 4.2 Hz, IH, Ce-H), 4.58 (s, 2H, 
CA-H2), 4.86 (s, 2H, O-C//2-CO), 3.49 (br m, IH, 
WA 14.9 Hz, Csa-//, axial), 1.56 (s, 3H, CH^), 1.17 
(s, 3H, C10-C//5), 0.72 (s, 3H, Cu-CHs), 0.91 and 
0.83 (other steroidal side-chain methyl protons). 
176.3 (C=0 of pyrazolinone ring), 61.24 (CH2 of 
pyrazolinone ring), 149.25 (C=N), 169.52 (OCH2-
C O ) , 62.52 (OCH2), 31.72 (Ci), 34.51 (C2), 78.35 
(C3), 39.56 (C4), 141.36 (C5), 128.53 (Ce), 31.12 
(C7), 26.58 (Cg), 40.72 (C9), 35.61 (C,o), 23.11 
(Cn), 30.47 (C,2), 39.91 (C13), 48.63 (CM), 23.68 
(C15), 25.06 (C16), 45.09 (Cn), 21.19 (Cg), 20.77 
(C19), 26.28 (C20), 19.65 (C21), 36.88 (C22), 26.715 
(C23), 40.51 (C24), 29.45 (C25), 22.57 (C26), 22.69 
(C27). 
3^-f5^-phenvl-l'^^4^-oxadiazol-2'-vnmethoxvcholest-5-enell2: 
To a solution of compound 110 (1 mmol), benzoic acid (1 mmol) and 
phosphoros oxychloride (2.5 mmol) was added drop wise in acetonitrile (40 ml), was 
refluxed on an oil bath for 8 h. After completion of reaction the reaction mixture was 
cooled to room temperature. The excess of solvent was distilled off and the residue 
was subjected to crystallization from ethanol which provided compound 112 having 
m.p. 125-126 "C, yield 69%. 
C, 79.45; H, 9.56; N, 5.18. Analysis found 
C36H52N2O2 requires 
IR(KBr) 
C, 79.36; H, 9.62; N, 5.14%. 
v™ax 1625, 1607 (C=N), 1620 (C=C), 1587, 1490, 
1445 (aromatic ring), 1245, 1220 cm"' (C-0). 
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' H IVMR (CDCI3) : d 7.07-6.91 (Ar-5/0, 5.41 (dd, J = 8.1, 5.9 Hz, IH, 
C6-/0. 3.54 (br m, IH, WA 15.4 Hz, axial, Csa-//), 
4.29 (s, 2H, O-C//2-), 1.15 (s, 3H, Cio-CZ/j), 0.74 (s, 
3H, C13-CH3), 0.90 and 0.85 (other steroidal side-
chain methyl protons). 
"CNMR(CDCl3) : S 138.03-127.85 (aromatic ring), 72.51 (CH2-O), 
111.53 (C2'), 123.92 (C5O, 18.91 substituted methyl, 
30.76 (Ci), 34.92 (C2), 76.11 (C3), 42.53 (C4), 
148.17 (C5), 126.98 (Ce), 31.10 (C7), 28.32 (Cg), 
40.43 (C9), 38.59 (Cio), 21.17 (Cn), 32.63 (Cn), 
41.52 (Ca), 49.71 (C^), 22.01 (Cj), 21.79 (Cie), 
47.18 (Cn), 20.81 (Cig), 21.09 (C19), 30.49 (C20), 
19.32 (C21), 36.93 (C22), 26.05 (C23), 38.93 (C24), 
29.07 (C25), 22.48 (Cse), 22.91 (C27). 
3jg-f5'-f4''-chloiophenyl)-l'^^4'-oxadiazol-2-yl1metfaoxycholest-5-ene 
113: 
A mixture of compound 110 (1 mmol), chlorobenzoic acid (1 mmol) and 
phosphoros oxychloride (2.5 mmol) in acetonitrile (50 ml), were refluxed on an oil 
bath for 10 h. The reaction mixture was cooled to room temperature. The excess of 
solvent was distilled off and the residue was subjected to crystallization from ethanol 
provided compound 113 having m.p. 136-139 °C, yield 66 %. 
Analysis found 
C36H51CIN2O2 requires 
IR(KBr) 
H^ NMR (CDCI3) 
C, 74.61; H, 8.84; N, 4.85. 
C, 74.65; H, 8.87; N, 4.84 %. 
v«ax 1629, 1612 (C=N), 1622 (C=C), 1594, 1495, 
1457 (aromatic ring), 1226, 1210 (C-0), 768 cm"' 
(C-Cl). 
6 7.16- 6.98 (Ar-4/0, 5.27 (dd, J= 7.9,4.8 Hz, IH, 
Ce-H), 3.76 (br m, W^/2 16.2 Hz, axial, Cja-H), 3.89 
(s, 2H, O-CH2-), 1.13 (s, 3H, Cio-CHj), 0.76 (s, 3H, 
Cn-CHs), 0.93 and 0.82 (other steroidal side-chain 
methyl protons). 
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"CNMRiCDCh) : S 135.97-128.15 (aromatic ring), 71.85 (CH2-O), 
113.03 (C2'), 126.14 (Cs'X 33.17 (Ci), 32.72 (C2), 
76.29 (C3), 41.50 (C4), 144.75 (C5), 122.48 (Cg), 
32.46 (C7), 29.13 (Cg), 41.54 (C9), 37.38 (Cio), 
21.83 (C„), 32.28 (C12). 40.87 (C13), 50.11 (Cu), 
20.69 (C15), 21.70 (C16), 46.08 (dv), 22.61 (Cig), 
21.16 (C,9), 31.89 (C20), 19.46 (C21), 37.91 (C22), 
25.40 (C23), 35.86 (C24), 30.05 (C25), 22.41 (Cje), 
22.82 (C27). 
3^-r5 '-(4 ' ' -ethylphenvl)-l '^\4 '-oxadiazole-2^-vl]methoxvcholest-5-ene 
114: 
To a solution of 4-ethylbenzoyl chloride (1 mmol), compound 110 (1 mmol) 
in dichlomethane (50 ml), phosphorous oxychloride (5 ml) was added drop wise and 
the mixture was refluxed for 7 h on an oil bath. The completion of reaction was 
monitored by TLC. The solvent and excess of POCI3 were distilled at reduced 
pressure. Reaction mass was cooled and poured onto crushed ice and left overnight. 
The separated solid was collected by fihration, washed with water, air dried and then 
recrystallized from ethanol to give compound 114, m.p. 131-133 °C, yield 69 %. 
Analysis found 
C38H56N2O2 requires 
IR(KBr) 
*H NMR (CDCI3) 
^^ C NMR (CDCI3) 
C, 79.70; H,9.81; N,4.92. 
C, 79.67; H, 9.85; N, 4.89 %. 
Vmax 3061 (aromatic C-H stret.), 1618 (C=C), 1578, 
1488, 1420 (aromatic ring), 1625, 1611 (C=N) and 
1196cm''(C-0). 
S 7.11-6.94 (Ar-4^, 5.28 (dd, 7 = 9.1, 5.8 Hz, IH, 
Ce-H), 3.81 (br m, W/i 16.5 Hz, axial, Csa-H), 4.68 
(s, 2H, O-CH2-), 1.43 (t, 3H, C//3-), 2.52 (q, 2H, 
CH3-C//2), 1.17 (s, 3H, C1Q-CH3), 0.74 (s, 3H, C13-
CHs), 0.93 and 0.84 (other steroidal side-chain 
methyl protons). 
S 136.98-129.15 (aromatic ring), 69.25 (CH2-O), 
118.72 (C2), 125.4 (C5-). 29.62 (-CH2), 19.15 (CH3) 
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of ethyl group, 32.53 (Ci), 34.50 (C2), 76.03 (C3), 
39.72 (C4), 146.09 (C5), 126.65 (Ce), 31.13 (C7), 
29.83 (Cg), 43.08 (C9), 40.17 (Cio), 21.86 (Cn), 
30.95 (C12X 42.04 (C13), 50.15 (CM), 23.62 (CM), 
24.18 (C16). 47.22 (Cn), 20.51 (Cig), 20.81 (C19), 
20.39 (C20X 19.54 (C2,), 36.80 (C22), 26.31 (C23), 
39.58 (C24), 29.64 (C25), 22.35 (Cze), 22.89 (C27). 
3^-(5'-phenyl-l'^',4'-oxadiazole-2'-vDmethoxvcholest-5-enell2: 
To a solution of benzoyl chloride (1 mmol), compound 110 (1 mmol) in 
dichlomethane (50 ml), phosphorous oxychloride (5 ml) was added drop wise, the 
mixture was refluxed for 9 h on an oil bath. The completion of reaction was 
monitored by TLC. The solvent and excess of POCI3 were distilled at reduced 
pressure. Reaction mass was cooled and poured onto crushed ice and left overnight. 
The separated solid was collected by fihration, washed with water, air dried and then 
recrystallized from ethanol to give compound 112, m.p. 125-126 °C, yield 71 %. 
• M.p., molecular formula, elemental analysis and spectral studies (IR, ' H NMR 
and '^ C NMR) are similar to compound 112 which is mention earlier in this 
chapter. 
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SyntfUsis and C^tacterization 
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The steroid nucleus is one of the largest rigid units readily available with 
multiple chiral centres. The biological importance of this structural entity is also well 
documented.' Dimeric steroids were first observed as synthetic byproducts '^''and then 
discovered in nature.'* With the discovery of a second dimeric steroid class/ it may be 
conjectured that eventually other naturally occurring dimeric steroids will be 
identified. This belief is further reinforced by the reported microbial transformation of 
dehydrocholic acid into steroid dimers in which carbon atoms comprise a benzene 
nucleus.^  Evidence that the dimerization of the steroid skeleton leads to unique 
characteristics and applications gradually began to emerge in different areas. A 
standard colour test for the presence of cholesterol is the formation of a green colour 
in concentrated sulfiiric acid, and this was shown to be due to a polyenyl steroidal 
dimer carbocation.'"^ Many dimeric and oligomeric steroids exhibit micellular, 
detergent, and liquid crystal behavior.'°''^ Steroidal dimers have been used as 
catalysts for some types of reactions'^  and may lead to new pharmacologically active 
steroids.''* For example, the cephalostatins is a group of dimeric steroids that are 
among the most potent natural cytotoxins.^  This exceptional activity of cephalostatins 
has led to interest in the synthesis of these compounds and analogues as potential 
antitumor agents.' 
Two steroid dimers were obtained upon irradiation of choest-5-en-7-one.'^  
Ether dimers were formed following acid-catalyzed rearrangement of lOa-ethyl-
5i?,6^-epoxy or lOa-ethynyl 5i?-hydroxy steroids.'^ Among other products, the 
saponification of 3a,5a-diactoxy-5a-cholestan-6-one oxime produced corresponding 
dimeric steroidal oximes.'^ 
A novel sulfiar-containing dimeric steroid, japindine (figure 1), was isolated 
fi-om the root-bark of Chonemorpha macrophylla.^ Its structure, which was elaborated 
fi-om spectroscopic studies, was subsequently confirmed by its synthesis. 
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Me2N/. 
i\NMe2 
I C I 
Me II Me 
O 
Figure 1 str. of japindine 
Therefore we have undertaken the present work on the synthesis and 
characterization of steroidal dimers. In the theoretical, part we have mentioned the 
related work available in the literature. 
Dulou and co-workers'* reported the pinacol-like synthesis of a dimeric steroid 
2 from cholest-4-en-3-one 1 (Scheme 1) by reductive condensation with Na (Hg). 
PsHi? 
C8Hi7 
Hg-Na 
Pb(0Ac)4 
98^17 
. Scheme 1 
The synthesis of a new type of steroid dimer was reported by Karmas.^' The 
cyclic ethylene hemithioketals 3 of saturated steroidal ketones were subjected to react 
with acetic anhydride in presence of/7-toluenesulfonic acid as catalyst to form enol 
ether dimers 4. It was also shown that 3,3-dialkyl ketals and A -^ and A -^enol ethers 
form similar dimers. Hydrolysis of the enol ether dimer 4 gave dimer p,y-
monoketones 5 (Scheme 2). 
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V O H 
TsOH 
AC2O 
CaHi? 
98^17 
OCH2CH2SAC 
1. HCL, THF 
^-
2. HjO 
^ 8 ^ 1 7 
Scheme 2 
98^17 
Devaquet and Salem °^ reported the photochemical dimerization of unsaturated 
steroidal ketone (Scheme 3). The only sterically allowed dimers were compounds 7 
and 8 obtained from photodimerization of compound 6. Similarly, the sterically 
allowed dimers from photodimerization of compound 9 are compounds 10 and 11. 
Photodimerization of estr-4-en-3-ones has also been reported.^ ^ 
O 
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re 
Scheme 3 
Martin and Hartney^^ reported the bischolesterienyl derivative 13 as the 
byproduct of oxidizing cholesterol (Scheme 4). 
C8Hi7 C8Hi7 
Fe(C104)3 
H2S04.AC20 
p8Hl7 
12 13 
Scheme 4 
McMurry '^ reported the synthesis of the dimers (15, 16) of 3-cholestanone 
(14) by TiCU/LiAlPti treatment (Scheme 5). A mixture of symmetrical and mixed 
coupling products was also obtained by the reductive dimerization of the enone. 
135 
CfiapterlV 
p8Hi7 
16 
Scheme 5 
Doering et al.^^'^^ reported the conversion of the 4-en-3-one steroid A-ring 
system 14 to the 3,5-dien-2-one system 20 which was accomplished by exploiting the 
well-known Bamford-Stevens reaction (14 to 17). Deployment of the McMurry 
reaction led to 21 and 22. The theoretically calculated enthalpies of reaction for the 
syn-anti thermal rearrangement of these dimers suggest that the anti form is more 
thermodynamically stable (Scheme 6). 
p8Hl7 
1. MeU, tosylhydrazine, 
THF 
^-
2. hn, CH2CI2, MeOH, Oj 
14 17 
psHi? 
ACQ 
1.AI-Na,THF, HjO 
2.AC2O * 
paHu 
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1. SOCI2, DMAP, CH2CI2 Hq, 
2. aq NAHCO3 
3. K2CO3, MeOH 
19 
p8Hl7 
o**~o 
l(OAc)3 
p8Hi7 
20 
CaHi? CsHiy CBH 17 
Zn-TiCU 
1 
THF.Py 
21 
CsHv 
Scheme 6 
Schmidt and coworkers^ '* reported a simple procedure to dimerize cross-
conjugated dienones to the corresponding olefins (24-26, Scheme 7). In contrast to 
the Mc-Murry reaction, this variant works without titanium halides. 
Ri 
24.Ri=OH,R2 = H,R3 = H 
25. Ri = OCCH2OAC, R2 = H, R3 = OH 
26. R, = CX:CH20Ac, R2 = OAc, R3 = OH 
Scheme 7 
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McKenna et a/.'° reported the synthesis of several bissteroids 28 derived from 
conessine 27 or cholic acid (Scheme 8). They found that these bissteroids solubilize 
perylene into aqueous solution without evidence of micelle formation and can also act 
as potential enzyme models. 
Me 
.N. 
MezN 
Br-(CH2)n-Br 
Mez'^ N 
Me2''N 
Scheme 8 
A dimeric steroid with catalytic properties was reported by Guthrie and co-
workers^^ (Scheme 9). The steroid dimer 30 was synthesized by reductive amination 
of monomer 29 by sodium cyanoborohydride. An aUernative multistep synthesis 
starting with monomer 31 corroborated the structure of 30. The dimer 30 acts as a 
catalyst for the hydrolysis of 3-arylpropionate esters of 3-hydroxy-4-nitrobenzoic 
acid. 
29 
^c^ii^^^^^' 
NHa-'CI-
NHa^Cr 
HCI NaBHaCN 
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H 
^ ^ NH2OH.HCI 
Na/n-PrOH 
II ff terephthalaldehyde 
N *^ 30 
NaBHaCN 
H,N 
Scheme 9 
Hoffmann and Kumpf^ ^ reported a synthesis where by two estrone 35, are 
joined through the A-rings with terephthalic acid to give 36 (Scheme 10) and through 
the D-rings with/7-phenylenediamine. 
COOH 
^ H O O C - ^ 
35 
Scheme 10 
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Pettit et al^^ reported the existence of a diester (a steroid dimer 38) as a by 
product during the total synthesis of bufalitoxin and bufotoxin (Scheme 11). 
siP-
O 
II 
(HjCJn ^ O 
37 
H OOC(CH2)6COO H 
38 
Scheme 11 
Sato and co-worlcers^ * prepared 3,3'-steroid dimer from epimeric 3-halogeno-
6-nitrocholestenes by cathodic electrolyses. They found that on cathodic reduction of 
3a-derivatives gave 6^,6/9'-dinitro-3a,3a'-cholesta 4,4'-dimer, as the major product via 
a one-electron process. 
Heathcock and Smith '^'^ '* reported efficient synthetic routes for both 
symmetrical and unsymmetrical bissteroidal pyrazines from readily available 
precursors. The C2-symmetric geometric isomer of the dimeric steroidal pyrazine 44 
derived from cholestane was prepared by reaction of 41 and 43 (Scheme 12). 
Fuchs and co-workers^' reported the synthesis and pharmacological evaluation 
of nonacyclic and tridecacyclic pyrazines related to cephalostatin. Steroidal a-azido 
ketones 46 were converted through catalytic reduction to C2 symmetrical nonacyclic 
pyrazines 47 (Scheme 13). 
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98^17 
CgHgNH^Bra 
*" 
NaNs 
AC2O, HCIO4 
dimethyldioxirane 
98^17 
AcO' 
Me4N*, AC2O 
PhCHa 
HBr, HOAc 
C R H 8^17 
43 
C8H17 
MeONH2 HCL 
PPh3H26 
PhCHa 
?8Hi7 CgHi? 
Scheme 12 
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Scheme 13 
Morita and co-workers^* reported the formation of dimeric steroid 51 by a 
transient Diels-Alder condensation (49 to 51) after acid-catalyzed dienol ether 
formation (Scheme 14). They thought that the formation of a bicyclooctane system by 
further cyclization of a Diels-Alder-type adduct bears a formal relation to the 
Woodward-Katz rearrangement. 
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AcO 
MeO 
AcO' 
48 49 
MeO 
AcO OAc 
MeO 
AcO OAc 
51 
Scheme 14 
Crabbe and Zderic^' reported the preparation of the bissteroid 53 by the cupric 
acetate-pyridine oxidation of 17-/J-ethynyl steroids 52 (Scheme 15). 
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,\C=CH 
Cu(OAc)2H20 
» 
Py 
ChapterlV 
,A\C2C-
53 
Scheme 15 
Suginome and Uchida^ "^^ ^ reported the formation of the bissteroid of 
androsterone derivatives 56 and 57 by photolysis or a chemical process (Scheme 16). 
NNH2 
R = H, 56 
R = Ac,57 
v\OR 
Scheme 16 
Mukherjee'*° reported the synthesis of dimer 60 of 3-oxo-5a-cholanoic acid 58 
and cholestanol 59, Scheme 17. 
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58 DCC 
DMAP 
THF 
59 
CsHi? 
CBHI? 
.41 Li and Dias reported a high-yielding synthesis of the a-dimer 64 of a 
lithocholic acid derivative (Scheme 18). a-Dimer was synthesized by using DCC and 
DMAP. 
OAc 
DCC DMAR CH2CI2 
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OOCCH3 
Bruke et al.'*^ reported that two step synthesis of 4-chromanones 66 from 4-
methyl-6-hydroxy-2-pyrone 65 undergo an amine catalysed decarboxylative 
dimerization (Scheme 19). 
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Introduction 
Dimeric and oligomeric steroids posses interesting micellular, detergent, and 
liquid crystal properties.'*^ Steroidal dimers have been used as catalysts for different 
types of reactions and many lead to enhance pharmacological activity.'*'''''^  For 
example, the dimeric steroids cephalostatins are among the most potent natural 
cytotoxins.^' This exceptional activity of cephalostatins spurred the interest in their 
synthesis as well as for their analogues as potential anti-tumor agents.'*^ It has been 
suggested that polyamine dimeric steroid binds to DNA due to the presence of two 
parts, one hydrophilic (positively charged nitrogen) and the other is hydrophobic 
steroid skeleton.'" 
It might be expected that polymers of steroidal ketones (or ketone derivatives) 
would readily be formed in reaction media of high acidity or basicity. There seems, 
however, to be only two instances of an aldol type of product having been isolated in 
sufficient quantity and purity to have merited reporting in the literature. 
Here we are presenting new dimeric steroids namely cholest-5-en-3-5/?7ro-
[6'a,5'-oxa]-5'a-cholest-3'-one 68, cholest-5-en-7-J5p/ro-[4'a,5'-oxa]-5'a-cholest-7'-one 
70 and 3y9-substitutedcholest-5-en-7-^/r(9-[4'a,5'-oxa]-3'^ -substituted-5'a-cholestan-
7'-ones 72 and 74 which were prepared from cholest-5-en-3-one 67, cholest-5-en-7-
one 69 and 3y?-substituted-cholest-5-en-7-one 71 and 73 respectively by amine 
catalysed dimerization'*^ using reducing agent DMAP and xylene. 
R 
70 H 
72 CI 
74 OAc 
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Reaction of cholest-5-en-3-one 67 with 4-(dimethvlamino)-pyridine 
(DMAP): Cholest-5-en-3-5pirp-r6'g^'-oxa1-5'g-cholestan-3'-one 68: 
To a stirred solution of cholest-5-en-3-one 67 in xylene, 4-(dimethylamino)-
pyridine was added. The resulting solution was heated under reflux for 2 h. After 
completion of reaction, the reaction mixture was usually worked up. Purification by 
column chromatography and recrystallization of the crude product from methanol 
provided cholest-5-en-3-5/7/>o-[6'a,5'-oxa]-5'a-cholestan-3'-one as solid m.p. 230-233 
°C in 52% yields. 
67 
Characterization of compound 68 having m.p. 230-233 °C as cholest-5-
en-3-5pt'ro-r6^q^^-oxaT-5''g-cholestan-3^-one: 
The obtained compound 68 was correctly analysed for C54H88O2 [M* 768]. 
The appearance of molecular ion at m/z 768 clearly suggested the formation of a 
dimer. Its IR spectrum exhibited characteristic absorption bands at 1730 (C=0), 1628 
(C=C), 1048 cm-' (C-O-C)."*^  The 'H NMR spectrum of compound 68 displayed two 
double doublets integrating for one proton each at d 5.59 {J= 7.6, 5.2 Hz) and 2.31 {J 
= 6.3, 4.8 Hz) for Ce-olefinic proton and Ce-methine proton, respectively. Two 
singlets for two protons each at 2.47 and 2.16 were assigned for C4-//2 and C4-H2 
respectively. Angular and side-chain methyl protons were observed at S 1.18 (Cio-
C//3), 1.14 (C10-C//3), 0.73 (C13-CH3), 0.77 (Ci3-C/^ 3), 0.92, 0.90, 0.84, 0.80 (other 
steroidal side-chain methyl protons).**' 
Its '^ C NMR spectrum of compound 68 showed characteristic peaks at 95.63 
(C3) and 204.75 for carbonyl carbon (C3). Other importants peaks were at S 155.56 
(C5), 131.09 (Ce), 103.51 (Cy) and 53.02 (C&). Remaining carbon atoms of steroidal 
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skeleton were appeared at expected regions. The Mass of compound 68 showed 
molecular ion peak at m/z 768 (M^ C54H88O2). Some other characteristic fragment 
ion peaks were recorded at m/z 532, 504, 491, 489, 459, 385, 367 along with other 
usual fragmentat ion peaks. 
Thus, on the basis of above evidences, solid compound 67 having m.p. 230-
233 °C has been characterized as cholest-5-en-3-5p/ro-[6'a,5'-oxa]-5'a-cholestan-3'-
one. 
The formation of of compound 67 was further supported by the proposed 
mechanism (Scheme 20). 
g j^Cj 
••B 
67 
B:H"' 
(-B:Ht) 
tautotn. 
Scheme 20 
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Reaction of cholest-5-en-7-one 69 with 4-fdimethvlammo)-pvridme 
(DMAP): Cholest-5-en-7-sptro-r4'a^'-oxa1-5'g-cholestan-7'-one 70: 
Cholest-5-en-7-one 69 was taken in xylene and to this solution DMAP was 
added. The reaction mixture was heated under reflux for 1 h 10 min. On completion 
of reaction it was usually worked up, and chromatographed over silica gel column. 
The crude product was then recrystallized from methanol to afford cholest-5-en-7-
^//•o-[4'a,5'-oxa]-5'a-cholestan-7'-one 70 as solid, m.p. 224-226 °C in 57% yields. 
69 
Qiaracterization of compound 70 having m.p. 224-226 °C as cholest-5-
en-7-s;?i'ro-f4^«^^-oxa1-5^a-cholestan-7^-one: 
The compound 70 was correctly analysed for C54H88O2 [M* 768]. Its IR 
spectrum exhibited characteristic peaks at 1719 (C=0), 1625 for C=C, 1042 cm' (C-
O-C).'** The ' H NMR spectrum of compound 70 displayed two singlets integrating for 
one and two protons at 8 5.31 and 2.74 for Ce-olefmic proton and C6-//2, respectively 
and a double doublet integrating for one proton at 8 2.41 (J= 5.7, 4.2 Hz) for Ci,-H. 
Angular and side-chain methyl protons were observed at 5 1.19 (C10-CH3), 0.76 (C13-
C//3), 1.15 (C10-CH3), 0.74 (Ci3-C/f3), 0.96, 0.92, 0.85, 0.80 (other steroidal side-
chain methyl protons).'*' 
In its '^ C NMR spectrum characteristic signals were observed at 8 206.53 for 
carbonyl carbon (CT) and 95.32 for C? spiro carbon atom. Other important peaks at 8 
152.91, 129.11, 58.13 and 97.36 were attributed for C5, Ce, C4' and Cs' respectively. 
Remaining carbon atoms of two steroidal skeletons appeared in expected region. 
On the basis of above evidence compound 70 having m.p. 224-226 °C has 
been characterised as cholest-5-en-7-jp/>'o-[4'a,5'-oxa]-5'a-cholestan-7'-one. 
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Reaction of 3^-chloro-cholest-5-en-7-one 71 with 4-fdimethylamino)-
pyridine: 3jg-chlorocholest-5-en-7-5;?t'ro-f4^gJ^-oxa1-3'^-chloro-5^a-
cholestan-7^-one 72: 
To a stirred solution of 3^-chlorocholest-5-en-7-one 71 in xylene, 4-
(dimethylamino)-pyridine was added. The resulting solution was heated under reflux 
for 1 h 35 min. After completion of reaction it was usually worked up. Purification by 
column chromatography and subsequent recrystallization from methanol provided 3^-
chlorocholest-5-en-7-5/?/ro-[4'a,5'-oxa]-3'y9-chloro-5'a-cholestan-7'-one 72 as solid, 
m.p. 240-242 °C in 62 % yields. 
71 
Characterization of compound 72 having m.p. 240-242 "C as 3p-
chlorochoIest-5-en-7-5piro-r4^g3^-oxaT-3^^-chloro-5^g-cholestan-7^-one: 
The compound 72 was correctly analysed for C54H86CI2O2. Its IR spectrum 
showed important characteristic peaks at 1717 for (C=0), 1622 (C=C), 1052 (C-0), 
728, 736 cm"' (C-Cl).'*^ The ' H NMR spectrum of compound 72 displayed a singlet at 
S 5.49 for Cs-olefinic proton and another two-proton singlet at d 2.42 for Ce-Z/j- Two 
broad multiplets integrating for one proton each at S 3.86 (WV2 = 17.3 Hz) and 3.59 
(WV2= 16.6 Hz) assigned to Csa-H and Cs-a-/^  respectively. Two doublets integrating 
for one and two protons at S 2.86 (J= 5.8 Hz) and 2.13 (J= 6.1 Hz) for C4-//and C4-
7/2, respectively. Angular and side-chain methyl protons appeared at <51.16 (Cio-C^s), 
0.75 {C13-CH3), 1.12 (C10-CH3), 0.70 (Ciy-CHi), 0.96, 0.94, 0.87, 0.81 (other 
steroidal side-chain methyl protons).'*' 
In its '"'C NMR spectrum characteristic signals were observed at S 205.31 for 
carbonyl carbon (C?) and 90.55 for C7 spiro carbon atom. Other important peaks at 3 
161.02, 125.42, 57.63, 93.07, 48.18 and 56.93 were assinged for C5, Ce, C4; Cj., C3. 
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and C3 respectively. Remaining carbon atoms of steroidal skeletons appeared in the 
expected region. 
On the basis of above evidences compound 72 having m.p. 240-242 °C has 
been characterised as 3y9-chlorocholest-5-en-7-J5p/ro-[4'a,5'-oxa]-3'y9-chloro-5'a-
cholestan-7'-one. 
Reaction of 3jg-acetoxycholest-5-en-7-one 73 with 4-(dimethvlamino)-
pyridine: 3)g-Acetoxvcholest-5-en-7-sptro-r4^g.5'-oxa1-3^^-acetoxy-5'«-
cholestan-7^-one 74: 
3^-Acetoxycholest-5-en-7-one 73 in xylene was similarly treated with 4-
(dimethylamino)-pyridine. The resulting solution was heated under reflux for 1 h. 
Completion of reaction was monitored by TLC, after cooling to room temperature, 
excess of solvent was distilled out under reduced pressure. Usual work up, 
purification by column chromatography and recrystallization from methanol provided 
3/9-acetoxycholest-5-en-7-J5p/r(?-[4'a,5'-oxa]-3'^ -acetoxy-5'a-cholestan-7'-one 74 as 
solid having m.p. 219-221 °C in 58 % yields. 
AcO 
AcO' 
73 
*OAc 
74 
Characterization of compound 74 having m.p. 219-221 °C as 3p-
acetoxycholest-5-en-7-spiro-r4^g,5^-oxa1-3'^-acetoxy-5^g- cholestan-7^-
one: 
The compound 74 was correctly analysed for C58H92O6. The IR spectrum of 
compound 74 exhibited characteristic peaks at 1714 for (C=0), 1739, 1732 (OAc), 
1621 for C=C, 1063 cm'' (C-O-C)."^ The 'H N M R spectrum of compound 74 
displayed two singlets integrating for one and two protons at (5 5.63 for Ce-olefmic 
and S 2.38 for Ce-Hi, two other singlets integrating for three protons each at S 2.04 
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and 2.01 for two acetoxy group and two broad multiplets integrating for one proton 
each at S 4.63 iW/2 = 17.6 Hz) and 4.46 (W/i = 16.8 Hz) for C3a-H and Cs-a-//, 
respectively. Two doublets integrating for one and two protons were at ^ 3.12 (J = 5.9 
Hz) and 2.51 (J= 6.6 Hz) for C4-//and C4-H2, respectively. Angular and side-chain 
methyl protons appeared at d 1.18 (C10-C//3), 0.70 (Cn-C/fs), 1.16 (C10-CH3), 0.74 
(C13-C//3), 0.94, 0.90, 0.83, 0.81 (other steroidal side-chain methyl protons).''^  
In its ^^ C NMR spectrum characteristic signals were observed at S 208.13 for 
carbonyl carbon (C7) and 88.03 for C7 spiro carbon. Other important peaks were at 
173.03 (C=0), 18.6 (-CH3) of acetoxy group attached at C3, 170.45 (C=0), 19.03 (-
CH3) of second acetoxy group. Other important peaks at d 158.27, 129.76, 61.38, 
96.08, 70.83 and 82.35 were attributed for C5, Ce, C4', Cy, Cy and C3, respectively. 
Remaining carbon atoms of steroidal skeletons appeared in the expected region. 
Therefore, in accordance with the analytical and spectral values, compound 73 
having m.p. 219-221 °C has been characterised as 3^-acetoxycholest-5-en-7-5p;>o-
[4'a,5'-oxa]-3'^-acetoxy-5'a-cholestan-7'-one. 
A tentative mechanism (Scheme 21) has been proposed for the formation of 
dimer 70, 72 and 74 for the respective steroidal ketones 69, 71 and 73. 
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Scheme 21 
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All melting points were observed in the capillary tube and are uncorrected, 
infrared (IR) spectra were recorded in KBr pellets with spectrolab interspec 2020 FT-
IR spectrometer and values are given in cm''. 'H N M R spectra were measured on a 
300 MHz instrument and '^ C NMR spectra on a Bruker Avance II400 spectrometer at 
100 MHz, using TMS as internal standard and CDCI3 as solvent. Chemical shift (6) 
were expressed in ppm downfield from internal standard TMS. Mass spectra were 
obtained on a Jeol spectrometer SX-I02 (FAB). The abbreviation s, d, dd, m, br 
denote "singlet, doublet, double doublet, multiplet, broad respectively. Thin layer 
chromatography (TLC) plates were coated with silica gel G and exposed to iodine 
vapours. Pet-ether refers to a fraction of b.p. 60 - 80 "C. Anhydrous sod. sulphate 
(Na2S04) was used as drying agent. 
3jg-Hvdoxy-5A, 6^-dibromocholestane: 
To a solution of cholesterol (5 g) in ether (30 ml) was added bromine solution 
(0.9 ml of bromine in 20 ml of glacial acetic acid containing 0.2 g of anhydrous 
sodium acetate) with stirring. The solution turned yellow and promptly set to a stiff 
paste of bromide. The mixture was cooled in an ice bath and stirred with a glass rod to 
ensure complete crystallization. The product was then collected by filteration under 
suction and washed with cold diethyl ether-acetic acid mixture (3:7) until the filtrate 
was completely colourless (6.9 g), m. p. 112-113 °C (reported^ m. p. 113 °C). 
5a. 6^-Dibromocholestan-3-one: 
3yff-Hydoxy-5a, 6y9-dibromocholestane (6.9 g) was suspended in acetone (150 
ml) in a three-necked round bottom flask fitted with a stirrer and dropping fimnel. The 
suspension was stirred for 5 min. and Jone's reagent*' (10 ml) was then added in 
drops from dropping funnel in 15 min. The temperature of reaction mixture, during 
oxidation was maintained between 0-5 °C by external cooling. After the complete 
addition, stirring was continued for 15 min. and cold water (200 ml) was added. The 
product was collected on a Buchner funnel and washed thoroughly with water and 
methanol and air-dried (5 g), m. p. 73-75 °C (decomposed) (reported*" m. p. 73-75 
°C). 
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Cholest-5-en-3" one 67; 
The moist 5a, 6^-dibromocholestan-3-one (5.0 g) was dissolved in ether (100 
ml) and glacial acetic acid (2.5 ml), zinc dust (7.5 g) was added in small portions 
during 30 min. with continous shaking. After the complete addition, the ethereal 
solution containing suspended zinc dust was filtered, washed with water, sodium bi 
carbonate solution (5%) and water and dried (anhydrous sodium sulphate). The oily 
residue thus obtained after the evaporation of the solvent was crystallized from 
methanol to give the desired product 67 (3.3 g), m. p. 126-127 °C (reported^" m. p. -
129 °C). 
Oiolest-5-en-3-5;?/m-f6^g^^-oxa1-5^g-cholestan-3^-one68: 
To a stirred solution of cholest-5-en-3-one 66 (1.3 mmol) in xylene (50 ml), 4-
(dimethylamino)-pyidine (1.3 mmol) was added. The resuhing solution was heated 
under reflux for 2 h. Completion of reaction was monitored by TLC. After cooling to 
room temperature, excess of solvent was distilled out under reduced pressure to give 
the oily residue. It was taken in diethyl ether and washed with water, 5% NaHCOa 
solution and again with water. The organic layer was dried over anhyd. sodium, 
sulphate and evaporation of solvent gave the crude product, which was purified by 
column chromatography on silica gel (mesh 100-200) with hexane - diethyl ether 
(5:1) as eluant, to give cholest-5-en-3-J5p/ro-[6'a,5'-oxa]-5'a-cholestan-3'-one 68, 
recrystallized from methanol, m.p. 230-233 °C, yield 52 %. 
Analysis found 
CS4H88O2 requires 
m(KBr) 
H^ NMR (CDCI3) 
C, 84.34; H, 11.48. 
C, 84.37; H, 11.45. 
Vm« 1730 (C=0), 1628 (C=C), 1048 cm'' (C-0). 
6 5.59 (dd, y = 7.6, 5.2 Hz, IH. Ce-olefmic proton), 
2.31 (dd, J= 6.3, 4.8 Bz, IH, Ce-methine proton), 
2.47 (s, 2H, CA-Hi), 2.16 (s, 2H, C^-Hi), 1.18 (s, 3H, 
C10-C//3). 0.77 (s, 3H, C13-C//3). 1.14 (s, 3H, Cio-
C//3), 0.73 (s, 3H, C13-C//3), 0.92, 0.90, 0.84, 0.80 
(other steroidal side-chain methyl protons). 
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: d 204.75 (C=0), 133.51 (Cj'), 95.63 (C3), 155.56 (C5), 
131.09 (Ce), 31.50 (Ci), 38.62 (C2), 49.07 (C4), 31.29 
(C7), 29.16 (Cg), 44.35 (C9), 40.72 (Cio), 20.96 (Cn), 
32.83 (C12), 38.46 (C13), 47.90 (CM), 21.86 (C15), 
21.06 (C16), 46.89 (C,7), 20.38 (Cis), 20.48 (€,9), 
31.01 (C20), 19.93 (C21), 37.08 (C22), 26.25 (C23), 
38.78 (C24), 29.90 (C25), 22.49 (C26), 22.74 (C27), 
27.03 (Cr), 48.53 (Cr), 48.75 (C4'), 53.02 (CeO, 21.96 
(Cr), 28.50 (Cg.), 37.11 (C?-), 43.26 (Co-), 21.19 
(Cr), 32.07 (C12O, 40.63 (CnO, 49.35 (CM), 21.98 
(C15.), 21.05 (Ci6'), 48.60 (CIT), 18.09 (Cig-), 19.06 
(C19O, 29.06 (C20O, 19.88 (C2r), 38.90 (C22), 26.01 
(C23O, 41.05 (C24'), 29.48 (C25O, 22.36 (C26'), 22.87 
(C2r). 
: 768 (Mt C54H88O2), 532, 504, 491, 489, 459, 385, 
367. 
Cholest-5-ene: 
3^-ChlorochoIest-5-ene (40 g) was dissolved in warm amyl alcohol (920 ml) 
and sodium metal (80 g) was added to the solution with continous stirring over a 
period of 8 h. The reaction mixture was warmed occasionally. When all the sodium 
metal was dissolved, the reaction mixture was poured into water, acidified with 
hydrochloric acid and then allowed to stand overnight. A white crystalline solid thus 
obtained was fihered under suction and washed thoroughly with water and air-dried. 
The crude material was recrystallized from acetone to provide cubic crystals of 
cholest-5-ene (34 g), m. p. 94 °C (reported" m. p. 89-91 °C). 
Cholest-5-en-7-one 69: 
A solution of t-butyl chromate [t-butyl alcohol (60 ml), CrOs (20 g), acetic 
acid (84 ml) and acetic anhydride (10 ml)] were added at 0 °C to a solution of cholest-
5-ene (8 g) in CCI4 (150 ml), glacial acetic acid (30 ml) and acetic anhydride (10 ml). 
The contents were refluxed for 3 h and then diluted with water. The organic layer was 
washed with NaHC03 solution (5 %) and water, and dried (anhyd. Na2S04). 
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Evaporation of the solvents under reduced pressure provided cholest-5-en-7-one as an 
oil which was crystallized from methanol to give cholest-5-en-7one 69 (3.1 g), m.p. 
128 °C (reported" m. p. 125 - 129 °C). 
Cholest-5-en-7-5;?/ro-r4^g^^-oxa]-5^g-cholestan-7^-one70: 
To a stirred solution of cholest-5-en-7-one 69 (1.3 mmol) in xylene (50 ml), 4-
(dimethylamino)-pyridine (1.3 mmol) was added. The resulting solution was heated 
under reflux for 1 h 10 min. Completion of reaction was monitored by TLC. Reaction 
mixture was cooled to room temperature, excess of solvent was distilled out under 
reduced pressure to give the oily residue, which was taken in diethyl ether, washed 
with water, 5% NaHCOs solution and again with water. The organic layer was dried 
over anhyd. sodium, sulphate and evaporation of solvent gave the crude product. 
Purification by column chromatography on silica gel (mesh 100-200) with hexane -
diethyl ether (5:1) as eluant and subsequent recrystallization from methanol provided 
cholest-5-en-7-j5p7ro-[4'a,5'-oxa]-5'a-cholestan-7'-one 70 as solid m.p. 224-226 °C in 
57 % yields. 
Analysis found 
CS4H88O2 requires 
IR(KBr) 
' H N M R (CDCI3) 
" C NMR (CDCI3) 
C, 84.27; H, 11.56. 
C, 84.31; H, 11.53. 
Vmax 1719 (C=0), 1625 (C=C), 1042 cm'^  (C-0). 
6 5.31 (s, IH, C6-olefmic proton), 2.74 (s, 2H, Ce-
H2), 2.19 (dd, y = 6.1, 4.8 Hz, C4-/6), 2.41 (dd, J = 
5.7, 4.2 Hz, C4-/O, 119 (s, 3H, Cio-C/^3), 0.76 (s, 
3H, Cx^-CH^), 1.15 (s. 3H, Cio-C/fj), 0.74 (s, 3H, 
Cia-C/fa), 0.96,0.92, 0.85, 0.80 (other steroidal side-
chain methyl protons). 
206.53 (C=0), 95.32 (C7), 152.91 (C5), 129.11 (Cg), 
58.13 (C4'). 97.36 (C5O, 37.91 (Ci), 29.53 (C2), 31.16 
(C3), 35.83 (C4), 40.01 (Cg), 35.04 (C9), 42.58 (Cio), 
21.62 (Cn), 32.03 (C12), 44.09 (C13), 49.17 (CH), 
21.38 (C,5), 22.99 (Cis), 39.16 (Cn), 20.27 (Cjg), 
20.68 (C19), 30.37 (C20), 19.65 (C21), 34.07 (C22), 
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27.42 (C23), 40.71 (C24), 28.81 (C25), 22.41 (Cje), 
22.85 (C27), 31.05 (Cr), 25.67 (C2O, 23.18 (CsO, 
49.39 (C&), 45.19 (Cg-), 30.66 (Cy), 42.38 (Cio), 
21.88 (CiiO, 33.16 (C12O, 40.28 (CnO, 48.11 (CM'), 
20.96 (Cij.), 21.01 (Ci6-), 39.90 (Cir), 19.10 (CisO, 
19.93 (Ci9'), 28.12 (C20'), 18.81 (Cjv), 35.43 (C22'), 
26.14 (C23'), 40.18 (C24-), 29.92 (C25), 22.28 (Cze), 
22.95 (C27). 
3^-Chlorocholest-5-ene; 
Freshly purified thionyl chloride (20 ml) was added gradually to cholesterol 
(25 g) at room temperature. A vigorous reaction ensued with the evolution of gaseous 
products. When the reaction slackened, the mixture was gently heated at a 
temperature of 50-60 °C on a water bath for 1 h, and then poured into cold water with 
stirring. The yellow solid thus obtained was filtered under suction, washed 
thouroughly with cold water and air-dried. Recrystallization from acetone gave 3y?-
chlorocholest-5-ene (23.5 g), m. p. 95 °C (reported" m. p. 96-97 °C). 
3/?-Chlorocholest-5-en-7-one 71: 
A solution of t-butyl chromate [t-butyl alcohol (60 ml), Cr03 (20 g), acetic 
acid (35 ml) and acetic anhydride (10 ml)] was added at 0 °C to a solution of 3yS-
chlorocholest-5-ene (8 g) in CCI4 (150 ml), acetic acid (30 ml) and acetic anhydride 
(10 ml). The contents were refluxed for 3 h. and then it was washed with NaHCOa 
solution (5 %) and water and dried over anhyd. Na2S04. Evaporation of the solvents 
under reduced pressure fiirnished the ketone as an oil which was crystallized from 
methanol to give 3^-chlorocholest-5-en-7-one (3.3 g), m.p. 144 °C (reported''' m. p. 
144-145 °C). 
3^-Chloiocholest-5-en-7-spt'ro-r4'a^^-oxa1-3'^-chloro-5'«-cholestan-7'-
one 72: 
To a stirred solution of 3^-chlorocholest-5-en-7-one 71 (1.19 mmol) in xylene 
(50 ml), 4-(dimethylamino)-pyridine (1.19 mmol) was added. The resuhing solution 
was heated under reflux for 1 h 35 min. After completion of reaction (monitored by 
TLC) reaction mixture was cooled to room temperature, excess of solvent was 
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distilled out under reduced pressure to give the oily residue. It was taken in diethyl 
ether, washed with water, 5% aq. NaHCOa solution and again with water. The organic 
layer was dried over anhyd. sodium, sulphate and evaporation of the solvent gave the 
crude product whic was purified by column chromatography on silica gel (mesh 100-
200) column with hexane - diethyl ether (5:1) as eluant, and then it was recrystallized 
from methanol to give 3^-chlorocholest-5-en-7-jf/?/ro-[4'a,5'-oxa]-3'^-chloro-5'a-
cholestan-7'-one 72 as solid m.p. 240-242 °C in 62 % yields. 
Analysis found 
C54H86CI2O2 requires 
IR(KBr) 
' H - N M R (CDCI3) 
"C NMR (CDCI3) 
: C, 77.36; H, 10.37. 
: C, 77.38; H, 10.34. 
: Vmax 1717 (C=0), 1622 (C=C), 1052 (C-0), 728, 736 
cm' (C-Cl). 
: d 5.49 (s, IH, Ce-olefinic proton), 2.42 (s, 2H, Ce-
H2X 3.86 (br m, IH, W/2, 17.3 Hz, Cja-H), 3.59 (br 
m, IH, WA, 16.6 Hz, Cs-a-ZO, 2.13 (d, 7 = 6.1 Hz, 
2H, C4-H2), 2.86 (d, J = 5.8 Hz, 2H, C4-H), 1.16 (s, 
3H, C,o-C//3), 0.75 (s, 3H, C13-C//3X M 2 (s, 3H, 
C10-CH3), 0.70 (s, 3H, Cw-CHj), 0.96, 0.94, 0.87, 
0.81 (other steroidal side-chain methyl protons). 
: S 205.31 (C=0), 90.55 (C7), 56.93 (C3), 161.02 (C5), 
125.42 (Ce), 48.18 (C3), 57.63 (€4-), 93.07 (C5), 34.19 
(Ci), 37.68 (C2), 45.02 (C4), 38.35 (Cg), 35.25 (C9), 
42.53 (Co). 21.15 (Cn). 32.18 (C12), 43.10 (C13), 
48.07 (C,4), 21.28 (Cs), 22.01 (Cie). 39.22 (Cn), 
20.13 (Cig), 20.38 (C19), 30.15 (C20), 18.98 (C21), 
36.43 (C22), 26.61 (C23), 39.66 (C24), 29.89 (C25), 
22.48 (C26), 22.96 (C27), 25.32 (Cr), 29.78 (C2'), 46.14 
(CfiO, 43.94 (Cg-X 31.57 (Cs'X 43.66 (Cio-X 21.18 
(CrX 32.43 (C12O, 40.91 (CB'X 48.06 (C,4'X 21.07 
(Ci5'X 21.49 (Cie-X 39.01 (CITX 20.01 (C,8-X 20.65 
(Ci9'X 29.83 (C20'X 19.11 (C2rX 36.23 (C22-X 27.19 
(C23'X 40.31 (C24O, 29.40 (C25), 22.15 (CzeO, 22.70 
(C27). 
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3^-Acetoxycholest-5-ene: 
A mixture of cholesterol (100 g), pyridine (150 ml) and acetic anhydride (100 
ml) was heated on a water bath for 2 h. The reaction mixture was poured into ice-
cooled water and the solid thus obtained was filtered under suction, washed 
thoroughly with water and air-dried. Recrystallization of the crude product from 
acetone gave 3y5-acetoxycholest-5-ene (95 g), m. p. 113-114 °C (reported^^ m. p. 115-
116T). 
3jg-Acetoxycholest-5-en-7-one 73: 
To a solution of 3^-acetoxycholest-5-ene (8 g) in carbon tetrachloride (150 
ml), acetic acid (30 ml) and acetic anhydride (10 ml) was added at 0°C a solution of 
tert-huty\ chromate [from /er/-butyl alcohol (60 ml), chromium trioxide (20 g), acetic 
acid (84 ml) and acetic anhydride (10 ml)]. The reaction was heated under reflux for 4 
h and then it was diluted with cold water. The organic layer was taken in diethyl ether, 
washed with water, sodium bicarbonate solution (5 %) and again with water and dried 
over anhyd. sodium sulphate. Evaporation of the solvent under reduced pressure gave 
an oil which was crystallized from methanol to give the ketone 73 (3.5 g), m. p. 156 
"C (reported^^ m. p. 156-158 °C). 
3^-Acetoxvcholest-5-en-7-sptro-r4^a^^-oxa1-3^^-acetoxy-5Vcholestan-
7^-one 74: 
To a stirred solution of 3^-acetoxycholest-5-en-7-one 73 (1.13 mmol) in 
xylene (50 ml), 4-(dimethylamino)-pyridine (1.13 mmol) was added. The resulting 
solution was heated under reflux for 1 h, after completion of reaction (monitored by 
TLC), reaction mixture was cooled to room temperature and excess of solvent was 
distilled out under reduced pressure, the residue was taken in diethyl ether, washed 
with water, 5% NaHCOs solution and again with water. The organic layer was dried 
over anhyd. sodium, sulphate and evaporation of the solvent gave the crude product, 
which was purified by column chromatography over silica gel (mesh 100-200) 
column with hexane - diethyl ether (5:1) as eluant and recrystallized from methanol to 
give 3y?-acetoxycholest-5-en-7-5p/ro-[4'a,5'-oxa]-3'^ -acetoxy-5'a-cholestan-7'-one 74 
as solid m.p. 219-221 °C in 58 % yields. 
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Analysis found 
C58H92O6 requires 
m (neat) 
' H N M R (CDCI3) 
"C NMR (CDCI3) 
: C. 78.76; H, 11.50. 
: C, 78.68; H, 10.47. 
: v ^ 1714 (C=0), 1739, 1732 (OAc), 1621 (C=C), 
1063 cm-^  (C-C). 
: d 5.63 (s, IH, Ce-olefinic proton), 2.38 (s, 2H, Ce-
H2\ 4.63 (br m, IH, WA, 17.6 Hz, C^a-H, axial), 
4.46 (br m, IH, WA, 16.8 Hz, Cya-H), 2.51 (d, J = 
6.6 Hz, 2H, C4-//2), 3.12 (d, y = 5.9 Hz, 2H, CA-H), 
2.04 (s, 3H, OCOC//3 of C3), 2.01 (s, 3H, OCOC//3 
of C3), 1.18 (s, 3H, Cio-Ci/j), 0.70 (s, 3H, C13-C//3), 
1.16 (s, 3H, Cio-C^3), 0.74 (s, 3H, C13-C//3), 0.94, 
0.90, 0.83, 0.81 (other steroidal side-chain methyl 
protons). 
: 6 208.13 (C=0), 88.03 (C7), 82.35 (C3), 158.27 (C5), 
129.76 (Ce), 70.83 (C3-), 61.38 (C4), 96.08 (C5), 33.25 
(C), 33.86 (C2), 41.93 (C4). 39.04 (Cg), 35.32 (C9), 
35.98 (Cio), 21.54 (C„), 32.01 (Cn), 42.06 (Cu), 
49.21 (C14), 21.28 (C15), 21.86 (Cis), 38.83 (Cn), 
20.39 (C18), 20.81 (C19), 30.18 (C20), 19.63 (C21), 
35.99 (C22), 26.15 (C23), 41.55 (C24), 28.87 (C25), 
22.35 (C26), 22.80 (C27), 173.03 and 18.6 for carbonyl 
carbon and methyl carbon of acetate, 24.11 (Ci), 
26.81 (C2), 45.97 (Cg), 44.90 (Cy), 30.55 (C9), 43.82 
(CioO, 20.68 (Cr) , 31.95 (Cn-), 41.52 (Cn), 48.11 
(C14O, 21.16 (C15). 21.35 (Ci6-), 40.71 (C17), 19.58 
(CisO, 20.09 (C19O, 29.84 (Cjo-), 19.16 (C2r), 37.02 
(C22O, 24.13 (C23'). 39.61 (C24O, 23.45 (C25'X 22.21 
(C26'), 22.62 (C2T), 170.45 and 19.3 for carbonyl 
carbon and methyl carbon of acetate (C3'). 
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